HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
182149.0,283460,2128-01-28 07:34:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Rash/Respiratory failure and hemorrhage/renal failure.
   24 Hour Events:
 PICC LINE - START [**2128-1-27**] 08:05 AM
 BLOOD CULTURED - At [**2128-1-27**] 09:30 AM
   two sets, one from each port of picc
 INVASIVE VENTILATION - START [**2128-1-27**] 10:40 AM
 EKG - At [**2128-1-27**] 12:15 PM
 ARTERIAL LINE - START [**2128-1-27**] 12:30 PM
 DIALYSIS CATHETER - START [**2128-1-27**] 01:05 PM
 BRONCHOSCOPY - At [**2128-1-27**] 01:25 PM
 TRANSTHORACIC ECHO - At [**2128-1-27**] 02:30 PM
   - HCT 27 -> 25.7 -> 24.4 (1U) -> 26 (1U) -> 27.5 -> 28
   - EKG: VPaced
   - Received Vit K IV
   - Renal: HD Line Placed,
   - Rheum: 1. Would change steroids to solumedrol 1000 mg IV Daily for 3
   days 2. Stop allopurinol indefinitely. 3. Agree with transfusion
   medicine consult for possible plasmapheresis.  4. F/u with anti-GBM and
   ANCA. 5. Repeat echocardiogram (TEE) to evaluate for current cardiac
   status/function, vegetations and possible CHF.
   - Derm: Nothing
   - Intubated, Aline placed, Dialysis Catheter Placed.
   - Bronchoscopy: Diffuse Bleeding
   - ECHO:The left atrium is moderately dilated. Left ventricular wall
   thickness, cavity size and regional/global systolic function are normal
   (LVEF >55%). [Intrinsic left ventricular systolic function is likely
   more depressed given the severity of valvular regurgitation.] Right
   ventricular chamber size is normal. with borderline normal free wall
   function. There is abnormal septal motion/position consistent with
   right ventricular pressure/volume overload. A bileaflet aortic valve
   prosthesis is present. The transaortic gradient is normal for this
   prosthesis. No masses or vegetations are seen on the aortic valve, but
   cannot be fully excluded due to suboptimal image quality. Trace aortic
   regurgitation is seen. [The amount of regurgitation present is normal
   for this prosthetic aortic valve.] The mitral valve leaflets are
   moderately thickened. No masses or vegetations are seen on the mitral
   valve, but cannot be fully excluded due to suboptimal image quality. An
   eccentric, posteriorly directed jet of moderate (2+) mitral
   regurgitation is seen. No masses or vegetations are seen on the
   tricuspid valve, but cannot be fully excluded due to suboptimal image
   quality. Moderate [2+] tricuspid regurgitation is seen. There is
   moderate pulmonary artery systolic hypertension. There is no
   pericardial effusion. If clinically suggested, the absence of a
   vegetation by 2D echocardiography does not exclude endocarditis,
   especially on a bileaflet aortic valve. Compared with the prior study
   (images reviewed) of [**2128-1-8**], the severity of mitral and tricuspid
   regurgitation has increased. The right ventricular function may be
   slighlty less vigorous.
   - ID: Fine to change to Cefepime/Vancomycin. From Cefazolin.
   - Path: Nothing
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-27**] 09:40 AM
   Cefazolin - [**2128-1-27**] 10:00 AM
   Cefipime - [**2128-1-27**] 01:10 PM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 1 mEq./hour
   Midazolam (Versed) - 5 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-27**] 09:40 AM
   Midazolam (Versed) - [**2128-1-27**] 01:00 PM
   Fentanyl - [**2128-1-27**] 01:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-28**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 95/50(67) {78/42(56) - 140/70(94)} mmHg
   RR: 20 (18 - 30) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 88.1 kg (admission): 85 kg
   Height: 68 Inch
           Total In:
                                                                  3,243 mL
                                                                  2,401 mL
   PO:
           TF:
   IVF:
                                                                  2,298 mL
                                                                  2,051 mL
   Blood products:
                                                                    945 mL
                                                                    350 mL
   Total out:
                                                                  2,598 mL
                                                                  3,069 mL
   Urine:
                                                                  1,140 mL
                                                                    345 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    645 mL
                                                                   -668 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 550 (500 - 550) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 28 cmH2O
   Plateau: 21 cmH2O
   Compliance: 50 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/40/125/23/0
   Ve: 3.9 L/min
   PaO2 / FiO2: 313
   Physical Examination
   General: Alert, oriented, tachypneic, frequent mildly weak cough.
   HEENT: Sclera anicteric, PERRL, EOMIs, MM slightly dry, oropharynx with
   large amount of dried and bright red blood over posterior pharynx and
   palate.  Nasopharynx without any evidence of blood.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning, but not clearly elevated.
   Lungs: Bilateral expiratory rhonchi and very coarse crackles.
   Tachypneic.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: CN II-XII intact.  Strength 5/5 in distal UEs and LEs.
   Labs / Radiology
   288 K/uL
   9.3 g/dL
   164 mg/dL
   2.1 mg/dL
   23 mEq/L
   4.7 mEq/L
   61 mg/dL
   101 mEq/L
   138 mEq/L
   28.0 %
   6.0 K/uL
        [image002.jpg]
                             [**2128-1-27**]  11:51 AM
                             [**2128-1-27**]  01:11 PM
                             [**2128-1-27**]  03:27 PM
                             [**2128-1-27**]  03:51 PM
                             [**2128-1-27**]  08:15 PM
                             [**2128-1-28**]  12:00 AM
                             [**2128-1-28**]  12:20 AM
                             [**2128-1-28**]  03:28 AM
                             [**2128-1-28**]  06:00 AM
                             [**2128-1-28**]  06:06 AM
   WBC
   13.4
   9.9
   6.0
   Hct
   25.7
   24.4
   26.0
   27.5
   28.0
   Plt
   [**Telephone/Fax (3) 11372**]88
   Cr
   3.1
   2.6
   2.1
   TCO2
   24
   23
   23
   25
   Glucose
   155
   193
   203
   164
   Other labs: PT / PTT / INR:17.6/28.7/1.6, Fibrinogen:373 mg/dL, Lactic
   Acid:0.8 mmol/L, Ca++:8.4 mg/dL, Mg++:2.3 mg/dL, PO4:4.3 mg/dL
   Fluid analysis / Other labs: BAL - no PMNs or bacteria seen on Gram
   stain.
   Imaging: Only line placement CXR today.
   Microbiology: No growth yet. C. difficile negative.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic vasculitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic respiratory failure and hemoptysis.  Concerning for DAH
   given CXR findings as well.  Could also be pulmonary edema with
   hemorrhage due to anticoagulation, HAP with hemorrhage, development of
   ARDS with bleeding for other reasons or from other source.  DAH most
   concerning, particularly in light of prior ARF (?renal manifestations),
   vasculitic rash, elevated ESR.  [**Doctor First Name 1205**] negative, ANCA negative
   - Intubate now (larger tube preferred).
   - Bronchoscopy today; looking for progressive or continued blood with
   subsequent BALs.
   - Run recent medication exposures for possible culprits of DAH.
   - Initiate workup for and ?treatment for anti-GBM disease.  Send
   anti-GBM.  ?future renal biopsy.
   - Consult rheumatology and pathology/pheresis.
   - Will increase steroids to 125 mg Q6h, ?further increase if rec by
   rheum.
   - Will discuss cyclophosphamide with rheumatology.
   - ?pheresis today given concern for anti-GBM disease.  Will plan on
   line placement in anticipation of this and/or hemodialysis in near
   future.
   - Broad spectrum treatment for HAP and send sputum culture.  Will
   discuss with ID re: appropriate regimen (vanc plus beta lactam, ?still
   need to continue cefazolin).
   - Hold heparin, will not give protamine at this time.  WIll given
   vitamin K IV.
   #. Endocarditis: Based on Duke Criteria (1 Major, 3 minor).  High grade
   MSSA bacteremia. Per ID, antibiotics for planned 8 week course.
   Switched from Nafcillin/Rifampin to Vancomycin [**1-17**] due to AIN.  Now on
   Cefazolin since [**1-22**] instead of Vanc as better for MSSA with increased
   dosing [**1-25**].
   - Repeat blood cultures.
   - Will continue cefazolin for now, but given would like to treat for
   HAP, will discuss appropriate regimen.
   # Atrial fibrillation/complete heart block. History this admission of
   CHB (as well as torsades, thought due to FQs), now s/p screw-in
   pacemaker.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permament pacer.
   #. Acute on Chronic Renal Failure: Cr 1.5 on presentation; trending up
   now 3.4. Thought to be AIN due to Nafcillin.  Now unclear if this is
   truly manifestation of systemic vasculitis or anti-GBM disease.  Has
   had microscopic hematuria in recent past.
   - Resend urine.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - renally dose meds.
   - Change steroid to IV solumedrol.
   - diuresis likely when stabilized, vs. proceeding with HD.
   - ?future renal biopsy.
   # Anemia: Guaiac + stools this admission and have nuclear scan
   (negative).  Now with pulmonary hemorrhage likely.
   - recheck Hct Q8-Q12.
   - Consented for blood products.
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD.  s/p CABG and with DES x3 in one graft.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   # Leukoclastic vasculitis.  Thought due to Nafcillin or IE. Improving
   overall.  ?Could be related to systemic disease causing DAH.
   - will discuss with derm re: any relation to DAH.
   - steroids as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above.
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   #. Hypertension.
   - Holding antiHTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2B
   # Access: PICC
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Rash/Respiratory failure and hemorrhage/renal failure.
   24 Hour Events:
 PICC LINE - START [**2128-1-27**] 08:05 AM
 BLOOD CULTURED - At [**2128-1-27**] 09:30 AM
   two sets, one from each port of picc
 INVASIVE VENTILATION - START [**2128-1-27**] 10:40 AM
 EKG - At [**2128-1-27**] 12:15 PM
 ARTERIAL LINE - START [**2128-1-27**] 12:30 PM
 DIALYSIS CATHETER - START [**2128-1-27**] 01:05 PM
 BRONCHOSCOPY - At [**2128-1-27**] 01:25 PM
 TRANSTHORACIC ECHO - At [**2128-1-27**] 02:30 PM
   - HCT 27 -> 25.7 -> 24.4 (1U) -> 26 (1U) -> 27.5 -> 28
   - EKG: VPaced
   - Received Vit K IV
   - Renal: HD Line Placed,
   - Rheum: 1. Would change steroids to solumedrol 1000 mg IV Daily for 3
   days 2. Stop allopurinol indefinitely. 3. Agree with transfusion
   medicine consult for possible plasmapheresis.  4. F/u with anti-GBM and
   ANCA. 5. Repeat echocardiogram (TEE) to evaluate for current cardiac
   status/function, vegetations and possible CHF.
   - Derm: Nothing
   - Intubated, Aline placed, Dialysis Catheter Placed.
   - Bronchoscopy: Diffuse Bleeding
   - ECHO:The left atrium is moderately dilated. Left ventricular wall
   thickness, cavity size and regional/global systolic function are normal
   (LVEF >55%). [Intrinsic left ventricular systolic function is likely
   more depressed given the severity of valvular regurgitation.] Right
   ventricular chamber size is normal. with borderline normal free wall
   function. There is abnormal septal motion/position consistent with
   right ventricular pressure/volume overload. A bileaflet aortic valve
   prosthesis is present. The transaortic gradient is normal for this
   prosthesis. No masses or vegetations are seen on the aortic valve, but
   cannot be fully excluded due to suboptimal image quality. Trace aortic
   regurgitation is seen. [The amount of regurgitation present is normal
   for this prosthetic aortic valve.] The mitral valve leaflets are
   moderately thickened. No masses or vegetations are seen on the mitral
   valve, but cannot be fully excluded due to suboptimal image quality. An
   eccentric, posteriorly directed jet of moderate (2+) mitral
   regurgitation is seen. No masses or vegetations are seen on the
   tricuspid valve, but cannot be fully excluded due to suboptimal image
   quality. Moderate [2+] tricuspid regurgitation is seen. There is
   moderate pulmonary artery systolic hypertension. There is no
   pericardial effusion. If clinically suggested, the absence of a
   vegetation by 2D echocardiography does not exclude endocarditis,
   especially on a bileaflet aortic valve. Compared with the prior study
   (images reviewed) of [**2128-1-8**], the severity of mitral and tricuspid
   regurgitation has increased. The right ventricular function may be
   slighlty less vigorous.
   - ID: Fine to change to Cefepime/Vancomycin. From Cefazolin.
   - Path: Nothing
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-27**] 09:40 AM
   Cefazolin - [**2128-1-27**] 10:00 AM
   Cefipime - [**2128-1-27**] 01:10 PM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 1 mEq./hour
   Midazolam (Versed) - 5 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-27**] 09:40 AM
   Midazolam (Versed) - [**2128-1-27**] 01:00 PM
   Fentanyl - [**2128-1-27**] 01:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-28**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 95/50(67) {78/42(56) - 140/70(94)} mmHg
   RR: 20 (18 - 30) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 88.1 kg (admission): 85 kg
   Height: 68 Inch
           Total In:
                                                                  3,243 mL
                                                                  2,401 mL
   PO:
           TF:
   IVF:
                                                                  2,298 mL
                                                                  2,051 mL
   Blood products:
                                                                    945 mL
                                                                    350 mL
   Total out:
                                                                  2,598 mL
                                                                  3,069 mL
   Urine:
                                                                  1,140 mL
                                                                    345 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    645 mL
                                                                   -668 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 550 (500 - 550) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 28 cmH2O
   Plateau: 21 cmH2O
   Compliance: 50 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/40/125/23/0
   Ve: 3.9 L/min
   PaO2 / FiO2: 313
   Physical Examination
   General: Alert, oriented, tachypneic, frequent mildly weak cough.
   HEENT: Sclera anicteric, PERRL, EOMIs, MM slightly dry, oropharynx with
   large amount of dried and bright red blood over posterior pharynx and
   palate.  Nasopharynx without any evidence of blood.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning, but not clearly elevated.
   Lungs: Bilateral expiratory rhonchi and very coarse crackles.
   Tachypneic.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: CN II-XII intact.  Strength 5/5 in distal UEs and LEs.
   Labs / Radiology
   288 K/uL
   9.3 g/dL
   164 mg/dL
   2.1 mg/dL
   23 mEq/L
   4.7 mEq/L
   61 mg/dL
   101 mEq/L
   138 mEq/L
   28.0 %
   6.0 K/uL
        [image002.jpg]
                             [**2128-1-27**]  11:51 AM
                             [**2128-1-27**]  01:11 PM
                             [**2128-1-27**]  03:27 PM
                             [**2128-1-27**]  03:51 PM
                             [**2128-1-27**]  08:15 PM
                             [**2128-1-28**]  12:00 AM
                             [**2128-1-28**]  12:20 AM
                             [**2128-1-28**]  03:28 AM
                             [**2128-1-28**]  06:00 AM
                             [**2128-1-28**]  06:06 AM
   WBC
   13.4
   9.9
   6.0
   Hct
   25.7
   24.4
   26.0
   27.5
   28.0
   Plt
   [**Telephone/Fax (3) 11372**]88
   Cr
   3.1
   2.6
   2.1
   TCO2
   24
   23
   23
   25
   Glucose
   155
   193
   203
   164
   Other labs: PT / PTT / INR:17.6/28.7/1.6, Fibrinogen:373 mg/dL, Lactic
   Acid:0.8 mmol/L, Ca++:8.4 mg/dL, Mg++:2.3 mg/dL, PO4:4.3 mg/dL
   Fluid analysis / Other labs: BAL - no PMNs or bacteria seen on Gram
   stain.
   Imaging: Only line placement CXR today.
   Microbiology: No growth yet. C. difficile negative.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic vasculitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic respiratory failure and hemoptysis.  Concerning for DAH
   given CXR findings as well.  Could also be pulmonary edema with
   hemorrhage due to anticoagulation, HAP with hemorrhage, development of
   ARDS with bleeding for other reasons or from other source.  DAH most
   concerning, particularly in light of prior ARF (?renal manifestations),
   vasculitic rash, elevated ESR.  [**Doctor First Name 1205**] negative, ANCA negative
   - Intubate now (larger tube preferred).
   - Bronchoscopy today; looking for progressive or continued blood with
   subsequent BALs.
   - Run recent medication exposures for possible culprits of DAH.
   - Initiate workup for and ?treatment for anti-GBM disease.  Send
   anti-GBM.  ?future renal biopsy.
   - Consult rheumatology and pathology/pheresis.
   - Will increase steroids to 125 mg Q6h, ?further increase if rec by
   rheum.
   - Will discuss cyclophosphamide with rheumatology.
   - ?pheresis today given concern for anti-GBM disease.  Will plan on
   line placement in anticipation of this and/or hemodialysis in near
   future.
   - Broad spectrum treatment for HAP and send sputum culture.  Will
   discuss with ID re: appropriate regimen (vanc plus beta lactam, ?still
   need to continue cefazolin).
   - Hold heparin, will not give protamine at this time.  WIll given
   vitamin K IV.
   #. Endocarditis: Based on Duke Criteria (1 Major, 3 minor).  High grade
   MSSA bacteremia. Per ID, antibiotics for planned 8 week course.
   Switched from Nafcillin/Rifampin to Vancomycin [**1-17**] due to AIN.  Now on
   Cefazolin since [**1-22**] instead of Vanc as better for MSSA with increased
   dosing [**1-25**].
   - Repeat blood cultures.
   - Will continue cefazolin for now, but given would like to treat for
   HAP, will discuss appropriate regimen.
   # Atrial fibrillation/complete heart block. History this admission of
   CHB (as well as torsades, thought due to FQs), now s/p screw-in
   pacemaker.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permament pacer.
   #. Acute on Chronic Renal Failure: Cr 1.5 on presentation; trending up
   now 3.4. Thought to be AIN due to Nafcillin.  Now unclear if this is
   truly manifestation of systemic vasculitis or anti-GBM disease.  Has
   had microscopic hematuria in recent past.
   - Resend urine.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - renally dose meds.
   - Change steroid to IV solumedrol.
   - diuresis likely when stabilized, vs. proceeding with HD.
   - ?future renal biopsy.
   # Anemia: Guaiac + stools this admission and have nuclear scan
   (negative).  Now with pulmonary hemorrhage likely.
   - recheck Hct Q8-Q12.
   - Consented for blood products.
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD.  s/p CABG and with DES x3 in one graft.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   # Leukoclastic vasculitis.  Thought due to Nafcillin or IE. Improving
   overall.  ?Could be related to systemic disease causing DAH.
   - will discuss with derm re: any relation to DAH.
   - steroids as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above.
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   #. Hypertension.
   - Holding antiHTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2B
   # Access: PICC
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of coronary artery disease, prior mechanical aortic valve replacement, and atrial fibrillation, who is currently hospitalized for methicillin-sensitive Staphylococcus aureus (MSSA) endocarditis with complications of acute renal failure (ARF), acute interstitial nephritis (AIN), and leukocytoclastic vasculitis. The patient has been intubated due to hypoxemic respiratory failure and hemoptysis, and is suspected to have diffuse alveolar hemorrhage (DAH). The patient's condition is complex and multifaceted, with several potential medical complications arising from his underlying conditions and treatment.

Potential Medical Complications:

1. Diffuse Alveolar Hemorrhage (DAH): The patient's hypoxemic respiratory failure and hemoptysis are concerning for DAH, which could be caused by various factors, including anticoagulation, hemorrhagic pneumonia, or vasculitis.
2. Acute Renal Failure (ARF): The patient's renal function is deteriorating, and he may require hemodialysis or peritoneal dialysis in the near future.
3. Atrial Fibrillation/Complete Heart Block: The patient has a history of atrial fibrillation and complete heart block, which may require further management and treatment.
4. Endocarditis: The patient has MSSA endocarditis, which may require a prolonged course of antibiotics and careful monitoring for complications.
5. Leukocytoclastic Vasculitis: The patient has leukocytoclastic vasculitis, which may be related to his underlying systemic disease or medication exposure.
6. Pulmonary Edema: The patient's respiratory failure and hemoptysis may be due to pulmonary edema, which could be caused by various factors, including anticoagulation, cardiac failure, or vasculitis.
7. Hemorrhagic Pneumonia: The patient's hemoptysis may be due to hemorrhagic pneumonia, which could be caused by various factors, including bacterial or fungal infection.
8. Anti-GBM Disease: The patient's renal failure and vasculitis may be related to anti-GBM disease, which could require further evaluation and treatment.

Recommendations:

1. Continue to monitor the patient's respiratory status and hemodynamic stability closely.
2. Consider further imaging studies, such as a computed tomography (CT) scan or magnetic resonance imaging (MRI), to evaluate for DAH or other pulmonary complications.
3. Consult with cardiology and infectious disease specialists to further evaluate and manage the patient's endocarditis and respiratory failure.
4. Consider plasmapheresis or other immunosuppressive therapies to treat the patient's vasculitis and potential anti-GBM disease.
5. Monitor the patient's renal function closely and consider hemodialysis or peritoneal dialysis if necessary.
6. Continue to manage the patient's atrial fibrillation and complete heart block with anticoagulation and other therapies as necessary."
182149.0,283460,2128-01-28 07:34:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Rash/Respiratory failure and hemorrhage/renal failure.
   24 Hour Events:
 PICC LINE - START [**2128-1-27**] 08:05 AM
 BLOOD CULTURED - At [**2128-1-27**] 09:30 AM
   two sets, one from each port of picc
 INVASIVE VENTILATION - START [**2128-1-27**] 10:40 AM
 EKG - At [**2128-1-27**] 12:15 PM
 ARTERIAL LINE - START [**2128-1-27**] 12:30 PM
 DIALYSIS CATHETER - START [**2128-1-27**] 01:05 PM
 BRONCHOSCOPY - At [**2128-1-27**] 01:25 PM
 TRANSTHORACIC ECHO - At [**2128-1-27**] 02:30 PM
   - HCT 27 -> 25.7 -> 24.4 (1U) -> 26 (1U) -> 27.5 -> 28
   - EKG: VPaced
   - Received Vit K IV
   - Renal: HD Line Placed,
   - Rheum: 1. Would change steroids to solumedrol 1000 mg IV Daily for 3
   days 2. Stop allopurinol indefinitely. 3. Agree with transfusion
   medicine consult for possible plasmapheresis.  4. F/u with anti-GBM and
   ANCA. 5. Repeat echocardiogram (TEE) to evaluate for current cardiac
   status/function, vegetations and possible CHF.
   - Derm: Nothing
   - Intubated, Aline placed, Dialysis Catheter Placed.
   - Bronchoscopy: Diffuse Bleeding
   - ECHO:The left atrium is moderately dilated. Left ventricular wall
   thickness, cavity size and regional/global systolic function are normal
   (LVEF >55%). [Intrinsic left ventricular systolic function is likely
   more depressed given the severity of valvular regurgitation.] Right
   ventricular chamber size is normal. with borderline normal free wall
   function. There is abnormal septal motion/position consistent with
   right ventricular pressure/volume overload. A bileaflet aortic valve
   prosthesis is present. The transaortic gradient is normal for this
   prosthesis. No masses or vegetations are seen on the aortic valve, but
   cannot be fully excluded due to suboptimal image quality. Trace aortic
   regurgitation is seen. [The amount of regurgitation present is normal
   for this prosthetic aortic valve.] The mitral valve leaflets are
   moderately thickened. No masses or vegetations are seen on the mitral
   valve, but cannot be fully excluded due to suboptimal image quality. An
   eccentric, posteriorly directed jet of moderate (2+) mitral
   regurgitation is seen. No masses or vegetations are seen on the
   tricuspid valve, but cannot be fully excluded due to suboptimal image
   quality. Moderate [2+] tricuspid regurgitation is seen. There is
   moderate pulmonary artery systolic hypertension. There is no
   pericardial effusion. If clinically suggested, the absence of a
   vegetation by 2D echocardiography does not exclude endocarditis,
   especially on a bileaflet aortic valve. Compared with the prior study
   (images reviewed) of [**2128-1-8**], the severity of mitral and tricuspid
   regurgitation has increased. The right ventricular function may be
   slighlty less vigorous.
   - ID: Fine to change to Cefepime/Vancomycin. From Cefazolin.
   - Path: Nothing
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-27**] 09:40 AM
   Cefazolin - [**2128-1-27**] 10:00 AM
   Cefipime - [**2128-1-27**] 01:10 PM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 1 mEq./hour
   Midazolam (Versed) - 5 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-27**] 09:40 AM
   Midazolam (Versed) - [**2128-1-27**] 01:00 PM
   Fentanyl - [**2128-1-27**] 01:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-28**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 95/50(67) {78/42(56) - 140/70(94)} mmHg
   RR: 20 (18 - 30) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 88.1 kg (admission): 85 kg
   Height: 68 Inch
           Total In:
                                                                  3,243 mL
                                                                  2,401 mL
   PO:
           TF:
   IVF:
                                                                  2,298 mL
                                                                  2,051 mL
   Blood products:
                                                                    945 mL
                                                                    350 mL
   Total out:
                                                                  2,598 mL
                                                                  3,069 mL
   Urine:
                                                                  1,140 mL
                                                                    345 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    645 mL
                                                                   -668 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 550 (500 - 550) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 28 cmH2O
   Plateau: 21 cmH2O
   Compliance: 50 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/40/125/23/0
   Ve: 3.9 L/min
   PaO2 / FiO2: 313
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   288 K/uL
   9.3 g/dL
   164 mg/dL
   2.1 mg/dL
   23 mEq/L
   4.7 mEq/L
   61 mg/dL
   101 mEq/L
   138 mEq/L
   28.0 %
   6.0 K/uL
        [image002.jpg]
                             [**2128-1-27**]  11:51 AM
                             [**2128-1-27**]  01:11 PM
                             [**2128-1-27**]  03:27 PM
                             [**2128-1-27**]  03:51 PM
                             [**2128-1-27**]  08:15 PM
                             [**2128-1-28**]  12:00 AM
                             [**2128-1-28**]  12:20 AM
                             [**2128-1-28**]  03:28 AM
                             [**2128-1-28**]  06:00 AM
                             [**2128-1-28**]  06:06 AM
   WBC
   13.4
   9.9
   6.0
   Hct
   25.7
   24.4
   26.0
   27.5
   28.0
   Plt
   [**Telephone/Fax (3) 11372**]88
   Cr
   3.1
   2.6
   2.1
   TCO2
   24
   23
   23
   25
   Glucose
   155
   193
   203
   164
   Other labs: PT / PTT / INR:17.6/28.7/1.6, Fibrinogen:373 mg/dL, Lactic
   Acid:0.8 mmol/L, Ca++:8.4 mg/dL, Mg++:2.3 mg/dL, PO4:4.3 mg/dL
   Fluid analysis / Other labs: BAL - no PMNs or bacteria seen on Gram
   stain.
   Imaging: Only line placement CXR today.
   Microbiology: No growth yet. C. difficile negative.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic vasculitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic respiratory failure and hemoptysis.  Concerning for DAH
   given CXR findings as well.  Could also be pulmonary edema with
   hemorrhage due to anticoagulation, HAP with hemorrhage, development of
   ARDS with bleeding for other reasons or from other source.  DAH most
   concerning, particularly in light of prior ARF (?renal manifestations),
   vasculitic rash, elevated ESR.  [**Doctor First Name 1205**] negative, ANCA negative
   - Intubate now (larger tube preferred).
   - Bronchoscopy today; looking for progressive or continued blood with
   subsequent BALs.
   - Run recent medication exposures for possible culprits of DAH.
   - Initiate workup for and ?treatment for anti-GBM disease.  Send
   anti-GBM.  ?future renal biopsy.
   - Consult rheumatology and pathology/pheresis.
   - Will increase steroids to 125 mg Q6h, ?further increase if rec by
   rheum.
   - Will discuss cyclophosphamide with rheumatology.
   - ?pheresis today given concern for anti-GBM disease.  Will plan on
   line placement in anticipation of this and/or hemodialysis in near
   future.
   - Broad spectrum treatment for HAP and send sputum culture.  Will
   discuss with ID re: appropriate regimen (vanc plus beta lactam, ?still
   need to continue cefazolin).
   - Hold heparin, will not give protamine at this time.  WIll given
   vitamin K IV.
   #. Endocarditis: Based on Duke Criteria (1 Major, 3 minor).  High grade
   MSSA bacteremia. Per ID, antibiotics for planned 8 week course.
   Switched from Nafcillin/Rifampin to Vancomycin [**1-17**] due to AIN.  Now on
   Cefazolin since [**1-22**] instead of Vanc as better for MSSA with increased
   dosing [**1-25**].
   - Repeat blood cultures.
   - Will continue cefazolin for now, but given would like to treat for
   HAP, will discuss appropriate regimen.
   # Atrial fibrillation/complete heart block. History this admission of
   CHB (as well as torsades, thought due to FQs), now s/p screw-in
   pacemaker.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permament pacer.
   #. Acute on Chronic Renal Failure: Cr 1.5 on presentation; trending up
   now 3.4. Thought to be AIN due to Nafcillin.  Now unclear if this is
   truly manifestation of systemic vasculitis or anti-GBM disease.  Has
   had microscopic hematuria in recent past.
   - Resend urine.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - renally dose meds.
   - Change steroid to IV solumedrol.
   - diuresis likely when stabilized, vs. proceeding with HD.
   - ?future renal biopsy.
   # Anemia: Guaiac + stools this admission and have nuclear scan
   (negative).  Now with pulmonary hemorrhage likely.
   - recheck Hct Q8-Q12.
   - Consented for blood products.
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD.  s/p CABG and with DES x3 in one graft.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   # Leukoclastic vasculitis.  Thought due to Nafcillin or IE. Improving
   overall.  ?Could be related to systemic disease causing DAH.
   - will discuss with derm re: any relation to DAH.
   - steroids as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above.
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   #. Hypertension.
   - Holding antiHTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2B
   # Access: PICC
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Rash/Respiratory failure and hemorrhage/renal failure.
   24 Hour Events:
 PICC LINE - START [**2128-1-27**] 08:05 AM
 BLOOD CULTURED - At [**2128-1-27**] 09:30 AM
   two sets, one from each port of picc
 INVASIVE VENTILATION - START [**2128-1-27**] 10:40 AM
 EKG - At [**2128-1-27**] 12:15 PM
 ARTERIAL LINE - START [**2128-1-27**] 12:30 PM
 DIALYSIS CATHETER - START [**2128-1-27**] 01:05 PM
 BRONCHOSCOPY - At [**2128-1-27**] 01:25 PM
 TRANSTHORACIC ECHO - At [**2128-1-27**] 02:30 PM
   - HCT 27 -> 25.7 -> 24.4 (1U) -> 26 (1U) -> 27.5 -> 28
   - EKG: VPaced
   - Received Vit K IV
   - Renal: HD Line Placed,
   - Rheum: 1. Would change steroids to solumedrol 1000 mg IV Daily for 3
   days 2. Stop allopurinol indefinitely. 3. Agree with transfusion
   medicine consult for possible plasmapheresis.  4. F/u with anti-GBM and
   ANCA. 5. Repeat echocardiogram (TEE) to evaluate for current cardiac
   status/function, vegetations and possible CHF.
   - Derm: Nothing
   - Intubated, Aline placed, Dialysis Catheter Placed.
   - Bronchoscopy: Diffuse Bleeding
   - ECHO:The left atrium is moderately dilated. Left ventricular wall
   thickness, cavity size and regional/global systolic function are normal
   (LVEF >55%). [Intrinsic left ventricular systolic function is likely
   more depressed given the severity of valvular regurgitation.] Right
   ventricular chamber size is normal. with borderline normal free wall
   function. There is abnormal septal motion/position consistent with
   right ventricular pressure/volume overload. A bileaflet aortic valve
   prosthesis is present. The transaortic gradient is normal for this
   prosthesis. No masses or vegetations are seen on the aortic valve, but
   cannot be fully excluded due to suboptimal image quality. Trace aortic
   regurgitation is seen. [The amount of regurgitation present is normal
   for this prosthetic aortic valve.] The mitral valve leaflets are
   moderately thickened. No masses or vegetations are seen on the mitral
   valve, but cannot be fully excluded due to suboptimal image quality. An
   eccentric, posteriorly directed jet of moderate (2+) mitral
   regurgitation is seen. No masses or vegetations are seen on the
   tricuspid valve, but cannot be fully excluded due to suboptimal image
   quality. Moderate [2+] tricuspid regurgitation is seen. There is
   moderate pulmonary artery systolic hypertension. There is no
   pericardial effusion. If clinically suggested, the absence of a
   vegetation by 2D echocardiography does not exclude endocarditis,
   especially on a bileaflet aortic valve. Compared with the prior study
   (images reviewed) of [**2128-1-8**], the severity of mitral and tricuspid
   regurgitation has increased. The right ventricular function may be
   slighlty less vigorous.
   - ID: Fine to change to Cefepime/Vancomycin. From Cefazolin.
   - Path: Nothing
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-27**] 09:40 AM
   Cefazolin - [**2128-1-27**] 10:00 AM
   Cefipime - [**2128-1-27**] 01:10 PM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 1 mEq./hour
   Midazolam (Versed) - 5 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-27**] 09:40 AM
   Midazolam (Versed) - [**2128-1-27**] 01:00 PM
   Fentanyl - [**2128-1-27**] 01:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-28**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 95/50(67) {78/42(56) - 140/70(94)} mmHg
   RR: 20 (18 - 30) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 88.1 kg (admission): 85 kg
   Height: 68 Inch
           Total In:
                                                                  3,243 mL
                                                                  2,401 mL
   PO:
           TF:
   IVF:
                                                                  2,298 mL
                                                                  2,051 mL
   Blood products:
                                                                    945 mL
                                                                    350 mL
   Total out:
                                                                  2,598 mL
                                                                  3,069 mL
   Urine:
                                                                  1,140 mL
                                                                    345 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    645 mL
                                                                   -668 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 550 (500 - 550) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 28 cmH2O
   Plateau: 21 cmH2O
   Compliance: 50 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/40/125/23/0
   Ve: 3.9 L/min
   PaO2 / FiO2: 313
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   288 K/uL
   9.3 g/dL
   164 mg/dL
   2.1 mg/dL
   23 mEq/L
   4.7 mEq/L
   61 mg/dL
   101 mEq/L
   138 mEq/L
   28.0 %
   6.0 K/uL
        [image002.jpg]
                             [**2128-1-27**]  11:51 AM
                             [**2128-1-27**]  01:11 PM
                             [**2128-1-27**]  03:27 PM
                             [**2128-1-27**]  03:51 PM
                             [**2128-1-27**]  08:15 PM
                             [**2128-1-28**]  12:00 AM
                             [**2128-1-28**]  12:20 AM
                             [**2128-1-28**]  03:28 AM
                             [**2128-1-28**]  06:00 AM
                             [**2128-1-28**]  06:06 AM
   WBC
   13.4
   9.9
   6.0
   Hct
   25.7
   24.4
   26.0
   27.5
   28.0
   Plt
   [**Telephone/Fax (3) 11372**]88
   Cr
   3.1
   2.6
   2.1
   TCO2
   24
   23
   23
   25
   Glucose
   155
   193
   203
   164
   Other labs: PT / PTT / INR:17.6/28.7/1.6, Fibrinogen:373 mg/dL, Lactic
   Acid:0.8 mmol/L, Ca++:8.4 mg/dL, Mg++:2.3 mg/dL, PO4:4.3 mg/dL
   Fluid analysis / Other labs: BAL - no PMNs or bacteria seen on Gram
   stain.
   Imaging: Only line placement CXR today.
   Microbiology: No growth yet. C. difficile negative.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic vasculitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic respiratory failure and hemoptysis.  Concerning for DAH
   given CXR findings as well.  Could also be pulmonary edema with
   hemorrhage due to anticoagulation, HAP with hemorrhage, development of
   ARDS with bleeding for other reasons or from other source.  DAH most
   concerning, particularly in light of prior ARF (?renal manifestations),
   vasculitic rash, elevated ESR.  [**Doctor First Name 1205**] negative, ANCA negative
   - Intubate now (larger tube preferred).
   - Bronchoscopy today; looking for progressive or continued blood with
   subsequent BALs.
   - Run recent medication exposures for possible culprits of DAH.
   - Initiate workup for and ?treatment for anti-GBM disease.  Send
   anti-GBM.  ?future renal biopsy.
   - Consult rheumatology and pathology/pheresis.
   - Will increase steroids to 125 mg Q6h, ?further increase if rec by
   rheum.
   - Will discuss cyclophosphamide with rheumatology.
   - ?pheresis today given concern for anti-GBM disease.  Will plan on
   line placement in anticipation of this and/or hemodialysis in near
   future.
   - Broad spectrum treatment for HAP and send sputum culture.  Will
   discuss with ID re: appropriate regimen (vanc plus beta lactam, ?still
   need to continue cefazolin).
   - Hold heparin, will not give protamine at this time.  WIll given
   vitamin K IV.
   #. Endocarditis: Based on Duke Criteria (1 Major, 3 minor).  High grade
   MSSA bacteremia. Per ID, antibiotics for planned 8 week course.
   Switched from Nafcillin/Rifampin to Vancomycin [**1-17**] due to AIN.  Now on
   Cefazolin since [**1-22**] instead of Vanc as better for MSSA with increased
   dosing [**1-25**].
   - Repeat blood cultures.
   - Will continue cefazolin for now, but given would like to treat for
   HAP, will discuss appropriate regimen.
   # Atrial fibrillation/complete heart block. History this admission of
   CHB (as well as torsades, thought due to FQs), now s/p screw-in
   pacemaker.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permament pacer.
   #. Acute on Chronic Renal Failure: Cr 1.5 on presentation; trending up
   now 3.4. Thought to be AIN due to Nafcillin.  Now unclear if this is
   truly manifestation of systemic vasculitis or anti-GBM disease.  Has
   had microscopic hematuria in recent past.
   - Resend urine.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - renally dose meds.
   - Change steroid to IV solumedrol.
   - diuresis likely when stabilized, vs. proceeding with HD.
   - ?future renal biopsy.
   # Anemia: Guaiac + stools this admission and have nuclear scan
   (negative).  Now with pulmonary hemorrhage likely.
   - recheck Hct Q8-Q12.
   - Consented for blood products.
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD.  s/p CABG and with DES x3 in one graft.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   # Leukoclastic vasculitis.  Thought due to Nafcillin or IE. Improving
   overall.  ?Could be related to systemic disease causing DAH.
   - will discuss with derm re: any relation to DAH.
   - steroids as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above.
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   #. Hypertension.
   - Holding antiHTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2B
   # Access: PICC
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 76-year-old male with a complex medical history, including coronary artery disease, mechanical aortic valve replacement, atrial fibrillation, and chronic renal failure. The patient was admitted to the hospital with suspected methicillin-sensitive Staphylococcus aureus (MSSA) endocarditis, acute kidney injury (AKI), and hemoptysis.

The patient's current condition is critical, with hypoxemic respiratory failure, hemoptysis, and acute on chronic renal failure. The patient is intubated and receiving mechanical ventilation. The patient's hemodynamic status is unstable, with a blood pressure of 95/50 mmHg and a heart rate of 75 beats per minute.

The patient's laboratory results are concerning, with a creatinine level of 3.4 mg/dL, a blood urea nitrogen (BUN) level of 28 mg/dL, and a lactate dehydrogenase (LDH) level of 61 mg/dL. The patient's white blood cell count is 13.4 x 10^9/L, and his platelet count is 88 x 10^9/L.

The patient's medical history is significant for atrial fibrillation, complete heart block, and torsades de pointes, which are likely related to his mechanical aortic valve replacement. The patient's current medications include warfarin, aspirin, and clopidogrel.

The patient's potential medical complications include:

1. Pulmonary hemorrhage: The patient's hemoptysis and hypoxemic respiratory failure suggest a high risk of pulmonary hemorrhage.
2. Acute respiratory distress syndrome (ARDS): The patient's hypoxemic respiratory failure and bilateral lung infiltrates on chest radiograph suggest a high risk of ARDS.
3. Septic shock: The patient's hypotension and tachycardia suggest a high risk of septic shock.
4. Cardiac tamponade: The patient's mechanical aortic valve replacement and atrial fibrillation suggest a high risk of cardiac tamponade.
5. Renal failure: The patient's acute on chronic renal failure and electrolyte imbalance suggest a high risk of worsening renal failure.
6. Bleeding complications: The patient's coagulopathy and platelet count of 88 x 10^9/L suggest a high risk of bleeding complications.

Based on the patient's condition, I recommend the following:

1. Continue mechanical ventilation and hemodynamic support.
2. Initiate antibiotics for suspected MSSA endocarditis.
3. Monitor the patient's blood pressure and heart rate closely, and consider vasopressors if necessary.
4. Monitor the patient's renal function and electrolyte levels closely, and consider dialysis if necessary.
5. Monitor the patient's coagulation status and platelet count closely, and consider transfusions if necessary.
6. Consider consulting with a cardiologist to evaluate the patient's cardiac status and potential complications.
7. Consider consulting with a nephrologist to evaluate the patient's renal function and potential complications.
8. Consider consulting with an intensivist to evaluate the patient's critical care needs.

In summary, the patient is a critically ill individual with a complex medical history and multiple potential complications. Close monitoring and management are necessary to prevent and treat these complications."
182149.0,283460,2128-01-28 07:34:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Rash/Respiratory failure and hemorrhage/renal failure.
   24 Hour Events:
 PICC LINE - START [**2128-1-27**] 08:05 AM
 BLOOD CULTURED - At [**2128-1-27**] 09:30 AM
   two sets, one from each port of picc
 INVASIVE VENTILATION - START [**2128-1-27**] 10:40 AM
 EKG - At [**2128-1-27**] 12:15 PM
 ARTERIAL LINE - START [**2128-1-27**] 12:30 PM
 DIALYSIS CATHETER - START [**2128-1-27**] 01:05 PM
 BRONCHOSCOPY - At [**2128-1-27**] 01:25 PM
 TRANSTHORACIC ECHO - At [**2128-1-27**] 02:30 PM
   - HCT 27 -> 25.7 -> 24.4 (1U) -> 26 (1U) -> 27.5 -> 28
   - EKG: VPaced
   - Received Vit K IV
   - Renal: HD Line Placed, receiving CVVH now.
   - Rheum: 1. Would change steroids to solumedrol 1000 mg IV Daily for 3
   days 2. Stop allopurinol indefinitely. 3. Agree with transfusion
   medicine consult for possible plasmapheresis.  4. F/u with anti-GBM and
   ANCA. 5. Repeat echocardiogram (TEE) to evaluate for current cardiac
   status/function, vegetations and possible CHF. They would like to start
   Cytoxan if ID (given bacteremia) and Renal (i.e. If they agree with
   diagnosis) on board. Also recommend plasmaphoresis before Cytoxan.
   - Derm: Nothing
   - Intubated, Aline placed, Dialysis Catheter Placed.
   - Bronchoscopy: Diffuse Bleeding
   - ECHO:The left atrium is moderately dilated. Left ventricular wall
   thickness, cavity size and regional/global systolic function are normal
   (LVEF >55%). [Intrinsic left ventricular systolic function is likely
   more depressed given the severity of valvular regurgitation.] Right
   ventricular chamber size is normal. with borderline normal free wall
   function. There is abnormal septal motion/position consistent with
   right ventricular pressure/volume overload. A bileaflet aortic valve
   prosthesis is present. The transaortic gradient is normal for this
   prosthesis. No masses or vegetations are seen on the aortic valve, but
   cannot be fully excluded due to suboptimal image quality. Trace aortic
   regurgitation is seen. [The amount of regurgitation present is normal
   for this prosthetic aortic valve.] The mitral valve leaflets are
   moderately thickened. No masses or vegetations are seen on the mitral
   valve, but cannot be fully excluded due to suboptimal image quality. An
   eccentric, posteriorly directed jet of moderate (2+) mitral
   regurgitation is seen. No masses or vegetations are seen on the
   tricuspid valve, but cannot be fully excluded due to suboptimal image
   quality. Moderate [2+] tricuspid regurgitation is seen. There is
   moderate pulmonary artery systolic hypertension. There is no
   pericardial effusion. If clinically suggested, the absence of a
   vegetation by 2D echocardiography does not exclude endocarditis,
   especially on a bileaflet aortic valve. Compared with the prior study
   (images reviewed) of [**2128-1-8**], the severity of mitral and tricuspid
   regurgitation has increased. The right ventricular function may be
   slighlty less vigorous.
   - ID: Fine to change to Cefepime/Vancomycin. From Cefazolin.
   - Path: Nothing
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-27**] 09:40 AM
   Cefazolin - [**2128-1-27**] 10:00 AM
   Cefipime - [**2128-1-27**] 01:10 PM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 1 mEq./hour
   Midazolam (Versed) - 5 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-27**] 09:40 AM
   Midazolam (Versed) - [**2128-1-27**] 01:00 PM
   Fentanyl - [**2128-1-27**] 01:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-28**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 95/50(67) {78/42(56) - 140/70(94)} mmHg
   RR: 20 (18 - 30) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 88.1 kg (admission): 85 kg
   Height: 68 Inch
           Total In:
                                                                  3,243 mL
                                                                  2,401 mL
   PO:
           TF:
   IVF:
                                                                  2,298 mL
                                                                  2,051 mL
   Blood products:
                                                                    945 mL
                                                                    350 mL
   Total out:
                                                                  2,598 mL
                                                                  3,069 mL
   Urine:
                                                                  1,140 mL
                                                                    345 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    645 mL
                                                                   -668 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 550 (500 - 550) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 28 cmH2O
   Plateau: 21 cmH2O
   Compliance: 50 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/40/125/23/0 (6 a.m.)
   Ve: 3.9 L/min
   PaO2 / FiO2: 313
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   then later some desynchrony.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Labs / Radiology
   288 K/uL
   9.3 g/dL
   164 mg/dL
   2.1 mg/dL
   23 mEq/L
   4.7 mEq/L
   61 mg/dL
   101 mEq/L
   138 mEq/L
   28.0 %
   6.0 K/uL
        [image002.jpg] Free Ca 1.05.
                             [**2128-1-27**]  11:51 AM
                             [**2128-1-27**]  01:11 PM
                             [**2128-1-27**]  03:27 PM
                             [**2128-1-27**]  03:51 PM
                             [**2128-1-27**]  08:15 PM
                             [**2128-1-28**]  12:00 AM
                             [**2128-1-28**]  12:20 AM
                             [**2128-1-28**]  03:28 AM
                             [**2128-1-28**]  06:00 AM
                             [**2128-1-28**]  06:06 AM
   WBC
   13.4
   9.9
   6.0
   Hct
   25.7
   24.4
   26.0
   27.5
   28.0
   Plt
   [**Telephone/Fax (3) 11372**]88
   Cr
   3.1
   2.6
   2.1
   TCO2
   24
   23
   23
   25
   Glucose
   155
   193
   203
   164
   Other labs: PT / PTT / INR:17.6/28.7/1.6, Fibrinogen:373 mg/dL, Lactic
   Acid:0.8 mmol/L, Ca++:8.4 mg/dL, Mg++:2.3 mg/dL, PO4:4.3 mg/dL
   Fluid analysis / Other labs: BAL - no PMNs or bacteria seen on Gram
   stain.
   Imaging: Only line placement CXR today.
   Microbiology: No growth yet. C. difficile negative.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable.
   # Hypoxemic Respiratory Failure and Possible Vasculitis
   Given findings on CXR, CVP, clinical presentation and bronchoscopy,
   likely secondary to diffuse alveolar hemorrhage and fluid overload. ESR
   is elevated, there is a pupruic macular rash and renal failure, all
   concerning for vasculitis, although there are other possibilities. [**Doctor First Name 1205**]
   and ANCA are negative and anti-GBM is pending. If we seek a unifying
   diagnosis, may be that anti-GBM is negative given skin process.
   Variability in antibody responsible may account for this, and general
   approaches and pathology may eventually be most helpful. Renal biopsy
   is possible (see below). Presently conditions of each organ stabilized
   on high dose steroids, also suggestive. Rheumatology raised Cytoxan
   treatment and plasmaphoresis, but we will need to discuss this further
   with Renal and Pathology.
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Repeat bronchoscopy today to remove thrombus plugging and examine
   again.
   - Await anti-GBM
   - Discuss renal biopsy
   - Continue to appreciate input of Rheumatology and Renal
   - Continue Solu-medrol
   - Consider Cytoxan and plasmapheresis with d/w Renal and Rheumatology
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
 stop
   cefazolin
   - Hold heparin, ASA
   # Hemoptysis and Coagulopathy
   Evidence, perhaps with purpuric rash, of coagulopathy, or potentially
   as a manifestation of vasculitis. For the former and possibly uremic
   platelets, anticoagulant therapy. In favor of the latter is unifying
   diagnosis and co-occurrence with renal disease and rash. See discussion
   above
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 2.1 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Now unclear if this is truly manifestation of systemic
   vasculitis or drug reaction. White cells and eosinophils in urine
   consistent with either, although more classic of AIN.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - Renally dose/CVVH dose meds.
   - Management as above, including IV Solu-medrol.
   - Possible renal biopsy tomorrow given that we are now holding
   anticoagulants
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.  Now on Cefazolin since [**1-22**]
   instead of Vanc as better for MSSA with increased dosing [**1-25**].
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8-Q12.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - No heparin for now
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Rash/Respiratory failure and hemorrhage/renal failure.
   24 Hour Events:
 PICC LINE - START [**2128-1-27**] 08:05 AM
 BLOOD CULTURED - At [**2128-1-27**] 09:30 AM
   two sets, one from each port of picc
 INVASIVE VENTILATION - START [**2128-1-27**] 10:40 AM
 EKG - At [**2128-1-27**] 12:15 PM
 ARTERIAL LINE - START [**2128-1-27**] 12:30 PM
 DIALYSIS CATHETER - START [**2128-1-27**] 01:05 PM
 BRONCHOSCOPY - At [**2128-1-27**] 01:25 PM
 TRANSTHORACIC ECHO - At [**2128-1-27**] 02:30 PM
   - HCT 27 -> 25.7 -> 24.4 (1U) -> 26 (1U) -> 27.5 -> 28
   - EKG: VPaced
   - Received Vit K IV
   - Renal: HD Line Placed, receiving CVVH now.
   - Rheum: 1. Would change steroids to solumedrol 1000 mg IV Daily for 3
   days 2. Stop allopurinol indefinitely. 3. Agree with transfusion
   medicine consult for possible plasmapheresis.  4. F/u with anti-GBM and
   ANCA. 5. Repeat echocardiogram (TEE) to evaluate for current cardiac
   status/function, vegetations and possible CHF. They would like to start
   Cytoxan if ID (given bacteremia) and Renal (i.e. If they agree with
   diagnosis) on board. Also recommend plasmaphoresis before Cytoxan.
   - Derm: Nothing
   - Intubated, Aline placed, Dialysis Catheter Placed.
   - Bronchoscopy: Diffuse Bleeding
   - ECHO:The left atrium is moderately dilated. Left ventricular wall
   thickness, cavity size and regional/global systolic function are normal
   (LVEF >55%). [Intrinsic left ventricular systolic function is likely
   more depressed given the severity of valvular regurgitation.] Right
   ventricular chamber size is normal. with borderline normal free wall
   function. There is abnormal septal motion/position consistent with
   right ventricular pressure/volume overload. A bileaflet aortic valve
   prosthesis is present. The transaortic gradient is normal for this
   prosthesis. No masses or vegetations are seen on the aortic valve, but
   cannot be fully excluded due to suboptimal image quality. Trace aortic
   regurgitation is seen. [The amount of regurgitation present is normal
   for this prosthetic aortic valve.] The mitral valve leaflets are
   moderately thickened. No masses or vegetations are seen on the mitral
   valve, but cannot be fully excluded due to suboptimal image quality. An
   eccentric, posteriorly directed jet of moderate (2+) mitral
   regurgitation is seen. No masses or vegetations are seen on the
   tricuspid valve, but cannot be fully excluded due to suboptimal image
   quality. Moderate [2+] tricuspid regurgitation is seen. There is
   moderate pulmonary artery systolic hypertension. There is no
   pericardial effusion. If clinically suggested, the absence of a
   vegetation by 2D echocardiography does not exclude endocarditis,
   especially on a bileaflet aortic valve. Compared with the prior study
   (images reviewed) of [**2128-1-8**], the severity of mitral and tricuspid
   regurgitation has increased. The right ventricular function may be
   slighlty less vigorous.
   - ID: Fine to change to Cefepime/Vancomycin. From Cefazolin.
   - Path: Nothing
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-27**] 09:40 AM
   Cefazolin - [**2128-1-27**] 10:00 AM
   Cefipime - [**2128-1-27**] 01:10 PM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 1 mEq./hour
   Midazolam (Versed) - 5 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-27**] 09:40 AM
   Midazolam (Versed) - [**2128-1-27**] 01:00 PM
   Fentanyl - [**2128-1-27**] 01:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-28**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 95/50(67) {78/42(56) - 140/70(94)} mmHg
   RR: 20 (18 - 30) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 88.1 kg (admission): 85 kg
   Height: 68 Inch
           Total In:
                                                                  3,243 mL
                                                                  2,401 mL
   PO:
           TF:
   IVF:
                                                                  2,298 mL
                                                                  2,051 mL
   Blood products:
                                                                    945 mL
                                                                    350 mL
   Total out:
                                                                  2,598 mL
                                                                  3,069 mL
   Urine:
                                                                  1,140 mL
                                                                    345 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    645 mL
                                                                   -668 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 550 (500 - 550) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 28 cmH2O
   Plateau: 21 cmH2O
   Compliance: 50 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/40/125/23/0 (6 a.m.)
   Ve: 3.9 L/min
   PaO2 / FiO2: 313
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   then later some desynchrony.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Labs / Radiology
   288 K/uL
   9.3 g/dL
   164 mg/dL
   2.1 mg/dL
   23 mEq/L
   4.7 mEq/L
   61 mg/dL
   101 mEq/L
   138 mEq/L
   28.0 %
   6.0 K/uL
        [image002.jpg] Free Ca 1.05.
                             [**2128-1-27**]  11:51 AM
                             [**2128-1-27**]  01:11 PM
                             [**2128-1-27**]  03:27 PM
                             [**2128-1-27**]  03:51 PM
                             [**2128-1-27**]  08:15 PM
                             [**2128-1-28**]  12:00 AM
                             [**2128-1-28**]  12:20 AM
                             [**2128-1-28**]  03:28 AM
                             [**2128-1-28**]  06:00 AM
                             [**2128-1-28**]  06:06 AM
   WBC
   13.4
   9.9
   6.0
   Hct
   25.7
   24.4
   26.0
   27.5
   28.0
   Plt
   [**Telephone/Fax (3) 11372**]88
   Cr
   3.1
   2.6
   2.1
   TCO2
   24
   23
   23
   25
   Glucose
   155
   193
   203
   164
   Other labs: PT / PTT / INR:17.6/28.7/1.6, Fibrinogen:373 mg/dL, Lactic
   Acid:0.8 mmol/L, Ca++:8.4 mg/dL, Mg++:2.3 mg/dL, PO4:4.3 mg/dL
   Fluid analysis / Other labs: BAL - no PMNs or bacteria seen on Gram
   stain.
   Imaging: Only line placement CXR today.
   Microbiology: No growth yet. C. difficile negative.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable.
   # Hypoxemic Respiratory Failure and Possible Vasculitis
   Given findings on CXR, CVP, clinical presentation and bronchoscopy,
   likely secondary to diffuse alveolar hemorrhage and fluid overload. ESR
   is elevated, there is a pupruic macular rash and renal failure, all
   concerning for vasculitis, although there are other possibilities. [**Doctor First Name 1205**]
   and ANCA are negative and anti-GBM is pending. If we seek a unifying
   diagnosis, may be that anti-GBM is negative given skin process.
   Variability in antibody responsible may account for this, and general
   approaches and pathology may eventually be most helpful. Renal biopsy
   is possible (see below). Presently conditions of each organ stabilized
   on high dose steroids, also suggestive. Rheumatology raised Cytoxan
   treatment and plasmaphoresis, but we will need to discuss this further
   with Renal and Pathology.
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Repeat bronchoscopy today to remove thrombus plugging and examine
   again.
   - Await anti-GBM
   - Discuss renal biopsy
   - Continue to appreciate input of Rheumatology and Renal
   - Continue Solu-medrol
   - Consider Cytoxan and plasmapheresis with d/w Renal and Rheumatology
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
 stop
   cefazolin
   - Hold heparin, ASA
   # Hemoptysis and Coagulopathy
   Evidence, perhaps with purpuric rash, of coagulopathy, or potentially
   as a manifestation of vasculitis. For the former and possibly uremic
   platelets, anticoagulant therapy. In favor of the latter is unifying
   diagnosis and co-occurrence with renal disease and rash. See discussion
   above
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 2.1 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Now unclear if this is truly manifestation of systemic
   vasculitis or drug reaction. White cells and eosinophils in urine
   consistent with either, although more classic of AIN.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - Renally dose/CVVH dose meds.
   - Management as above, including IV Solu-medrol.
   - Possible renal biopsy tomorrow given that we are now holding
   anticoagulants
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.  Now on Cefazolin since [**1-22**]
   instead of Vanc as better for MSSA with increased dosing [**1-25**].
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8-Q12.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - No heparin for now
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of coronary artery disease (CAD), status post coronary artery bypass grafting (CABG) and mechanical aortic valve replacement (AVR). He is currently hospitalized with respiratory failure, hemorrhage, and renal failure, and is suspected to have endocarditis, vasculitis, and leukocytoclastic dermatitis.

The patient's condition is complex and requires close monitoring and management. He is intubated and receiving invasive ventilation, and has a PICC line, arterial line, and dialysis catheter in place. He is receiving high-dose steroids and antibiotics, and is being treated for potential vasculitis and coagulopathy.

Potential medical complications that can arise include:

1. Diffuse alveolar hemorrhage (DAH) and respiratory failure: The patient's respiratory status is unstable, and there is a risk of further bleeding and respiratory failure.
2. Vasculitis and coagulopathy: The patient's vasculitis and coagulopathy can lead to further bleeding, organ dysfunction, and increased risk of thrombosis.
3. Endocarditis: The patient has a mechanical aortic valve replacement, and there is a risk of further endocarditis and valve dysfunction.
4. Renal failure: The patient's renal function is compromised, and there is a risk of further kidney damage and dialysis dependence.
5. Leukocytoclastic dermatitis: The patient's skin lesions may worsen and spread, leading to further skin damage and increased risk of infection.
6. Bacteremia: The patient has a high-grade MSSA bacteremia, and there is a risk of further sepsis and organ dysfunction.
7. Atrial fibrillation and complete heart block: The patient's arrhythmias may worsen, leading to further cardiac complications.
8. Anemia: The patient's anemia may worsen, leading to further fatigue, weakness, and increased risk of bleeding.

The patient requires close monitoring and management to prevent and treat these potential complications. His treatment plan should be individualized and adjusted as necessary to address his specific needs and condition."
182149.0,283460,2128-01-28 07:34:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Rash/Respiratory failure and hemorrhage/renal failure.
   24 Hour Events:
 PICC LINE - START [**2128-1-27**] 08:05 AM
 BLOOD CULTURED - At [**2128-1-27**] 09:30 AM
   two sets, one from each port of picc
 INVASIVE VENTILATION - START [**2128-1-27**] 10:40 AM
 EKG - At [**2128-1-27**] 12:15 PM
 ARTERIAL LINE - START [**2128-1-27**] 12:30 PM
 DIALYSIS CATHETER - START [**2128-1-27**] 01:05 PM
 BRONCHOSCOPY - At [**2128-1-27**] 01:25 PM
 TRANSTHORACIC ECHO - At [**2128-1-27**] 02:30 PM
   - HCT 27 -> 25.7 -> 24.4 (1U) -> 26 (1U) -> 27.5 -> 28
   - EKG: VPaced
   - Received Vit K IV
   - Renal: HD Line Placed, receiving CVVH now.
   - Rheum: 1. Would change steroids to solumedrol 1000 mg IV Daily for 3
   days 2. Stop allopurinol indefinitely. 3. Agree with transfusion
   medicine consult for possible plasmapheresis.  4. F/u with anti-GBM and
   ANCA. 5. Repeat echocardiogram (TEE) to evaluate for current cardiac
   status/function, vegetations and possible CHF. They would like to start
   Cytoxan if ID (given bacteremia) and Renal (i.e. If they agree with
   diagnosis) on board. Also recommend plasmaphoresis before Cytoxan.
   - Derm: Nothing
   - Intubated, Aline placed, Dialysis Catheter Placed.
   - Bronchoscopy: Diffuse Bleeding
   - ECHO:The left atrium is moderately dilated. Left ventricular wall
   thickness, cavity size and regional/global systolic function are normal
   (LVEF >55%). [Intrinsic left ventricular systolic function is likely
   more depressed given the severity of valvular regurgitation.] Right
   ventricular chamber size is normal. with borderline normal free wall
   function. There is abnormal septal motion/position consistent with
   right ventricular pressure/volume overload. A bileaflet aortic valve
   prosthesis is present. The transaortic gradient is normal for this
   prosthesis. No masses or vegetations are seen on the aortic valve, but
   cannot be fully excluded due to suboptimal image quality. Trace aortic
   regurgitation is seen. [The amount of regurgitation present is normal
   for this prosthetic aortic valve.] The mitral valve leaflets are
   moderately thickened. No masses or vegetations are seen on the mitral
   valve, but cannot be fully excluded due to suboptimal image quality. An
   eccentric, posteriorly directed jet of moderate (2+) mitral
   regurgitation is seen. No masses or vegetations are seen on the
   tricuspid valve, but cannot be fully excluded due to suboptimal image
   quality. Moderate [2+] tricuspid regurgitation is seen. There is
   moderate pulmonary artery systolic hypertension. There is no
   pericardial effusion. If clinically suggested, the absence of a
   vegetation by 2D echocardiography does not exclude endocarditis,
   especially on a bileaflet aortic valve. Compared with the prior study
   (images reviewed) of [**2128-1-8**], the severity of mitral and tricuspid
   regurgitation has increased. The right ventricular function may be
   slighlty less vigorous.
   - ID: Fine to change to Cefepime/Vancomycin. From Cefazolin.
   - Path: Nothing
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-27**] 09:40 AM
   Cefazolin - [**2128-1-27**] 10:00 AM
   Cefipime - [**2128-1-27**] 01:10 PM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 1 mEq./hour
   Midazolam (Versed) - 5 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-27**] 09:40 AM
   Midazolam (Versed) - [**2128-1-27**] 01:00 PM
   Fentanyl - [**2128-1-27**] 01:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-28**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 95/50(67) {78/42(56) - 140/70(94)} mmHg
   RR: 20 (18 - 30) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 88.1 kg (admission): 85 kg
   Height: 68 Inch
           Total In:
                                                                  3,243 mL
                                                                  2,401 mL
   PO:
           TF:
   IVF:
                                                                  2,298 mL
                                                                  2,051 mL
   Blood products:
                                                                    945 mL
                                                                    350 mL
   Total out:
                                                                  2,598 mL
                                                                  3,069 mL
   Urine:
                                                                  1,140 mL
                                                                    345 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    645 mL
                                                                   -668 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 550 (500 - 550) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 28 cmH2O
   Plateau: 21 cmH2O
   Compliance: 50 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/40/125/23/0 (6 a.m.)
   Ve: 3.9 L/min
   PaO2 / FiO2: 313
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   then later some desynchrony.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Labs / Radiology
   288 K/uL
   9.3 g/dL
   164 mg/dL
   2.1 mg/dL
   23 mEq/L
   4.7 mEq/L
   61 mg/dL
   101 mEq/L
   138 mEq/L
   28.0 %
   6.0 K/uL
        [image002.jpg] Free Ca 1.05.
                             [**2128-1-27**]  11:51 AM
                             [**2128-1-27**]  01:11 PM
                             [**2128-1-27**]  03:27 PM
                             [**2128-1-27**]  03:51 PM
                             [**2128-1-27**]  08:15 PM
                             [**2128-1-28**]  12:00 AM
                             [**2128-1-28**]  12:20 AM
                             [**2128-1-28**]  03:28 AM
                             [**2128-1-28**]  06:00 AM
                             [**2128-1-28**]  06:06 AM
   WBC
   13.4
   9.9
   6.0
   Hct
   25.7
   24.4
   26.0
   27.5
   28.0
   Plt
   [**Telephone/Fax (3) 11372**]88
   Cr
   3.1
   2.6
   2.1
   TCO2
   24
   23
   23
   25
   Glucose
   155
   193
   203
   164
   Other labs: PT / PTT / INR:17.6/28.7/1.6, Fibrinogen:373 mg/dL, Lactic
   Acid:0.8 mmol/L, Ca++:8.4 mg/dL, Mg++:2.3 mg/dL, PO4:4.3 mg/dL
   Fluid analysis / Other labs: BAL - no PMNs or bacteria seen on Gram
   stain.
   Imaging: Only line placement CXR today.
   Microbiology: No growth yet. C. difficile negative.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable. This case will likely need pathophysiological rather than
   ontological approach.
   # Hypoxemic Respiratory Failure
   Concerning for DAH given CXR findings as well.  Could also be pulmonary
   edema with hemorrhage due to anticoagulation, HAP with hemorrhage,
   development of ARDS with bleeding for other reasons or from other
   source.  DAH most concerning, particularly in light of prior ARF
   (?renal manifestations), vasculitic rash, elevated ESR.  [**Doctor First Name 1205**] negative,
   ANCA negative
   - Intubate now (larger tube preferred).
   - Bronchoscopy today; looking for progressive or continued blood with
   subsequent BALs.
   - Run recent medication exposures for possible culprits of DAH.
   - Initiate workup for and ?treatment for anti-GBM disease.  Send
   anti-GBM.  ?future renal biopsy.
   - Consult rheumatology and pathology/pheresis.
   - Will increase steroids to 125 mg Q6h, ?further increase if rec by
   rheum.
   - Will discuss cyclophosphamide with rheumatology.
   - ?pheresis today given concern for anti-GBM disease.  Will plan on
   line placement in anticipation of this and/or hemodialysis in near
   future.
   - Broad spectrum treatment for HAP and send sputum culture.  Will
   discuss with ID re: appropriate regimen (vanc plus beta lactam, ?still
   need to continue cefazolin).
   - Hold heparin, will not give protamine at this time.  WIll given
   vitamin K IV.
   # Hemoptysis
   Evidence, perhaps with purpuric rash, of coagulopathy, or potentially
   as a manifestation of vasculitis. For the former and possibly uremic
   platelets, anticoagulant therapy. In favor of the latter is unifying
   diagnosis and co-occurrence with renal disease and rash.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; trending up now 3.4. Thought to be AIN due to
   Nafcillin.  Now unclear if this is truly manifestation of systemic
   vasculitis or anti-GBM disease.  Has had microscopic hematuria in
   recent past.
   - Resend urine.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - renally dose meds.
   - Change steroid to IV solumedrol.
   - diuresis likely when stabilized, vs. proceeding with HD.
   - ?future renal biopsy.
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or IE. Improving overall.  ?Could be related
   to systemic disease causing DAH.
   - will discuss with derm re: any relation to DAH.
   - steroids as above.
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.  Now on Cefazolin since [**1-22**]
   instead of Vanc as better for MSSA with increased dosing [**1-25**].
   - Repeat blood cultures.
   - Will continue cefazolin for now, but given would like to treat for
   HAP, will discuss appropriate regimen.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia: Guaiac + stools this admission and have nuclear scan
   (negative).  Now with pulmonary hemorrhage likely.
   - recheck Hct Q8-Q12.
   - Consented for blood products.
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above.
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   #. Hypertension.
   - Holding antiHTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2B
   # Access: PICC
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Rash/Respiratory failure and hemorrhage/renal failure.
   24 Hour Events:
 PICC LINE - START [**2128-1-27**] 08:05 AM
 BLOOD CULTURED - At [**2128-1-27**] 09:30 AM
   two sets, one from each port of picc
 INVASIVE VENTILATION - START [**2128-1-27**] 10:40 AM
 EKG - At [**2128-1-27**] 12:15 PM
 ARTERIAL LINE - START [**2128-1-27**] 12:30 PM
 DIALYSIS CATHETER - START [**2128-1-27**] 01:05 PM
 BRONCHOSCOPY - At [**2128-1-27**] 01:25 PM
 TRANSTHORACIC ECHO - At [**2128-1-27**] 02:30 PM
   - HCT 27 -> 25.7 -> 24.4 (1U) -> 26 (1U) -> 27.5 -> 28
   - EKG: VPaced
   - Received Vit K IV
   - Renal: HD Line Placed, receiving CVVH now.
   - Rheum: 1. Would change steroids to solumedrol 1000 mg IV Daily for 3
   days 2. Stop allopurinol indefinitely. 3. Agree with transfusion
   medicine consult for possible plasmapheresis.  4. F/u with anti-GBM and
   ANCA. 5. Repeat echocardiogram (TEE) to evaluate for current cardiac
   status/function, vegetations and possible CHF. They would like to start
   Cytoxan if ID (given bacteremia) and Renal (i.e. If they agree with
   diagnosis) on board. Also recommend plasmaphoresis before Cytoxan.
   - Derm: Nothing
   - Intubated, Aline placed, Dialysis Catheter Placed.
   - Bronchoscopy: Diffuse Bleeding
   - ECHO:The left atrium is moderately dilated. Left ventricular wall
   thickness, cavity size and regional/global systolic function are normal
   (LVEF >55%). [Intrinsic left ventricular systolic function is likely
   more depressed given the severity of valvular regurgitation.] Right
   ventricular chamber size is normal. with borderline normal free wall
   function. There is abnormal septal motion/position consistent with
   right ventricular pressure/volume overload. A bileaflet aortic valve
   prosthesis is present. The transaortic gradient is normal for this
   prosthesis. No masses or vegetations are seen on the aortic valve, but
   cannot be fully excluded due to suboptimal image quality. Trace aortic
   regurgitation is seen. [The amount of regurgitation present is normal
   for this prosthetic aortic valve.] The mitral valve leaflets are
   moderately thickened. No masses or vegetations are seen on the mitral
   valve, but cannot be fully excluded due to suboptimal image quality. An
   eccentric, posteriorly directed jet of moderate (2+) mitral
   regurgitation is seen. No masses or vegetations are seen on the
   tricuspid valve, but cannot be fully excluded due to suboptimal image
   quality. Moderate [2+] tricuspid regurgitation is seen. There is
   moderate pulmonary artery systolic hypertension. There is no
   pericardial effusion. If clinically suggested, the absence of a
   vegetation by 2D echocardiography does not exclude endocarditis,
   especially on a bileaflet aortic valve. Compared with the prior study
   (images reviewed) of [**2128-1-8**], the severity of mitral and tricuspid
   regurgitation has increased. The right ventricular function may be
   slighlty less vigorous.
   - ID: Fine to change to Cefepime/Vancomycin. From Cefazolin.
   - Path: Nothing
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-27**] 09:40 AM
   Cefazolin - [**2128-1-27**] 10:00 AM
   Cefipime - [**2128-1-27**] 01:10 PM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 1 mEq./hour
   Midazolam (Versed) - 5 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-27**] 09:40 AM
   Midazolam (Versed) - [**2128-1-27**] 01:00 PM
   Fentanyl - [**2128-1-27**] 01:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-28**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 95/50(67) {78/42(56) - 140/70(94)} mmHg
   RR: 20 (18 - 30) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 88.1 kg (admission): 85 kg
   Height: 68 Inch
           Total In:
                                                                  3,243 mL
                                                                  2,401 mL
   PO:
           TF:
   IVF:
                                                                  2,298 mL
                                                                  2,051 mL
   Blood products:
                                                                    945 mL
                                                                    350 mL
   Total out:
                                                                  2,598 mL
                                                                  3,069 mL
   Urine:
                                                                  1,140 mL
                                                                    345 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    645 mL
                                                                   -668 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 550 (500 - 550) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 28 cmH2O
   Plateau: 21 cmH2O
   Compliance: 50 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/40/125/23/0 (6 a.m.)
   Ve: 3.9 L/min
   PaO2 / FiO2: 313
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   then later some desynchrony.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Labs / Radiology
   288 K/uL
   9.3 g/dL
   164 mg/dL
   2.1 mg/dL
   23 mEq/L
   4.7 mEq/L
   61 mg/dL
   101 mEq/L
   138 mEq/L
   28.0 %
   6.0 K/uL
        [image002.jpg] Free Ca 1.05.
                             [**2128-1-27**]  11:51 AM
                             [**2128-1-27**]  01:11 PM
                             [**2128-1-27**]  03:27 PM
                             [**2128-1-27**]  03:51 PM
                             [**2128-1-27**]  08:15 PM
                             [**2128-1-28**]  12:00 AM
                             [**2128-1-28**]  12:20 AM
                             [**2128-1-28**]  03:28 AM
                             [**2128-1-28**]  06:00 AM
                             [**2128-1-28**]  06:06 AM
   WBC
   13.4
   9.9
   6.0
   Hct
   25.7
   24.4
   26.0
   27.5
   28.0
   Plt
   [**Telephone/Fax (3) 11372**]88
   Cr
   3.1
   2.6
   2.1
   TCO2
   24
   23
   23
   25
   Glucose
   155
   193
   203
   164
   Other labs: PT / PTT / INR:17.6/28.7/1.6, Fibrinogen:373 mg/dL, Lactic
   Acid:0.8 mmol/L, Ca++:8.4 mg/dL, Mg++:2.3 mg/dL, PO4:4.3 mg/dL
   Fluid analysis / Other labs: BAL - no PMNs or bacteria seen on Gram
   stain.
   Imaging: Only line placement CXR today.
   Microbiology: No growth yet. C. difficile negative.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable. This case will likely need pathophysiological rather than
   ontological approach.
   # Hypoxemic Respiratory Failure
   Concerning for DAH given CXR findings as well.  Could also be pulmonary
   edema with hemorrhage due to anticoagulation, HAP with hemorrhage,
   development of ARDS with bleeding for other reasons or from other
   source.  DAH most concerning, particularly in light of prior ARF
   (?renal manifestations), vasculitic rash, elevated ESR.  [**Doctor First Name 1205**] negative,
   ANCA negative
   - Intubate now (larger tube preferred).
   - Bronchoscopy today; looking for progressive or continued blood with
   subsequent BALs.
   - Run recent medication exposures for possible culprits of DAH.
   - Initiate workup for and ?treatment for anti-GBM disease.  Send
   anti-GBM.  ?future renal biopsy.
   - Consult rheumatology and pathology/pheresis.
   - Will increase steroids to 125 mg Q6h, ?further increase if rec by
   rheum.
   - Will discuss cyclophosphamide with rheumatology.
   - ?pheresis today given concern for anti-GBM disease.  Will plan on
   line placement in anticipation of this and/or hemodialysis in near
   future.
   - Broad spectrum treatment for HAP and send sputum culture.  Will
   discuss with ID re: appropriate regimen (vanc plus beta lactam, ?still
   need to continue cefazolin).
   - Hold heparin, will not give protamine at this time.  WIll given
   vitamin K IV.
   # Hemoptysis
   Evidence, perhaps with purpuric rash, of coagulopathy, or potentially
   as a manifestation of vasculitis. For the former and possibly uremic
   platelets, anticoagulant therapy. In favor of the latter is unifying
   diagnosis and co-occurrence with renal disease and rash.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; trending up now 3.4. Thought to be AIN due to
   Nafcillin.  Now unclear if this is truly manifestation of systemic
   vasculitis or anti-GBM disease.  Has had microscopic hematuria in
   recent past.
   - Resend urine.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - renally dose meds.
   - Change steroid to IV solumedrol.
   - diuresis likely when stabilized, vs. proceeding with HD.
   - ?future renal biopsy.
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or IE. Improving overall.  ?Could be related
   to systemic disease causing DAH.
   - will discuss with derm re: any relation to DAH.
   - steroids as above.
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.  Now on Cefazolin since [**1-22**]
   instead of Vanc as better for MSSA with increased dosing [**1-25**].
   - Repeat blood cultures.
   - Will continue cefazolin for now, but given would like to treat for
   HAP, will discuss appropriate regimen.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia: Guaiac + stools this admission and have nuclear scan
   (negative).  Now with pulmonary hemorrhage likely.
   - recheck Hct Q8-Q12.
   - Consented for blood products.
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above.
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   #. Hypertension.
   - Holding antiHTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2B
   # Access: PICC
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of CAD, s/p CABG, and s/p mechanical AVR, who is currently hospitalized for MSSA endocarditis with complications of ARF, AIN, CHB, and torsades. He is now in the ICU with respiratory distress, hypoxemia, and hemoptysis, concerning for DAH. The patient has a diffuse rash on his trunk and extremities, which is thought to be leukoclastic dermatitis. The patient's laboratory results show elevated ESR, and the rheumatology team suspects a possible immune-mediated unifying diagnosis, such as vasculitis.

Potential Medical Complications:

1. Hypoxemic Respiratory Failure: The patient's respiratory distress and hypoxemia are concerning for DAH, which could be caused by a variety of factors, including pulmonary edema, HAP, or ARDS.
2. Hemoptysis: The patient's hemoptysis could be caused by coagulopathy, vasculitis, or uremic platelets.
3. Acute on Chronic Renal Failure: The patient's Cr level is trending upward, and the renal team suspects AIN due to Nafcillin. However, it is unclear if this is a manifestation of systemic vasculitis or anti-GBM disease.
4. Leukoclastic Dermatitis: The patient's rash is thought to be due to Nafcillin or IE, but it could also be related to systemic disease causing DAH.
5. Bacteremia: The patient has a high-grade MSSA bacteremia, which fulfills the Duke Criteria for endocarditis.
6. Atrial Fibrillation/Complete Heart Block: The patient has a history of CHB and torsades, and is currently ventricularly pacing with a screw-in pacemaker.
7. Anemia: The patient has anemia, which is thought to be caused by gastrointestinal bleeding.
8. CAD: The patient has a history of CAD and is off anticoagulants due to coagulopathy.
9. s/p AVR: The patient has a history of AVR and is at risk for abscess formation.
10. Hypertension: The patient has hypertension, which is being held due to bleeding.

Treatment Plan:

1. Intubate the patient with a larger tube and initiate bronchoscopy to evaluate for DAH.
2. Run recent medication exposures for possible culprits of DAH.
3. Initiate workup for and treatment of anti-GBM disease, including sending anti-GBM antibody tests and considering plasmapheresis.
4. Consult rheumatology and pathology/pheresis to determine the best course of treatment.
5. Increase steroids to 125 mg Q6h and consider further increasing if recommended by rheumatology.
6. Discuss cyclophosphamide with rheumatology and consider initiating treatment.
7. Hold heparin and protamine, and give vitamin K IV.
8. Broad-spectrum treatment for HAP and send sputum culture.
9. Continue cefazolin for now, but discuss appropriate regimen with ID.
10. Reassess the patient's condition and adjust treatment plan as necessary."
182149.0,283460,2128-01-29 07:26:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: Endocarditis, Renal Failure, DAH
   24 Hour Events:
   - Some desynchrony with vent today, so fent and Versed increased
   - Bronch today some bronchial plugging with thrombus.
   - Rheumatology want us to continue discussing cytoxan and would like us
   to touch base with ID about starting this in the context of
   bacteremia/endocarditis. They would also like to ses phoresis prior to
   starting Cytoxan. They would like everyone to agree on the diagnosis of
   vasculitis before this proceeds.
   - Started tube feeds
   - Finished second unit of PRCs in a.m.
   - Spoke to both daughters yesterday with Renal - they agreed upon
   course of action (steroids and biopsy then decide about phoresis and
   Cytoxan)
   - Renal biopsy on a.m. of [**1-29**] - we will round on him early and would
   like to have DDAVP, platelets, coags drawn.
   - Final Renal recs: One dose DDAVP and FFP to start at 9:30. Biopsy
   will be around 11:00 and Changed cefepime 2g q12 for CVVH.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefazolin - [**2128-1-27**] 10:00 AM
   Vancomycin - [**2128-1-28**] 10:00 AM
   Cefipime - [**2128-1-28**] 12:00 PM
   Infusions:
   Midazolam (Versed) - 7 mg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 2 mEq./hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-28**] 08:00 AM
   Midazolam (Versed) - [**2128-1-29**] 03:25 AM
   Fentanyl - [**2128-1-29**] 03:26 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-29**] 07:22 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.9
C (96.7
   HR: 75 (75 - 75) bpm
   BP: 106/54(73) {73/30(46) - 123/59(82)} mmHg
   RR: 20 (12 - 29) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 84 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 16 (12 - 22)mmHg
   Total In:
                                                                  7,656 mL
                                                                  2,214 mL
   PO:
   TF:
                                                                     85 mL
                                                                    159 mL
   IVF:
                                                                  7,041 mL
                                                                  2,055 mL
   Blood products:
                                                                    350 mL
   Total out:
                                                                 10,809 mL
                                                                  2,842 mL
   Urine:
                                                                    664 mL
                                                                    148 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -3,153 mL
                                                                   -628 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 440 (440 - 550) mL
   Vt (Spontaneous): 406 (406 - 406) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 12 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 31 cmH2O
   Plateau: 24 cmH2O
   Compliance: 44 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/47/90.[**Numeric Identifier 128**]/25/2
   Ve: 10 L/min
   PaO2 / FiO2: 225
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Skin: Petechial rash lower extremity.
   Labs / Radiology
   237 K/uL
   9.0 g/dL
   200 mg/dL
   1.8 mg/dL
   25 mEq/L
   4.5 mEq/L
   47 mg/dL
   99 mEq/L
   137 mEq/L
   26.7 %
   6.3 K/uL
        [image002.jpg]
                             [**2128-1-28**]  06:06 AM
                             [**2128-1-28**]  10:55 AM
                             [**2128-1-28**]  11:02 AM
                             [**2128-1-28**]  04:28 PM
                             [**2128-1-28**]  05:35 PM
                             [**2128-1-28**]  05:44 PM
                             [**2128-1-28**]  10:00 PM
                             [**2128-1-28**]  10:24 PM
                             [**2128-1-29**]  03:57 AM
                             [**2128-1-29**]  04:00 AM
   WBC
   4.4
   5.9
   6.3
   Hct
   26.3
   27.2
   27.2
   26.7
   Plt
   249
   250
   237
   Cr
   1.9
   1.9
   1.8
   TCO2
   25
   28
   28
   29
   29
   30
   Glucose
   [**Telephone/Fax (3) 11377**]93
   200
   Other labs: PT / PTT / INR:15.7/26.4/1.4, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:9.0 mg/dL, Mg++:2.1 mg/dL, PO4:3.5 mg/dL
   Imaging: Chest Xray ([**1-27**]): Pending
   Microbiology: Sputum:
      GRAM STAIN (Final [**2128-1-27**]):
         [**11-8**] PMNs and <10 epithelial cells/100X field.
         1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S).
      RESPIRATORY CULTURE (Preliminary):
         SPARSE GROWTH OROPHARYNGEAL FLORA.
         GRAM NEGATIVE ROD(S).    MODERATE GROWTH.
   BAL:
      GRAM STAIN (Final [**2128-1-27**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      RESPIRATORY CULTURE (Preliminary):    NO GROWTH, <1000 CFU/ml.
   Blood ([**1-27**]): Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable.
   # Hypoxemic Respiratory Failure and Possible Vasculitis
   Given findings on CXR, CVP, clinical presentation and bronchoscopy,
   likely secondary to diffuse alveolar hemorrhage and fluid overload. ESR
   is elevated, there is a pupruic macular rash and renal failure, all
   concerning for vasculitis, although there are other possibilities. [**Doctor First Name 1205**]
   and ANCA are negative and anti-GBM is pending. If we seek a unifying
   diagnosis, may be that anti-GBM is negative given skin process.
   Variability in antibody responsible may account for this, and general
   approaches and pathology may eventually be most helpful. Renal biopsy
   is possible (see below). Presently conditions of each organ stabilized
   on high dose steroids, also suggestive. Rheumatology raised Cytoxan
   treatment and plasmaphoresis, but we will need to discuss this further
   with Renal and Pathology.
   - Renal Biopsy this AM
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Await anti-GBM
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Continue Solu-medrol
   - sp Renal Biopsy, consider Cytoxan and plasmapheresis with d/w Renal
   and Rheumatology
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Hold heparin, ASA
   - Continue to remove fluid with CVVH
   # Coagulopathy: Plan for Kidney Biopsy today. INR 1.4 this AM,
   Platelets NL however may be dysfunctional given ASA /Uremia.
   - DDAVP today
   - FFP during procedure
   - One unit platlets.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.8 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Now unclear if this is truly manifestation of systemic
   vasculitis or drug reaction. White cells and eosinophils in urine
   consistent with either, although more classic of AIN.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - Renally dose/CVVH dose meds.
   - Management as above, including IV Solu-medrol.
   - Possible renal biopsy tomorrow given that we are now holding
   anticoagulants
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above, will restart anticoagulation sp biopsy with
   very low ptt goal.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - No heparin for now
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition: Tube Feeds
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:  H2R Blocker
   VAP:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: Endocarditis, Renal Failure, DAH
   24 Hour Events:
   - Some desynchrony with vent today, so fent and Versed increased
   - Bronch today some bronchial plugging with thrombus.
   - Rheumatology want us to continue discussing cytoxan and would like us
   to touch base with ID about starting this in the context of
   bacteremia/endocarditis. They would also like to ses phoresis prior to
   starting Cytoxan. They would like everyone to agree on the diagnosis of
   vasculitis before this proceeds.
   - Started tube feeds
   - Finished second unit of PRCs in a.m.
   - Spoke to both daughters yesterday with Renal - they agreed upon
   course of action (steroids and biopsy then decide about phoresis and
   Cytoxan)
   - Renal biopsy on a.m. of [**1-29**] - we will round on him early and would
   like to have DDAVP, platelets, coags drawn.
   - Final Renal recs: One dose DDAVP and FFP to start at 9:30. Biopsy
   will be around 11:00 and Changed cefepime 2g q12 for CVVH.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefazolin - [**2128-1-27**] 10:00 AM
   Vancomycin - [**2128-1-28**] 10:00 AM
   Cefipime - [**2128-1-28**] 12:00 PM
   Infusions:
   Midazolam (Versed) - 7 mg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 2 mEq./hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-28**] 08:00 AM
   Midazolam (Versed) - [**2128-1-29**] 03:25 AM
   Fentanyl - [**2128-1-29**] 03:26 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-29**] 07:22 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.9
C (96.7
   HR: 75 (75 - 75) bpm
   BP: 106/54(73) {73/30(46) - 123/59(82)} mmHg
   RR: 20 (12 - 29) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 84 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 16 (12 - 22)mmHg
   Total In:
                                                                  7,656 mL
                                                                  2,214 mL
   PO:
   TF:
                                                                     85 mL
                                                                    159 mL
   IVF:
                                                                  7,041 mL
                                                                  2,055 mL
   Blood products:
                                                                    350 mL
   Total out:
                                                                 10,809 mL
                                                                  2,842 mL
   Urine:
                                                                    664 mL
                                                                    148 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -3,153 mL
                                                                   -628 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 440 (440 - 550) mL
   Vt (Spontaneous): 406 (406 - 406) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 12 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 31 cmH2O
   Plateau: 24 cmH2O
   Compliance: 44 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/47/90.[**Numeric Identifier 128**]/25/2
   Ve: 10 L/min
   PaO2 / FiO2: 225
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Skin: Petechial rash lower extremity.
   Labs / Radiology
   237 K/uL
   9.0 g/dL
   200 mg/dL
   1.8 mg/dL
   25 mEq/L
   4.5 mEq/L
   47 mg/dL
   99 mEq/L
   137 mEq/L
   26.7 %
   6.3 K/uL
        [image002.jpg]
                             [**2128-1-28**]  06:06 AM
                             [**2128-1-28**]  10:55 AM
                             [**2128-1-28**]  11:02 AM
                             [**2128-1-28**]  04:28 PM
                             [**2128-1-28**]  05:35 PM
                             [**2128-1-28**]  05:44 PM
                             [**2128-1-28**]  10:00 PM
                             [**2128-1-28**]  10:24 PM
                             [**2128-1-29**]  03:57 AM
                             [**2128-1-29**]  04:00 AM
   WBC
   4.4
   5.9
   6.3
   Hct
   26.3
   27.2
   27.2
   26.7
   Plt
   249
   250
   237
   Cr
   1.9
   1.9
   1.8
   TCO2
   25
   28
   28
   29
   29
   30
   Glucose
   [**Telephone/Fax (3) 11377**]93
   200
   Other labs: PT / PTT / INR:15.7/26.4/1.4, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:9.0 mg/dL, Mg++:2.1 mg/dL, PO4:3.5 mg/dL
   Imaging: Chest Xray ([**1-27**]): Pending
   Microbiology: Sputum:
      GRAM STAIN (Final [**2128-1-27**]):
         [**11-8**] PMNs and <10 epithelial cells/100X field.
         1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S).
      RESPIRATORY CULTURE (Preliminary):
         SPARSE GROWTH OROPHARYNGEAL FLORA.
         GRAM NEGATIVE ROD(S).    MODERATE GROWTH.
   BAL:
      GRAM STAIN (Final [**2128-1-27**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      RESPIRATORY CULTURE (Preliminary):    NO GROWTH, <1000 CFU/ml.
   Blood ([**1-27**]): Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable.
   # Hypoxemic Respiratory Failure and Possible Vasculitis
   Given findings on CXR, CVP, clinical presentation and bronchoscopy,
   likely secondary to diffuse alveolar hemorrhage and fluid overload. ESR
   is elevated, there is a pupruic macular rash and renal failure, all
   concerning for vasculitis, although there are other possibilities. [**Doctor First Name 1205**]
   and ANCA are negative and anti-GBM is pending. If we seek a unifying
   diagnosis, may be that anti-GBM is negative given skin process.
   Variability in antibody responsible may account for this, and general
   approaches and pathology may eventually be most helpful. Renal biopsy
   is possible (see below). Presently conditions of each organ stabilized
   on high dose steroids, also suggestive. Rheumatology raised Cytoxan
   treatment and plasmaphoresis, but we will need to discuss this further
   with Renal and Pathology.
   - Renal Biopsy this AM
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Await anti-GBM
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Continue Solu-medrol
   - sp Renal Biopsy, consider Cytoxan and plasmapheresis with d/w Renal
   and Rheumatology
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Hold heparin, ASA
   - Continue to remove fluid with CVVH
   # Coagulopathy: Plan for Kidney Biopsy today. INR 1.4 this AM,
   Platelets NL however may be dysfunctional given ASA /Uremia.
   - DDAVP today
   - FFP during procedure
   - One unit platlets.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.8 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Now unclear if this is truly manifestation of systemic
   vasculitis or drug reaction. White cells and eosinophils in urine
   consistent with either, although more classic of AIN.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - Renally dose/CVVH dose meds.
   - Management as above, including IV Solu-medrol.
   - Possible renal biopsy tomorrow given that we are now holding
   anticoagulants
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above, will restart anticoagulation sp biopsy with
   very low ptt goal.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - No heparin for now
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition: Tube Feeds
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:  H2R Blocker
   VAP:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of CAD, s/p CABG, and mechanical AVR, who was admitted for MSSA endocarditis with complications of ARF, AIN, CHB, and torsades, and leukocytoclastic dermatitis on skin biopsy. He was transferred to the MICU with respiratory distress, hypoxemia, and hemoptysis concerning for DAH. The patient has a complex medical history, including a recent mechanical AVR, and is currently receiving treatment for endocarditis, ARF, and AIN.

Potential Medical Complications:

1. Diffuse Alveolar Hemorrhage (DAH): The patient's respiratory status is critical, and DAH is a potential complication that could worsen his condition.
2. Vasculitis: The patient's skin biopsy shows leukocytoclastic dermatitis, which may be a sign of vasculitis. If confirmed, this could lead to further complications, including organ failure.
3. Coagulopathy: The patient's INR is elevated, and he is at risk for bleeding. This could be exacerbated by his anticoagulation therapy.
4. Acute Kidney Injury (AKI): The patient's Cr is elevated, and he is at risk for further kidney injury.
5. Endocarditis: The patient has a high-grade MSSA bacteremia and fulfills Duke Criteria for endocarditis. This could lead to further complications, including abscess formation and embolization.
6. Atrial Fibrillation/Complete Heart Block: The patient's cardiac status is unstable, and he is at risk for further arrhythmias.
7. Anemia: The patient's Hct is low, and he may be at risk for further bleeding.

Assessment and Plan:

The patient's conditions are currently stabilized, but his medical status is critical. The plan is to maintain intubation and mechanical ventilation, and to continue treatment for endocarditis, ARF, and AIN. The patient will undergo a renal biopsy today, and further testing will be done to determine the underlying cause of his vasculitis. The patient's coagulopathy will be managed with DDAVP and FFP, and his anemia will be monitored closely. The patient's cardiac status will be closely monitored, and he will be followed by the EP service."
182149.0,283460,2128-01-29 07:26:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: Endocarditis, Renal Failure, DAH
   24 Hour Events:
   - Some desynchrony with vent today, so fent and Versed increased
   - Bronch today some bronchial plugging with thrombus.
   - Rheumatology want us to continue discussing cytoxan and would like us
   to touch base with ID about starting this in the context of
   bacteremia/endocarditis. They would also like to ses phoresis prior to
   starting Cytoxan. They would like everyone to agree on the diagnosis of
   vasculitis before this proceeds.
   - Started tube feeds
   - Finished second unit of PRCs in a.m.
   - Spoke to both daughters yesterday with Renal - they agreed upon
   course of action (steroids and biopsy then decide about phoresis and
   Cytoxan)
   - Renal biopsy on a.m. of [**1-29**] - we will round on him early and would
   like to have DDAVP, platelets, coags drawn.
   - Final Renal recs: One dose DDAVP and FFP to start at 9:30. Biopsy
   will be around 11:00 and Changed cefepime 2g q12 for CVVH.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefazolin - [**2128-1-27**] 10:00 AM
   Vancomycin - [**2128-1-28**] 10:00 AM
   Cefipime - [**2128-1-28**] 12:00 PM
   Infusions:
   Midazolam (Versed) - 7 mg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 2 mEq./hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-28**] 08:00 AM
   Midazolam (Versed) - [**2128-1-29**] 03:25 AM
   Fentanyl - [**2128-1-29**] 03:26 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-29**] 07:22 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.9
C (96.7
   HR: 75 (75 - 75) bpm
   BP: 106/54(73) {73/30(46) - 123/59(82)} mmHg
   RR: 20 (12 - 29) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 84 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 16 (12 - 22)mmHg
   Total In:
                                                                  7,656 mL
                                                                  2,214 mL
   PO:
   TF:
                                                                     85 mL
                                                                    159 mL
   IVF:
                                                                  7,041 mL
                                                                  2,055 mL
   Blood products:
                                                                    350 mL
   Total out:
                                                                 10,809 mL
                                                                  2,842 mL
   Urine:
                                                                    664 mL
                                                                    148 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -3,153 mL
                                                                   -628 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 440 (440 - 550) mL
   Vt (Spontaneous): 406 (406 - 406) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 12 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 31 cmH2O
   Plateau: 24 cmH2O
   Compliance: 44 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/47/90.[**Numeric Identifier 128**]/25/2
   Ve: 10 L/min
   PaO2 / FiO2: 225
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   then later some desynchrony.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Labs / Radiology
   237 K/uL
   9.0 g/dL
   200 mg/dL
   1.8 mg/dL
   25 mEq/L
   4.5 mEq/L
   47 mg/dL
   99 mEq/L
   137 mEq/L
   26.7 %
   6.3 K/uL
        [image002.jpg]
                             [**2128-1-28**]  06:06 AM
                             [**2128-1-28**]  10:55 AM
                             [**2128-1-28**]  11:02 AM
                             [**2128-1-28**]  04:28 PM
                             [**2128-1-28**]  05:35 PM
                             [**2128-1-28**]  05:44 PM
                             [**2128-1-28**]  10:00 PM
                             [**2128-1-28**]  10:24 PM
                             [**2128-1-29**]  03:57 AM
                             [**2128-1-29**]  04:00 AM
   WBC
   4.4
   5.9
   6.3
   Hct
   26.3
   27.2
   27.2
   26.7
   Plt
   249
   250
   237
   Cr
   1.9
   1.9
   1.8
   TCO2
   25
   28
   28
   29
   29
   30
   Glucose
   [**Telephone/Fax (3) 11377**]93
   200
   Other labs: PT / PTT / INR:15.7/26.4/1.4, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:9.0 mg/dL, Mg++:2.1 mg/dL, PO4:3.5 mg/dL
   Imaging: Chest Xray ([**1-27**]): Pending
   Microbiology: Sputum:
      GRAM STAIN (Final [**2128-1-27**]):
         [**11-8**] PMNs and <10 epithelial cells/100X field.
         1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S).
      RESPIRATORY CULTURE (Preliminary):
         SPARSE GROWTH OROPHARYNGEAL FLORA.
         GRAM NEGATIVE ROD(S).    MODERATE GROWTH.
   BAL:
      GRAM STAIN (Final [**2128-1-27**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      RESPIRATORY CULTURE (Preliminary):    NO GROWTH, <1000 CFU/ml.
   Blood ([**1-27**]): Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable.
   # Hypoxemic Respiratory Failure and Possible Vasculitis
   Given findings on CXR, CVP, clinical presentation and bronchoscopy,
   likely secondary to diffuse alveolar hemorrhage and fluid overload. ESR
   is elevated, there is a pupruic macular rash and renal failure, all
   concerning for vasculitis, although there are other possibilities. [**Doctor First Name 1205**]
   and ANCA are negative and anti-GBM is pending. If we seek a unifying
   diagnosis, may be that anti-GBM is negative given skin process.
   Variability in antibody responsible may account for this, and general
   approaches and pathology may eventually be most helpful. Renal biopsy
   is possible (see below). Presently conditions of each organ stabilized
   on high dose steroids, also suggestive. Rheumatology raised Cytoxan
   treatment and plasmaphoresis, but we will need to discuss this further
   with Renal and Pathology.
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Repeat bronchoscopy today to remove thrombus plugging and examine
   again.
   - Await anti-GBM
   - Discuss renal biopsy
   - Continue to appreciate input of Rheumatology and Renal
   - Continue Solu-medrol
   - Consider Cytoxan and plasmapheresis with d/w Renal and Rheumatology
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
 stop
   cefazolin
   - Hold heparin, ASA
   # Hemoptysis and Coagulopathy
   Evidence, perhaps with purpuric rash, of coagulopathy, or potentially
   as a manifestation of vasculitis. For the former and possibly uremic
   platelets, anticoagulant therapy. In favor of the latter is unifying
   diagnosis and co-occurrence with renal disease and rash. See discussion
   above
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 2.1 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Now unclear if this is truly manifestation of systemic
   vasculitis or drug reaction. White cells and eosinophils in urine
   consistent with either, although more classic of AIN.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - Renally dose/CVVH dose meds.
   - Management as above, including IV Solu-medrol.
   - Possible renal biopsy tomorrow given that we are now holding
   anticoagulants
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.  Now on Cefazolin since [**1-22**]
   instead of Vanc as better for MSSA with increased dosing [**1-25**].
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8-Q12.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - No heparin for now
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition: Tube Feeds
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:  H2R Blocker
   VAP:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: Endocarditis, Renal Failure, DAH
   24 Hour Events:
   - Some desynchrony with vent today, so fent and Versed increased
   - Bronch today some bronchial plugging with thrombus.
   - Rheumatology want us to continue discussing cytoxan and would like us
   to touch base with ID about starting this in the context of
   bacteremia/endocarditis. They would also like to ses phoresis prior to
   starting Cytoxan. They would like everyone to agree on the diagnosis of
   vasculitis before this proceeds.
   - Started tube feeds
   - Finished second unit of PRCs in a.m.
   - Spoke to both daughters yesterday with Renal - they agreed upon
   course of action (steroids and biopsy then decide about phoresis and
   Cytoxan)
   - Renal biopsy on a.m. of [**1-29**] - we will round on him early and would
   like to have DDAVP, platelets, coags drawn.
   - Final Renal recs: One dose DDAVP and FFP to start at 9:30. Biopsy
   will be around 11:00 and Changed cefepime 2g q12 for CVVH.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefazolin - [**2128-1-27**] 10:00 AM
   Vancomycin - [**2128-1-28**] 10:00 AM
   Cefipime - [**2128-1-28**] 12:00 PM
   Infusions:
   Midazolam (Versed) - 7 mg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 2 mEq./hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-28**] 08:00 AM
   Midazolam (Versed) - [**2128-1-29**] 03:25 AM
   Fentanyl - [**2128-1-29**] 03:26 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-29**] 07:22 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.9
C (96.7
   HR: 75 (75 - 75) bpm
   BP: 106/54(73) {73/30(46) - 123/59(82)} mmHg
   RR: 20 (12 - 29) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 84 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 16 (12 - 22)mmHg
   Total In:
                                                                  7,656 mL
                                                                  2,214 mL
   PO:
   TF:
                                                                     85 mL
                                                                    159 mL
   IVF:
                                                                  7,041 mL
                                                                  2,055 mL
   Blood products:
                                                                    350 mL
   Total out:
                                                                 10,809 mL
                                                                  2,842 mL
   Urine:
                                                                    664 mL
                                                                    148 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -3,153 mL
                                                                   -628 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 440 (440 - 550) mL
   Vt (Spontaneous): 406 (406 - 406) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 12 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 31 cmH2O
   Plateau: 24 cmH2O
   Compliance: 44 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/47/90.[**Numeric Identifier 128**]/25/2
   Ve: 10 L/min
   PaO2 / FiO2: 225
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   then later some desynchrony.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Labs / Radiology
   237 K/uL
   9.0 g/dL
   200 mg/dL
   1.8 mg/dL
   25 mEq/L
   4.5 mEq/L
   47 mg/dL
   99 mEq/L
   137 mEq/L
   26.7 %
   6.3 K/uL
        [image002.jpg]
                             [**2128-1-28**]  06:06 AM
                             [**2128-1-28**]  10:55 AM
                             [**2128-1-28**]  11:02 AM
                             [**2128-1-28**]  04:28 PM
                             [**2128-1-28**]  05:35 PM
                             [**2128-1-28**]  05:44 PM
                             [**2128-1-28**]  10:00 PM
                             [**2128-1-28**]  10:24 PM
                             [**2128-1-29**]  03:57 AM
                             [**2128-1-29**]  04:00 AM
   WBC
   4.4
   5.9
   6.3
   Hct
   26.3
   27.2
   27.2
   26.7
   Plt
   249
   250
   237
   Cr
   1.9
   1.9
   1.8
   TCO2
   25
   28
   28
   29
   29
   30
   Glucose
   [**Telephone/Fax (3) 11377**]93
   200
   Other labs: PT / PTT / INR:15.7/26.4/1.4, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:9.0 mg/dL, Mg++:2.1 mg/dL, PO4:3.5 mg/dL
   Imaging: Chest Xray ([**1-27**]): Pending
   Microbiology: Sputum:
      GRAM STAIN (Final [**2128-1-27**]):
         [**11-8**] PMNs and <10 epithelial cells/100X field.
         1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S).
      RESPIRATORY CULTURE (Preliminary):
         SPARSE GROWTH OROPHARYNGEAL FLORA.
         GRAM NEGATIVE ROD(S).    MODERATE GROWTH.
   BAL:
      GRAM STAIN (Final [**2128-1-27**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      RESPIRATORY CULTURE (Preliminary):    NO GROWTH, <1000 CFU/ml.
   Blood ([**1-27**]): Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable.
   # Hypoxemic Respiratory Failure and Possible Vasculitis
   Given findings on CXR, CVP, clinical presentation and bronchoscopy,
   likely secondary to diffuse alveolar hemorrhage and fluid overload. ESR
   is elevated, there is a pupruic macular rash and renal failure, all
   concerning for vasculitis, although there are other possibilities. [**Doctor First Name 1205**]
   and ANCA are negative and anti-GBM is pending. If we seek a unifying
   diagnosis, may be that anti-GBM is negative given skin process.
   Variability in antibody responsible may account for this, and general
   approaches and pathology may eventually be most helpful. Renal biopsy
   is possible (see below). Presently conditions of each organ stabilized
   on high dose steroids, also suggestive. Rheumatology raised Cytoxan
   treatment and plasmaphoresis, but we will need to discuss this further
   with Renal and Pathology.
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Repeat bronchoscopy today to remove thrombus plugging and examine
   again.
   - Await anti-GBM
   - Discuss renal biopsy
   - Continue to appreciate input of Rheumatology and Renal
   - Continue Solu-medrol
   - Consider Cytoxan and plasmapheresis with d/w Renal and Rheumatology
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
 stop
   cefazolin
   - Hold heparin, ASA
   # Hemoptysis and Coagulopathy
   Evidence, perhaps with purpuric rash, of coagulopathy, or potentially
   as a manifestation of vasculitis. For the former and possibly uremic
   platelets, anticoagulant therapy. In favor of the latter is unifying
   diagnosis and co-occurrence with renal disease and rash. See discussion
   above
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 2.1 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Now unclear if this is truly manifestation of systemic
   vasculitis or drug reaction. White cells and eosinophils in urine
   consistent with either, although more classic of AIN.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - Renally dose/CVVH dose meds.
   - Management as above, including IV Solu-medrol.
   - Possible renal biopsy tomorrow given that we are now holding
   anticoagulants
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.  Now on Cefazolin since [**1-22**]
   instead of Vanc as better for MSSA with increased dosing [**1-25**].
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8-Q12.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - No heparin for now
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition: Tube Feeds
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:  H2R Blocker
   VAP:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of coronary artery disease, mechanical aortic valve replacement, and atrial fibrillation, who was admitted to the hospital with a diagnosis of methicillin-sensitive Staphylococcus aureus (MSSA) endocarditis, acute renal failure, and diffuse alveolar hemorrhage (DAH). He has been transferred to the intensive care unit (ICU) due to worsening respiratory distress, hypoxemia, and hemoptysis. The patient has a purpuric macular rash on his skin, which is concerning for vasculitis.

The patient has been treated with high-dose steroids, and his condition has been stabilized. However, his respiratory status remains unstable, and he requires mechanical ventilation. His renal function is improving, but he still requires continuous renal replacement therapy (CRRT). His coagulopathy is being managed with anticoagulant therapy, and his platelet count is low.

The patient's diagnosis is complex and uncertain, and further testing is needed to determine the underlying cause of his vasculitis and DAH. A renal biopsy is planned to help determine the diagnosis and guide further treatment.

Potential medical complications that can arise from the patient's condition include:

1. Respiratory failure: The patient's respiratory status remains unstable, and he may require further interventions, such as tracheostomy or extracorporeal membrane oxygenation (ECMO), to support his breathing.
2. Coagulopathy: The patient's coagulopathy is being managed with anticoagulant therapy, but he may be at risk for bleeding complications, such as gastrointestinal bleeding or intracranial hemorrhage.
3. Renal failure: The patient's renal function is improving, but he may still require dialysis or CRRT to manage his kidney function.
4. Endocarditis: The patient has a diagnosis of MSSA endocarditis, and he may require long-term antibiotics to treat this condition.
5. Vasculitis: The patient's vasculitis may be caused by a variety of factors, including autoimmune disorders, infections, or medications. Further testing is needed to determine the underlying cause of his vasculitis and guide further treatment.
6. Leukoclastic dermatitis: The patient has a purpuric macular rash on his skin, which may be a manifestation of his vasculitis or a separate condition. Further evaluation is needed to determine the cause of his rash and guide further treatment.

In summary, the patient's condition is complex and uncertain, and further testing and treatment are needed to determine the underlying cause of his vasculitis and DAH. Potential medical complications that can arise from his condition include respiratory failure, coagulopathy, renal failure, endocarditis, vasculitis, and leukoclastic dermatitis."
182149.0,283460,2128-01-30 07:41:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: Endocarditis, [**Last Name (un) **], DAH
   24 Hour Events:
   - Called lab processing anti GBM and verbally reported to be negative.
   - Serial hematocrit s/p procedure: stable
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefazolin - [**2128-1-27**] 10:00 AM
   Vancomycin - [**2128-1-29**] 01:33 PM
   Cefipime - [**2128-1-30**] 12:03 AM
   Infusions:
   Fentanyl - 125 mcg/hour
   Midazolam (Versed) - 3 mg/hour
   KCl (CRRT) - 2 mEq./hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-29**] 08:25 AM
   Fentanyl - [**2128-1-29**] 11:28 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-30**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 134/62(88) {100/50(69) - 146/70(95)} mmHg
   RR: 15 (9 - 27) insp/min
   SpO2: 99%
   Heart rhythm: V Paced
   Wgt (current): 78.6 kg (admission): 85 kg
   Height: 68 Inch
             Total In:
                                                                  7,709 mL
                                                                  2,170 mL
   PO:
             TF:
                                                                    497 mL
                                                                    228 mL
   IVF:
                                                                  6,409 mL
                                                                  1,942 mL
   Blood products:
                                                                    573 mL
   Total out:
                                                                  9,633 mL
                                                                  3,659 mL
   Urine:
                                                                    473 mL
                                                                    170 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,924 mL
                                                                 -1,489 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 440 (440 - 440) mL
   Vt (Spontaneous): 781 (711 - 781) mL
   PS : 10 cmH2O
   RR (Set): 20
   RR (Spontaneous): 10
   PEEP: 12 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 23 cmH2O
   Plateau: 21 cmH2O
   Compliance: 62.9 cmH2O/mL
   SpO2: 99%
   ABG: 7.43/44/160/26/4
   Ve: 8.2 L/min
   PaO2 / FiO2: 400
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Skin: Petechial rash lower extremity.
   Labs / Radiology
   248 K/uL
   9.2 g/dL
   271 mg/dL
   1.6 mg/dL
   26 mEq/L
   4.2 mEq/L
   44 mg/dL
   99 mEq/L
   138 mEq/L
   28.2 %
   8.5 K/uL
        [image002.jpg]
                             [**2128-1-29**]  12:33 PM
                             [**2128-1-29**]  12:34 PM
                             [**2128-1-29**]  12:46 PM
                             [**2128-1-29**]  04:42 PM
                             [**2128-1-29**]  06:19 PM
                             [**2128-1-29**]  06:29 PM
                             [**2128-1-30**]  12:14 AM
                             [**2128-1-30**]  12:24 AM
                             [**2128-1-30**]  04:20 AM
                             [**2128-1-30**]  04:28 AM
   WBC
   8.5
   Hct
   27.4
   27.9
   28.7
   28.2
   Plt
   263
   248
   Cr
   1.8
   1.7
   1.6
   TCO2
   31
   32
   30
   30
   Glucose
   175
   252
   272
   271
   Other labs: PT / PTT / INR:15.2/26.0/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.9 mg/dL, Mg++:2.0 mg/dL, PO4:2.5 mg/dL
   Imaging: CXR: Pending
   Microbiology: [**2128-1-27**] 2:16 am SPUTUM      Source: Expectorated.
      GRAM STAIN (Final [**2128-1-27**]):
         [**11-8**] PMNs and <10 epithelial cells/100X field.
         1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S).
      RESPIRATORY CULTURE (Preliminary):
         MODERATE GROWTH OROPHARYNGEAL FLORA.
         GRAM NEGATIVE ROD(S).    MODERATE GROWTH.
   [**2128-1-27**] 1:34 pm BRONCHOALVEOLAR LAVAGE
                               **FINAL REPORT [**2128-1-29**]**
      GRAM STAIN (Final [**2128-1-27**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      RESPIRATORY CULTURE (Final [**2128-1-29**]):    NO GROWTH, <1000 CFU/ml.
   Blood Cultures: [**1-27**] Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic Respiratory Failure:
   At this time thought to be secondary to pulmonary edema and
   anticoagulation given negative anti-GBM and rather unrevealing renal
   biopsy. ESR is elevated, there is a pupruic macular rash and renal
   failure, all concerning for vasculitis, although there are other
   possibilities. [**Doctor First Name 1205**] and ANCA are negative. Patient clinically improving
   sp diuresis and steroids. HCT stable.
   - FU Renal Biopsy
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Restart Heparin this AM, no bolus. PTT goal 50-70,
   - Hold ASA until tomorrow
   - Continue to remove fluid with CVVH
   - Continue lower dose steroids at this time.
   .
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.6 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Renal biopsy without changes consistent with AIN, may be
   secondary to immune complex deposition in the setting of endocarditis.
   Awaiting immunostaining currently.
   - f/u renal recs, discuss thoughts
   - Renally dose/CVVH dose meds.
   - Lower Dose steroids at this time, however will follow up with renal
   regarding further treatment.
   - FU biopsy results
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - restart heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for until tomorrow, knowing high risk with DES.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - Heparin as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-30**] 04:26 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: H2Blocker
   VAP:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU for now.
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: Endocarditis, [**Last Name (un) **], DAH
   24 Hour Events:
   - Called lab processing anti GBM and verbally reported to be negative.
   - Serial hematocrit s/p procedure: stable
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefazolin - [**2128-1-27**] 10:00 AM
   Vancomycin - [**2128-1-29**] 01:33 PM
   Cefipime - [**2128-1-30**] 12:03 AM
   Infusions:
   Fentanyl - 125 mcg/hour
   Midazolam (Versed) - 3 mg/hour
   KCl (CRRT) - 2 mEq./hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-29**] 08:25 AM
   Fentanyl - [**2128-1-29**] 11:28 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-30**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 134/62(88) {100/50(69) - 146/70(95)} mmHg
   RR: 15 (9 - 27) insp/min
   SpO2: 99%
   Heart rhythm: V Paced
   Wgt (current): 78.6 kg (admission): 85 kg
   Height: 68 Inch
             Total In:
                                                                  7,709 mL
                                                                  2,170 mL
   PO:
             TF:
                                                                    497 mL
                                                                    228 mL
   IVF:
                                                                  6,409 mL
                                                                  1,942 mL
   Blood products:
                                                                    573 mL
   Total out:
                                                                  9,633 mL
                                                                  3,659 mL
   Urine:
                                                                    473 mL
                                                                    170 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,924 mL
                                                                 -1,489 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 440 (440 - 440) mL
   Vt (Spontaneous): 781 (711 - 781) mL
   PS : 10 cmH2O
   RR (Set): 20
   RR (Spontaneous): 10
   PEEP: 12 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 23 cmH2O
   Plateau: 21 cmH2O
   Compliance: 62.9 cmH2O/mL
   SpO2: 99%
   ABG: 7.43/44/160/26/4
   Ve: 8.2 L/min
   PaO2 / FiO2: 400
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Skin: Petechial rash lower extremity.
   Labs / Radiology
   248 K/uL
   9.2 g/dL
   271 mg/dL
   1.6 mg/dL
   26 mEq/L
   4.2 mEq/L
   44 mg/dL
   99 mEq/L
   138 mEq/L
   28.2 %
   8.5 K/uL
        [image002.jpg]
                             [**2128-1-29**]  12:33 PM
                             [**2128-1-29**]  12:34 PM
                             [**2128-1-29**]  12:46 PM
                             [**2128-1-29**]  04:42 PM
                             [**2128-1-29**]  06:19 PM
                             [**2128-1-29**]  06:29 PM
                             [**2128-1-30**]  12:14 AM
                             [**2128-1-30**]  12:24 AM
                             [**2128-1-30**]  04:20 AM
                             [**2128-1-30**]  04:28 AM
   WBC
   8.5
   Hct
   27.4
   27.9
   28.7
   28.2
   Plt
   263
   248
   Cr
   1.8
   1.7
   1.6
   TCO2
   31
   32
   30
   30
   Glucose
   175
   252
   272
   271
   Other labs: PT / PTT / INR:15.2/26.0/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.9 mg/dL, Mg++:2.0 mg/dL, PO4:2.5 mg/dL
   Imaging: CXR: Pending
   Microbiology: [**2128-1-27**] 2:16 am SPUTUM      Source: Expectorated.
      GRAM STAIN (Final [**2128-1-27**]):
         [**11-8**] PMNs and <10 epithelial cells/100X field.
         1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S).
      RESPIRATORY CULTURE (Preliminary):
         MODERATE GROWTH OROPHARYNGEAL FLORA.
         GRAM NEGATIVE ROD(S).    MODERATE GROWTH.
   [**2128-1-27**] 1:34 pm BRONCHOALVEOLAR LAVAGE
                               **FINAL REPORT [**2128-1-29**]**
      GRAM STAIN (Final [**2128-1-27**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      RESPIRATORY CULTURE (Final [**2128-1-29**]):    NO GROWTH, <1000 CFU/ml.
   Blood Cultures: [**1-27**] Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic Respiratory Failure:
   At this time thought to be secondary to pulmonary edema and
   anticoagulation given negative anti-GBM and rather unrevealing renal
   biopsy. ESR is elevated, there is a pupruic macular rash and renal
   failure, all concerning for vasculitis, although there are other
   possibilities. [**Doctor First Name 1205**] and ANCA are negative. Patient clinically improving
   sp diuresis and steroids. HCT stable.
   - FU Renal Biopsy
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Restart Heparin this AM, no bolus. PTT goal 50-70,
   - Hold ASA until tomorrow
   - Continue to remove fluid with CVVH
   - Continue lower dose steroids at this time.
   .
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.6 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Renal biopsy without changes consistent with AIN, may be
   secondary to immune complex deposition in the setting of endocarditis.
   Awaiting immunostaining currently.
   - f/u renal recs, discuss thoughts
   - Renally dose/CVVH dose meds.
   - Lower Dose steroids at this time, however will follow up with renal
   regarding further treatment.
   - FU biopsy results
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - restart heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for until tomorrow, knowing high risk with DES.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - Heparin as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-30**] 04:26 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: H2Blocker
   VAP:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU for now.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of coronary artery disease, who was admitted for methicillin-sensitive Staphylococcus aureus (MSSA) endocarditis, acute kidney injury, and apparent acute interstitial nephritis. He has been intubated and is receiving mechanical ventilation for respiratory distress and hypoxemia. He has a history of atrial fibrillation, complete heart block, and torsades de pointes, and is currently receiving ventricular pacing.

The patient's current condition is as follows:

* Respiratory status: Hypoxemic respiratory failure, secondary to pulmonary edema and anticoagulation.
* Renal status: Acute kidney injury, with a creatinine level of 1.6 mg/dL, and a blood urea nitrogen (BUN) level of 28.2 mg/dL.
* Hematological status: Anemia, with a hemoglobin level of 9.2 g/dL, and a platelet count of 263,000/mm3.
* Cardiovascular status: Hypertension, with a blood pressure of 134/62 mmHg, and a heart rate of 75 beats per minute.
* Dermatological status: Leukocytoclastic dermatitis, with a macular non-blanching purpuric rash on the trunk and extremities.

Potential medical complications:

1. Pulmonary hemorrhage: The patient's respiratory status is critical, and there is a risk of pulmonary hemorrhage due to the anticoagulation therapy and the patient's history of bleeding disorders.
2. Renal failure: The patient's creatinine level is elevated, and there is a risk of further renal failure due to the ongoing endocarditis and acute kidney injury.
3. Atrial fibrillation: The patient's history of atrial fibrillation and complete heart block increases the risk of further cardiac arrhythmias, including torsades de pointes.
4. Leukocytoclastic dermatitis: The patient's dermatological condition is concerning, and there is a risk of further skin lesions and systemic complications.
5. Bacteremia: The patient's blood cultures are positive for MSSA, and there is a risk of further bacteremia and endocarditis.

Assessment and plan:

1. Continue to monitor the patient's respiratory status closely, and adjust the ventilator settings as needed.
2. Continue to manage the patient's anticoagulation therapy, and monitor for signs of bleeding or hemorrhage.
3. Continue to manage the patient's renal status, and monitor for signs of further renal failure.
4. Continue to manage the patient's dermatological condition, and monitor for signs of further skin lesions or systemic complications.
5. Continue to monitor the patient's blood cultures, and adjust the antibiotic therapy as needed.
6. Consider performing a transesophageal echocardiogram (TEE) to evaluate the patient's cardiac structure and function.
7. Consider consulting with a rheumatologist, nephrologist, and dermatologist to further evaluate the patient's condition and develop a comprehensive treatment plan."
182149.0,283460,2128-01-30 07:41:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: Endocarditis, [**Last Name (un) **], DAH
   24 Hour Events:
   - Called lab processing anti GBM and verbally reported to be negative.
   - Serial hematocrit s/p procedure: stable
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefazolin - [**2128-1-27**] 10:00 AM
   Vancomycin - [**2128-1-29**] 01:33 PM
   Cefipime - [**2128-1-30**] 12:03 AM
   Infusions:
   Fentanyl - 125 mcg/hour
   Midazolam (Versed) - 3 mg/hour
   KCl (CRRT) - 2 mEq./hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-29**] 08:25 AM
   Fentanyl - [**2128-1-29**] 11:28 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-30**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 134/62(88) {100/50(69) - 146/70(95)} mmHg
   RR: 15 (9 - 27) insp/min
   SpO2: 99%
   Heart rhythm: V Paced
   Wgt (current): 78.6 kg (admission): 85 kg
   Height: 68 Inch
             Total In:
                                                                  7,709 mL
                                                                  2,170 mL
   PO:
             TF:
                                                                    497 mL
                                                                    228 mL
   IVF:
                                                                  6,409 mL
                                                                  1,942 mL
   Blood products:
                                                                    573 mL
   Total out:
                                                                  9,633 mL
                                                                  3,659 mL
   Urine:
                                                                    473 mL
                                                                    170 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,924 mL
                                                                 -1,489 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 440 (440 - 440) mL
   Vt (Spontaneous): 781 (711 - 781) mL
   PS : 10 cmH2O
   RR (Set): 20
   RR (Spontaneous): 10
   PEEP: 12 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 23 cmH2O
   Plateau: 21 cmH2O
   Compliance: 62.9 cmH2O/mL
   SpO2: 99%
   ABG: 7.43/44/160/26/4
   Ve: 8.2 L/min
   PaO2 / FiO2: 400
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Skin: Petechial rash lower extremity.
   Labs / Radiology
   248 K/uL
   9.2 g/dL
   271 mg/dL
   1.6 mg/dL
   26 mEq/L
   4.2 mEq/L
   44 mg/dL
   99 mEq/L
   138 mEq/L
   28.2 %
   8.5 K/uL
        [image002.jpg]
                             [**2128-1-29**]  12:33 PM
                             [**2128-1-29**]  12:34 PM
                             [**2128-1-29**]  12:46 PM
                             [**2128-1-29**]  04:42 PM
                             [**2128-1-29**]  06:19 PM
                             [**2128-1-29**]  06:29 PM
                             [**2128-1-30**]  12:14 AM
                             [**2128-1-30**]  12:24 AM
                             [**2128-1-30**]  04:20 AM
                             [**2128-1-30**]  04:28 AM
   WBC
   8.5
   Hct
   27.4
   27.9
   28.7
   28.2
   Plt
   263
   248
   Cr
   1.8
   1.7
   1.6
   TCO2
   31
   32
   30
   30
   Glucose
   175
   252
   272
   271
   Other labs: PT / PTT / INR:15.2/26.0/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.9 mg/dL, Mg++:2.0 mg/dL, PO4:2.5 mg/dL
   Imaging: CXR: Pending
   Microbiology: [**2128-1-27**] 2:16 am SPUTUM      Source: Expectorated.
      GRAM STAIN (Final [**2128-1-27**]):
         [**11-8**] PMNs and <10 epithelial cells/100X field.
         1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S).
      RESPIRATORY CULTURE (Preliminary):
         MODERATE GROWTH OROPHARYNGEAL FLORA.
         GRAM NEGATIVE ROD(S).    MODERATE GROWTH.
   [**2128-1-27**] 1:34 pm BRONCHOALVEOLAR LAVAGE
                               **FINAL REPORT [**2128-1-29**]**
      GRAM STAIN (Final [**2128-1-27**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      RESPIRATORY CULTURE (Final [**2128-1-29**]):    NO GROWTH, <1000 CFU/ml.
   Blood Cultures: [**1-27**] Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable.
   # Hypoxemic Respiratory Failure and Possible Vasculitis
   Given findings on CXR, CVP, clinical presentation and bronchoscopy,
   likely secondary to diffuse alveolar hemorrhage and fluid overload. ESR
   is elevated, there is a pupruic macular rash and renal failure, all
   concerning for vasculitis, although there are other possibilities. [**Doctor First Name 1205**]
   and ANCA are negative and anti-GBM is pending. If we seek a unifying
   diagnosis, may be that anti-GBM is negative given skin process.
   Variability in antibody responsible may account for this, and general
   approaches and pathology may eventually be most helpful. Renal biopsy
   is possible (see below). Presently conditions of each organ stabilized
   on high dose steroids, also suggestive. Rheumatology raised Cytoxan
   treatment and plasmaphoresis, but we will need to discuss this further
   with Renal and Pathology.
   - Renal Biopsy this AM
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Await anti-GBM
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Continue Solu-medrol
   - sp Renal Biopsy, consider Cytoxan and plasmapheresis with d/w Renal
   and Rheumatology
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Hold heparin, ASA
   - Continue to remove fluid with CVVH
   # Coagulopathy: Plan for Kidney Biopsy today. INR 1.4 this AM,
   Platelets NL however may be dysfunctional given ASA /Uremia.
   - DDAVP today
   - FFP during procedure
   - One unit platlets.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.8 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Now unclear if this is truly manifestation of systemic
   vasculitis or drug reaction. White cells and eosinophils in urine
   consistent with either, although more classic of AIN.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - Renally dose/CVVH dose meds.
   - Management as above, including IV Solu-medrol.
   - Possible renal biopsy tomorrow given that we are now holding
   anticoagulants
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above, will restart anticoagulation sp biopsy with
   very low ptt goal.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - No heparin for now
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-30**] 04:26 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: H2Blocker
   VAP:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU for now.
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: Endocarditis, [**Last Name (un) **], DAH
   24 Hour Events:
   - Called lab processing anti GBM and verbally reported to be negative.
   - Serial hematocrit s/p procedure: stable
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefazolin - [**2128-1-27**] 10:00 AM
   Vancomycin - [**2128-1-29**] 01:33 PM
   Cefipime - [**2128-1-30**] 12:03 AM
   Infusions:
   Fentanyl - 125 mcg/hour
   Midazolam (Versed) - 3 mg/hour
   KCl (CRRT) - 2 mEq./hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-29**] 08:25 AM
   Fentanyl - [**2128-1-29**] 11:28 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-30**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 134/62(88) {100/50(69) - 146/70(95)} mmHg
   RR: 15 (9 - 27) insp/min
   SpO2: 99%
   Heart rhythm: V Paced
   Wgt (current): 78.6 kg (admission): 85 kg
   Height: 68 Inch
             Total In:
                                                                  7,709 mL
                                                                  2,170 mL
   PO:
             TF:
                                                                    497 mL
                                                                    228 mL
   IVF:
                                                                  6,409 mL
                                                                  1,942 mL
   Blood products:
                                                                    573 mL
   Total out:
                                                                  9,633 mL
                                                                  3,659 mL
   Urine:
                                                                    473 mL
                                                                    170 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,924 mL
                                                                 -1,489 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 440 (440 - 440) mL
   Vt (Spontaneous): 781 (711 - 781) mL
   PS : 10 cmH2O
   RR (Set): 20
   RR (Spontaneous): 10
   PEEP: 12 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 23 cmH2O
   Plateau: 21 cmH2O
   Compliance: 62.9 cmH2O/mL
   SpO2: 99%
   ABG: 7.43/44/160/26/4
   Ve: 8.2 L/min
   PaO2 / FiO2: 400
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Skin: Petechial rash lower extremity.
   Labs / Radiology
   248 K/uL
   9.2 g/dL
   271 mg/dL
   1.6 mg/dL
   26 mEq/L
   4.2 mEq/L
   44 mg/dL
   99 mEq/L
   138 mEq/L
   28.2 %
   8.5 K/uL
        [image002.jpg]
                             [**2128-1-29**]  12:33 PM
                             [**2128-1-29**]  12:34 PM
                             [**2128-1-29**]  12:46 PM
                             [**2128-1-29**]  04:42 PM
                             [**2128-1-29**]  06:19 PM
                             [**2128-1-29**]  06:29 PM
                             [**2128-1-30**]  12:14 AM
                             [**2128-1-30**]  12:24 AM
                             [**2128-1-30**]  04:20 AM
                             [**2128-1-30**]  04:28 AM
   WBC
   8.5
   Hct
   27.4
   27.9
   28.7
   28.2
   Plt
   263
   248
   Cr
   1.8
   1.7
   1.6
   TCO2
   31
   32
   30
   30
   Glucose
   175
   252
   272
   271
   Other labs: PT / PTT / INR:15.2/26.0/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.9 mg/dL, Mg++:2.0 mg/dL, PO4:2.5 mg/dL
   Imaging: CXR: Pending
   Microbiology: [**2128-1-27**] 2:16 am SPUTUM      Source: Expectorated.
      GRAM STAIN (Final [**2128-1-27**]):
         [**11-8**] PMNs and <10 epithelial cells/100X field.
         1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S).
      RESPIRATORY CULTURE (Preliminary):
         MODERATE GROWTH OROPHARYNGEAL FLORA.
         GRAM NEGATIVE ROD(S).    MODERATE GROWTH.
   [**2128-1-27**] 1:34 pm BRONCHOALVEOLAR LAVAGE
                               **FINAL REPORT [**2128-1-29**]**
      GRAM STAIN (Final [**2128-1-27**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      RESPIRATORY CULTURE (Final [**2128-1-29**]):    NO GROWTH, <1000 CFU/ml.
   Blood Cultures: [**1-27**] Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable.
   # Hypoxemic Respiratory Failure and Possible Vasculitis
   Given findings on CXR, CVP, clinical presentation and bronchoscopy,
   likely secondary to diffuse alveolar hemorrhage and fluid overload. ESR
   is elevated, there is a pupruic macular rash and renal failure, all
   concerning for vasculitis, although there are other possibilities. [**Doctor First Name 1205**]
   and ANCA are negative and anti-GBM is pending. If we seek a unifying
   diagnosis, may be that anti-GBM is negative given skin process.
   Variability in antibody responsible may account for this, and general
   approaches and pathology may eventually be most helpful. Renal biopsy
   is possible (see below). Presently conditions of each organ stabilized
   on high dose steroids, also suggestive. Rheumatology raised Cytoxan
   treatment and plasmaphoresis, but we will need to discuss this further
   with Renal and Pathology.
   - Renal Biopsy this AM
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Await anti-GBM
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Continue Solu-medrol
   - sp Renal Biopsy, consider Cytoxan and plasmapheresis with d/w Renal
   and Rheumatology
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Hold heparin, ASA
   - Continue to remove fluid with CVVH
   # Coagulopathy: Plan for Kidney Biopsy today. INR 1.4 this AM,
   Platelets NL however may be dysfunctional given ASA /Uremia.
   - DDAVP today
   - FFP during procedure
   - One unit platlets.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.8 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Now unclear if this is truly manifestation of systemic
   vasculitis or drug reaction. White cells and eosinophils in urine
   consistent with either, although more classic of AIN.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - Renally dose/CVVH dose meds.
   - Management as above, including IV Solu-medrol.
   - Possible renal biopsy tomorrow given that we are now holding
   anticoagulants
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above, will restart anticoagulation sp biopsy with
   very low ptt goal.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - No heparin for now
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-30**] 04:26 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: H2Blocker
   VAP:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU for now.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of CAD, s/p CABG, and s/p mechanical AVR, who is currently hospitalized for MSSA endocarditis with complications of ARF, AIN, CHB, and leukocytoclastic dermatitis. He is now transferred to the MICU with respiratory distress, hypoxemia, and hemoptysis, concerning for DAH. The patient's condition is complex and multifaceted, with potential medical complications including:

1. Hypoxemic Respiratory Failure: The patient's respiratory status is critical, with a high risk of further deterioration.
2. Vasculitis: The patient's presentation is concerning for vasculitis, with evidence of diffuse alveolar hemorrhage, elevated ESR, and a purpuric macular rash.
3. Coagulopathy: The patient has a coagulopathy, with an INR of 1.4 and platelets that may be dysfunctional.
4. Acute on Chronic Renal Failure: The patient has a high-grade MSSA bacteremia and fulfills Duke Criteria for endocarditis, with a high risk of further renal deterioration.
5. Leukoclastic Dermatitis: The patient has a rash consistent with leukoclastic dermatitis, which may be related to Nafcillin or allopurinol.
6. Bacteremia: The patient has a high-grade MSSA bacteremia, which requires continued antibiotic treatment.
7. Atrial Fibrillation/Complete Heart Block: The patient has a history of CHB and torsades, which is now being managed with a ventricularly pacing pacemaker.
8. Anemia: The patient's anemia is likely secondary to pulmonary hemorrhage, and further evaluation is needed to rule out other sites of blood loss.
9. CAD: The patient's CAD is a risk factor for increased thrombosis, and anticoagulation therapy is being withheld due to the patient's coagulopathy.
10. s/p AVR: The patient has a history of s/p AVR, which may be related to his endocarditis.

Potential medical complications that can arise from these conditions include:

* Further respiratory deterioration
* Worsening of vasculitis
* Increased risk of bleeding due to coagulopathy
* Further renal deterioration
* Increased risk of infection due to bacteremia
* Cardiac arrhythmias
* Anemia
* Increased risk of thrombosis
* Abscess formation
* Septic shock

The patient's treatment plan includes:

* High-dose steroids
* Plasmapheresis
* Cytoxan therapy
* Broad-spectrum antibiotics
* CVVH
* DDAVP
* FFP
* One unit of platelets
* H2 blocker
* Statin
* Holding ASA and ACE
* Holding heparin
* Monitoring for signs of bleeding and infection
* Close monitoring of renal function and electrolyte levels
* Regular blood cultures and respiratory support
* Consideration of renal biopsy and TEE"
182149.0,283460,2128-01-31 07:30:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 76M with CAD s/p CABG, s/p mechanical AVR, Afib;
   currently hospitalized for MSSA endocarditis with complications of ARF
   and apparent AIN, CHB and torsades, and leukocytoclastic dermatitis on
   skin biopsy, now transferred to MICU with respiratory distress,
   hypoxemia, and hemoptysis concerning for DAH.
   24 Hour Events:
   [**1-29**]
   - Called lab processing anti GBM and verbally reported to be negative.
   - Serial hematocrit s/p procedure: 27.4 -> 27.9 -> xx
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis.
   [**1-30**]
   - Changed to methyprednisone 40mg IV Q12
   - Heparin gtt restarted @ 1000, goal ptt 50-70. Met goal citrate
   stopped.
   - Rheum: Continue Steroids taper.
   - Renal: Restart Heparin, No Ultrasound, Steroids?
   - Tube Feeds at goal
   - Derm: Do not typically treat with steroids unless systemic, so would
   not need systemic therapy.
   - CVVH to remove 250cc hour, up to 400cc hour later.
   - HCT: 28.5 ->29.4 ->30.6
   - Continued bloody secretions with suctioning, hematuria.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-30**] 10:00 AM
   Cefipime - [**2128-1-30**] 11:16 PM
   Infusions:
   Heparin Sodium - 1,150 units/hour
   Fentanyl - 115 mcg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 2 mEq./hour
   Midazolam (Versed) - 2 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-30**] 09:30 AM
   Midazolam (Versed) - [**2128-1-30**] 12:40 PM
   Fentanyl - [**2128-1-30**] 12:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-31**] 07:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.3
C (97.4
   Tcurrent: 36.3
C (97.4
   HR: 75 (75 - 87) bpm
   BP: 128/57(83) {100/48(67) - 180/76(113)} mmHg
   RR: 14 (10 - 22) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 15 (6 - 20)mmHg
   Total In:
                                                                  7,933 mL
                                                                  2,810 mL
   PO:
   TF:
                                                                    722 mL
                                                                    223 mL
   IVF:
                                                                  7,151 mL
                                                                  2,407 mL
   Blood products:
   Total out:
                                                                 12,684 mL
                                                                  3,244 mL
   Urine:
                                                                    613 mL
                                                                    176 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,751 mL
                                                                   -434 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 654 (440 - 704) mL
   PS : 5 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 35
   PIP: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/39/111/28/3
   Ve: 9 L/min
   PaO2 / FiO2: 277
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   292 K/uL
   9.6 g/dL
   203 mg/dL
   1.2 mg/dL
   28 mEq/L
   4.1 mEq/L
   39 mg/dL
   100 mEq/L
   139 mEq/L
   30.0 %
   13.1 K/uL
        [image002.jpg]
                             [**2128-1-30**]  10:24 AM
                             [**2128-1-30**]  10:34 AM
                             [**2128-1-30**]  04:17 PM
                             [**2128-1-30**]  04:21 PM
                             [**2128-1-30**]  04:35 PM
                             [**2128-1-30**]  10:17 PM
                             [**2128-1-30**]  10:28 PM
                             [**2128-1-31**]  04:15 AM
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
   WBC
   13.1
   Hct
   28.5
   29.4
   30.6
   30.0
   Plt
   292
   Cr
   1.6
   1.4
   1.2
   TCO2
   30
   29
   29
   32
   28
   Glucose
   [**Telephone/Fax (3) 11389**]03
   Other labs: PT / PTT / INR:14.7/53.3/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.7 mg/dL, Mg++:1.9 mg/dL, PO4:1.6 mg/dL
   Imaging: Asymmetric, severe pulmonary hemorrhage, both lungs,
   previously improved,stable since [**2128-1-29**].
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic Respiratory Failure:
   At this time thought to be secondary to pulmonary edema and
   anticoagulation given negative anti-GBM and rather unrevealing renal
   biopsy. ESR is elevated, there is a pupruic macular rash and renal
   failure, all concerning for vasculitis, although there are other
   possibilities. [**Doctor First Name 1205**] and ANCA are negative. Patient clinically improving
   sp diuresis and steroids. HCT stable.
   - FU Renal Biopsy
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Restart Heparin this AM, no bolus. PTT goal 50-70,
   - Hold ASA until tomorrow
   - Continue to remove fluid with CVVH
   - Continue lower dose steroids at this time.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.6 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Renal biopsy without changes consistent with AIN, may be
   secondary to immune complex deposition in the setting of endocarditis.
   Awaiting immunostaining currently.
   - f/u renal recs, discuss thoughts
   - Renally dose/CVVH dose meds.
   - Lower Dose steroids at this time, however will follow up with renal
   regarding further treatment.
   - FU biopsy results
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - restart heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for until tomorrow, knowing high risk with DES.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - Heparin as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-31**] 04:19 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 76M with CAD s/p CABG, s/p mechanical AVR, Afib;
   currently hospitalized for MSSA endocarditis with complications of ARF
   and apparent AIN, CHB and torsades, and leukocytoclastic dermatitis on
   skin biopsy, now transferred to MICU with respiratory distress,
   hypoxemia, and hemoptysis concerning for DAH.
   24 Hour Events:
   [**1-29**]
   - Called lab processing anti GBM and verbally reported to be negative.
   - Serial hematocrit s/p procedure: 27.4 -> 27.9 -> xx
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis.
   [**1-30**]
   - Changed to methyprednisone 40mg IV Q12
   - Heparin gtt restarted @ 1000, goal ptt 50-70. Met goal citrate
   stopped.
   - Rheum: Continue Steroids taper.
   - Renal: Restart Heparin, No Ultrasound, Steroids?
   - Tube Feeds at goal
   - Derm: Do not typically treat with steroids unless systemic, so would
   not need systemic therapy.
   - CVVH to remove 250cc hour, up to 400cc hour later.
   - HCT: 28.5 ->29.4 ->30.6
   - Continued bloody secretions with suctioning, hematuria.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-30**] 10:00 AM
   Cefipime - [**2128-1-30**] 11:16 PM
   Infusions:
   Heparin Sodium - 1,150 units/hour
   Fentanyl - 115 mcg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 2 mEq./hour
   Midazolam (Versed) - 2 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-30**] 09:30 AM
   Midazolam (Versed) - [**2128-1-30**] 12:40 PM
   Fentanyl - [**2128-1-30**] 12:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-31**] 07:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.3
C (97.4
   Tcurrent: 36.3
C (97.4
   HR: 75 (75 - 87) bpm
   BP: 128/57(83) {100/48(67) - 180/76(113)} mmHg
   RR: 14 (10 - 22) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 15 (6 - 20)mmHg
   Total In:
                                                                  7,933 mL
                                                                  2,810 mL
   PO:
   TF:
                                                                    722 mL
                                                                    223 mL
   IVF:
                                                                  7,151 mL
                                                                  2,407 mL
   Blood products:
   Total out:
                                                                 12,684 mL
                                                                  3,244 mL
   Urine:
                                                                    613 mL
                                                                    176 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,751 mL
                                                                   -434 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 654 (440 - 704) mL
   PS : 5 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 35
   PIP: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/39/111/28/3
   Ve: 9 L/min
   PaO2 / FiO2: 277
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   292 K/uL
   9.6 g/dL
   203 mg/dL
   1.2 mg/dL
   28 mEq/L
   4.1 mEq/L
   39 mg/dL
   100 mEq/L
   139 mEq/L
   30.0 %
   13.1 K/uL
        [image002.jpg]
                             [**2128-1-30**]  10:24 AM
                             [**2128-1-30**]  10:34 AM
                             [**2128-1-30**]  04:17 PM
                             [**2128-1-30**]  04:21 PM
                             [**2128-1-30**]  04:35 PM
                             [**2128-1-30**]  10:17 PM
                             [**2128-1-30**]  10:28 PM
                             [**2128-1-31**]  04:15 AM
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
   WBC
   13.1
   Hct
   28.5
   29.4
   30.6
   30.0
   Plt
   292
   Cr
   1.6
   1.4
   1.2
   TCO2
   30
   29
   29
   32
   28
   Glucose
   [**Telephone/Fax (3) 11389**]03
   Other labs: PT / PTT / INR:14.7/53.3/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.7 mg/dL, Mg++:1.9 mg/dL, PO4:1.6 mg/dL
   Imaging: Asymmetric, severe pulmonary hemorrhage, both lungs,
   previously improved,stable since [**2128-1-29**].
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic Respiratory Failure:
   At this time thought to be secondary to pulmonary edema and
   anticoagulation given negative anti-GBM and rather unrevealing renal
   biopsy. ESR is elevated, there is a pupruic macular rash and renal
   failure, all concerning for vasculitis, although there are other
   possibilities. [**Doctor First Name 1205**] and ANCA are negative. Patient clinically improving
   sp diuresis and steroids. HCT stable.
   - FU Renal Biopsy
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Restart Heparin this AM, no bolus. PTT goal 50-70,
   - Hold ASA until tomorrow
   - Continue to remove fluid with CVVH
   - Continue lower dose steroids at this time.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.6 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Renal biopsy without changes consistent with AIN, may be
   secondary to immune complex deposition in the setting of endocarditis.
   Awaiting immunostaining currently.
   - f/u renal recs, discuss thoughts
   - Renally dose/CVVH dose meds.
   - Lower Dose steroids at this time, however will follow up with renal
   regarding further treatment.
   - FU biopsy results
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - restart heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for until tomorrow, knowing high risk with DES.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - Heparin as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-31**] 04:19 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of CAD, s/p CABG, s/p mechanical AVR, and Afib, currently hospitalized for MSSA endocarditis with complications of ARF, AIN, CHB, and torsades. He is now transferred to the MICU with respiratory distress, hypoxemia, and hemoptysis concerning for DAH. The patient has a complex medical history, with multiple comorbidities and ongoing treatments.

Potential Medical Complications:

1. Pulmonary Edema: The patient's respiratory distress and hypoxemia may be secondary to pulmonary edema, which can be caused by various factors such as fluid overload, cardiac failure, or medication side effects.
2. Vasculitis: The patient's elevated ESR, purpuric macular rash, and renal failure are concerning for vasculitis, although the diagnosis is not yet confirmed.
3. Atrial Fibrillation/Complete Heart Block: The patient's history of Afib and CHB, as well as his current ventricularly pacing, may increase his risk of cardiac complications.
4. Anemia: The patient's anemia may be secondary to pulmonary hemorrhage, diffuse vasculitis, or primary coagulopathy.
5. Endocarditis: The patient's MSSA endocarditis may lead to further complications such as valve damage, abscess formation, or embolization.
6. Renal Failure: The patient's ARF may progress to chronic renal failure if not properly managed.
7. Gastrointestinal Bleeding: The patient's hemoptysis and anemia may indicate gastrointestinal bleeding, which can be life-threatening.
8. Coagulopathy: The patient's coagulopathy may increase his risk of bleeding complications, including gastrointestinal bleeding and pulmonary hemorrhage.

Recommendations:

1. Continue to monitor the patient's respiratory status and adjust treatment as necessary to manage pulmonary edema.
2. Consider further evaluation for vasculitis, including immunostaining and renal biopsy.
3. Continue anticoagulation therapy with heparin and consider transitioning to coumadin if possible.
4. Monitor the patient's anemia and consider transfusions as necessary.
5. Continue antibiotic therapy for endocarditis and consider adding antifungal therapy if necessary.
6. Monitor the patient's renal function and adjust treatment as necessary to manage ARF.
7. Consider endoscopy or other diagnostic tests to evaluate the patient's gastrointestinal tract and identify any potential bleeding sources.
8. Monitor the patient's coagulopathy and adjust treatment as necessary to prevent bleeding complications."
182149.0,283460,2128-01-31 07:30:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 76M with CAD s/p CABG, s/p mechanical AVR, Afib;
   currently hospitalized for MSSA endocarditis with complications of ARF
   and apparent AIN, CHB and torsades, and leukocytoclastic dermatitis on
   skin biopsy, now transferred to MICU with respiratory distress,
   hypoxemia, and hemoptysis concerning for DAH.
   24 Hour Events:
   [**1-29**]
   - Called lab processing anti GBM and verbally reported to be negative.
   - Serial hematocrit s/p procedure: 27.4 -> 27.9 -> xx
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis.
   [**1-30**]
   - Changed to methyprednisone 40mg IV Q12
   - Heparin gtt restarted @ 1000, goal ptt 50-70. Met goal citrate
   stopped.
   - Rheum: Continue Steroids taper.
   - Renal: Restart Heparin, No Ultrasound, Steroids?
   - Tube Feeds at goal
   - Derm: Do not typically treat with steroids unless systemic, so would
   not need systemic therapy.
   - CVVH to remove 250cc hour, up to 400cc hour later.
   - HCT: 28.5 ->29.4 ->30.6
   - Continued bloody secretions with suctioning, hematuria.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-30**] 10:00 AM
   Cefipime - [**2128-1-30**] 11:16 PM
   Infusions:
   Heparin Sodium - 1,150 units/hour
   Fentanyl - 115 mcg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 2 mEq./hour
   Midazolam (Versed) - 2 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-30**] 09:30 AM
   Midazolam (Versed) - [**2128-1-30**] 12:40 PM
   Fentanyl - [**2128-1-30**] 12:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-31**] 07:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.3
C (97.4
   Tcurrent: 36.3
C (97.4
   HR: 75 (75 - 87) bpm
   BP: 128/57(83) {100/48(67) - 180/76(113)} mmHg
   RR: 14 (10 - 22) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 15 (6 - 20)mmHg
   Total In:
                                                                  7,933 mL
                                                                  2,810 mL
   PO:
   TF:
                                                                    722 mL
                                                                    223 mL
   IVF:
                                                                  7,151 mL
                                                                  2,407 mL
   Blood products:
   Total out:
                                                                 12,684 mL
                                                                  3,244 mL
   Urine:
                                                                    613 mL
                                                                    176 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,751 mL
                                                                   -434 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 654 (440 - 704) mL
   PS : 5 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 35
   PIP: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/39/111/28/3
   Ve: 9 L/min
   PaO2 / FiO2: 277
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Skin: Petechial rash lower extremity.
   Labs / Radiology
   292 K/uL
   9.6 g/dL
   203 mg/dL
   1.2 mg/dL
   28 mEq/L
   4.1 mEq/L
   39 mg/dL
   100 mEq/L
   139 mEq/L
   30.0 %
   13.1 K/uL
        [image002.jpg]
                             [**2128-1-30**]  10:24 AM
                             [**2128-1-30**]  10:34 AM
                             [**2128-1-30**]  04:17 PM
                             [**2128-1-30**]  04:21 PM
                             [**2128-1-30**]  04:35 PM
                             [**2128-1-30**]  10:17 PM
                             [**2128-1-30**]  10:28 PM
                             [**2128-1-31**]  04:15 AM
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
   WBC
   13.1
   Hct
   28.5
   29.4
   30.6
   30.0
   Plt
   292
   Cr
   1.6
   1.4
   1.2
   TCO2
   30
   29
   29
   32
   28
   Glucose
   [**Telephone/Fax (3) 11389**]03
   Other labs: PT / PTT / INR:14.7/53.3/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.7 mg/dL, Mg++:1.9 mg/dL, PO4:1.6 mg/dL
   Imaging: Asymmetric, severe pulmonary hemorrhage, both lungs,
   previously improved,stable since [**2128-1-29**].
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic Respiratory Failure:
   At this time thought to be secondary to pulmonary edema and
   anticoagulation given negative anti-GBM and rather unrevealing renal
   biopsy. ESR is elevated, there is a pupruic macular rash and renal
   failure, all concerning for vasculitis, although there are other
   possibilities. [**Doctor First Name 1205**] and ANCA are negative. Patient clinically improving
   sp diuresis and steroids. HCT stable.
   - FU Renal Biopsy
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Restart Heparin this AM, no bolus. PTT goal 50-70,
   - Hold ASA until tomorrow
   - Continue to remove fluid with CVVH
   - Continue lower dose steroids at this time.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.6 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Renal biopsy without changes consistent with AIN, may be
   secondary to immune complex deposition in the setting of endocarditis.
   Awaiting immunostaining currently.
   - f/u renal recs, discuss thoughts
   - Renally dose/CVVH dose meds.
   - Lower Dose steroids at this time, however will follow up with renal
   regarding further treatment.
   - FU biopsy results
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - restart heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for until tomorrow, knowing high risk with DES.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - Heparin as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-31**] 04:19 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 76M with CAD s/p CABG, s/p mechanical AVR, Afib;
   currently hospitalized for MSSA endocarditis with complications of ARF
   and apparent AIN, CHB and torsades, and leukocytoclastic dermatitis on
   skin biopsy, now transferred to MICU with respiratory distress,
   hypoxemia, and hemoptysis concerning for DAH.
   24 Hour Events:
   [**1-29**]
   - Called lab processing anti GBM and verbally reported to be negative.
   - Serial hematocrit s/p procedure: 27.4 -> 27.9 -> xx
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis.
   [**1-30**]
   - Changed to methyprednisone 40mg IV Q12
   - Heparin gtt restarted @ 1000, goal ptt 50-70. Met goal citrate
   stopped.
   - Rheum: Continue Steroids taper.
   - Renal: Restart Heparin, No Ultrasound, Steroids?
   - Tube Feeds at goal
   - Derm: Do not typically treat with steroids unless systemic, so would
   not need systemic therapy.
   - CVVH to remove 250cc hour, up to 400cc hour later.
   - HCT: 28.5 ->29.4 ->30.6
   - Continued bloody secretions with suctioning, hematuria.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-30**] 10:00 AM
   Cefipime - [**2128-1-30**] 11:16 PM
   Infusions:
   Heparin Sodium - 1,150 units/hour
   Fentanyl - 115 mcg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 2 mEq./hour
   Midazolam (Versed) - 2 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-30**] 09:30 AM
   Midazolam (Versed) - [**2128-1-30**] 12:40 PM
   Fentanyl - [**2128-1-30**] 12:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-31**] 07:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.3
C (97.4
   Tcurrent: 36.3
C (97.4
   HR: 75 (75 - 87) bpm
   BP: 128/57(83) {100/48(67) - 180/76(113)} mmHg
   RR: 14 (10 - 22) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 15 (6 - 20)mmHg
   Total In:
                                                                  7,933 mL
                                                                  2,810 mL
   PO:
   TF:
                                                                    722 mL
                                                                    223 mL
   IVF:
                                                                  7,151 mL
                                                                  2,407 mL
   Blood products:
   Total out:
                                                                 12,684 mL
                                                                  3,244 mL
   Urine:
                                                                    613 mL
                                                                    176 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,751 mL
                                                                   -434 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 654 (440 - 704) mL
   PS : 5 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 35
   PIP: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/39/111/28/3
   Ve: 9 L/min
   PaO2 / FiO2: 277
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Skin: Petechial rash lower extremity.
   Labs / Radiology
   292 K/uL
   9.6 g/dL
   203 mg/dL
   1.2 mg/dL
   28 mEq/L
   4.1 mEq/L
   39 mg/dL
   100 mEq/L
   139 mEq/L
   30.0 %
   13.1 K/uL
        [image002.jpg]
                             [**2128-1-30**]  10:24 AM
                             [**2128-1-30**]  10:34 AM
                             [**2128-1-30**]  04:17 PM
                             [**2128-1-30**]  04:21 PM
                             [**2128-1-30**]  04:35 PM
                             [**2128-1-30**]  10:17 PM
                             [**2128-1-30**]  10:28 PM
                             [**2128-1-31**]  04:15 AM
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
   WBC
   13.1
   Hct
   28.5
   29.4
   30.6
   30.0
   Plt
   292
   Cr
   1.6
   1.4
   1.2
   TCO2
   30
   29
   29
   32
   28
   Glucose
   [**Telephone/Fax (3) 11389**]03
   Other labs: PT / PTT / INR:14.7/53.3/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.7 mg/dL, Mg++:1.9 mg/dL, PO4:1.6 mg/dL
   Imaging: Asymmetric, severe pulmonary hemorrhage, both lungs,
   previously improved,stable since [**2128-1-29**].
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic Respiratory Failure:
   At this time thought to be secondary to pulmonary edema and
   anticoagulation given negative anti-GBM and rather unrevealing renal
   biopsy. ESR is elevated, there is a pupruic macular rash and renal
   failure, all concerning for vasculitis, although there are other
   possibilities. [**Doctor First Name 1205**] and ANCA are negative. Patient clinically improving
   sp diuresis and steroids. HCT stable.
   - FU Renal Biopsy
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Restart Heparin this AM, no bolus. PTT goal 50-70,
   - Hold ASA until tomorrow
   - Continue to remove fluid with CVVH
   - Continue lower dose steroids at this time.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.6 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Renal biopsy without changes consistent with AIN, may be
   secondary to immune complex deposition in the setting of endocarditis.
   Awaiting immunostaining currently.
   - f/u renal recs, discuss thoughts
   - Renally dose/CVVH dose meds.
   - Lower Dose steroids at this time, however will follow up with renal
   regarding further treatment.
   - FU biopsy results
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - restart heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for until tomorrow, knowing high risk with DES.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - Heparin as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-31**] 04:19 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the progress note, the patient is a 76-year-old male with a complex medical history, including coronary artery disease, mechanical aortic valve replacement, atrial fibrillation, and recent diagnosis of MSSA endocarditis. He is currently in the intensive care unit (ICU) with respiratory distress, hypoxemia, and hemoptysis, concerning for diffuse alveolar hemorrhage (DAH).

The patient's laboratory results show elevated white blood cell count, hemoglobin, and creatinine, indicating active infection and kidney damage. His coagulation profile is abnormal, with elevated international normalized ratio (INR) and partial thromboplastin time (PTT), suggesting disseminated intravascular coagulation (DIC).

The patient's physical examination reveals bilateral expiratory rhonchi and coarse crackles, indicating respiratory distress, as well as a diffuse rash over the trunk and extremities, which is consistent with leukocytoclastic dermatitis.

The patient's treatment plan includes:

1. Broad-spectrum antibiotics for MSSA endocarditis and possible hospital-acquired pneumonia (HAP).
2. Restarting heparin therapy to prevent further thrombosis and DIC.
3. Maintaining intubation and mechanical ventilation to support respiratory function.
4. Continuing CVVH to remove fluid and waste products.
5. Lower-dose steroids to reduce inflammation and prevent further organ damage.
6. Repeated blood cultures to monitor for bacteremia.
7. Electrolyte repletion and correction of acid-base imbalance.

Potential medical complications that may arise include:

1. Further respiratory distress and hypoxemia, potentially leading to respiratory failure.
2. Increased bleeding risk due to coagulopathy and platelet dysfunction.
3. Renal failure and acute kidney injury, potentially requiring dialysis.
4. Cardiac arrhythmias and heart block, potentially requiring pacemaker implantation.
5. Infection and sepsis, potentially leading to multi-organ dysfunction.
6. Neurological complications, such as seizures and stroke, potentially due to DIC or endocarditis.

To address these potential complications, the patient's care team should:

1. Monitor the patient's respiratory function closely and adjust ventilator settings as needed.
2. Closely monitor the patient's coagulation profile and adjust heparin therapy accordingly.
3. Repeatedly assess the patient's renal function and adjust fluid management and electrolyte repletion accordingly.
4. Monitor the patient's cardiac rhythm and adjust pacemaker settings as needed.
5. Repeatedly assess the patient's neurological status and address any potential complications promptly.
6. Repeatedly assess the patient's infection status and adjust antibiotic therapy accordingly.

Overall, the patient's complex medical condition requires close monitoring and multidisciplinary care to prevent further complications and ensure optimal outcomes."
182149.0,283460,2128-01-31 07:30:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Presented with bacteremia. Tranferred to ICU with
   respiratory failure and hemoptysis.
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   24 Hour Events:
   [**1-29**]
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis (but awaiting final results).
   [**1-30**]
   - Changed to methyprednisone 40mg IV Q12
   - Heparin gtt restarted @ 1000, goal ptt 50-70. Met goal citrate
   stopped.
   - Rheum: Continue Steroids taper.
   - Renal: Restart Heparin, No Ultrasound, Steroids (for AIN in this
   case)
   - Tube Feeds at goal
   - Derm: Do not typically treat with steroids unless systemic, so would
   not need systemic therapy (for leukocytoclastic cutaneous vasculitis)
   - CVVH to remove 250cc hour, up to 400cc hour later, then back to 200
   cc this a.m.
   - HCT: 28.5 ->29.4 ->30.6
   - Continued bloody secretions with suctioning, hematuria with about 300
   mL output of light red wine shaded respiratory secretions from midnight
   until 10 a.m.
   - Still await final pathology results
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-30**] 10:00 AM
   Cefipime - [**2128-1-30**] 11:16 PM
   Infusions:
   Heparin Sodium - 1,150 units/hour
   Fentanyl - 115 mcg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 2 mEq./hour
   Midazolam (Versed) - 2 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-30**] 09:30 AM
   Midazolam (Versed) - [**2128-1-30**] 12:40 PM
   Fentanyl - [**2128-1-30**] 12:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-31**] 07:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.3
C (97.4
   Tcurrent: 36.3
C (97.4
   HR: 75 (75 - 87) bpm
   BP: 128/57(83) {100/48(67) - 180/76(113)} mmHg
   RR: 14 (10 - 22) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 15 (6 - 20)mmHg
   Total In:
                                                                  7,933 mL
                                                                  2,810 mL
   PO:
   TF:
                                                                    722 mL
                                                                    223 mL
   IVF:
                                                                  7,151 mL
                                                                  2,407 mL
   Blood products:
   Total out:
                                                                 12,684 mL
                                                                  3,244 mL
   Urine:
                                                                    613 mL
                                                                    176 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,751 mL
                                                                   -434 mL
   LOS fluid balance
 10 L
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 654 (440 - 704) mL
   PS : 5 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 35
   PIP: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/39/111/28/3
   Ve: 9 L/min
   PaO2 / FiO2: 277
   Physical Examination
   General: Intubated, moderately sedated, but able to interact and follow
   instructions, pressure support of [**5-19**]. Draining thin secretions from
   lung that are moderately blood, like light red wine.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: Foley in place with hematuria color of red wine.
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Sedated but rousable and able to interact meaningfully.
   Spontaneously moving all limbs, CNs II-XII intact (within limit of exam
   in intubated patient).
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   292 K/uL
   9.6 g/dL
   203 mg/dL
   1.2 mg/dL
   28 mEq/L
   4.1 mEq/L
   39 mg/dL
   100 mEq/L
   139 mEq/L
   30.0 %
   13.1 K/uL
        [image002.jpg]
                             [**2128-1-30**]  10:24 AM
                             [**2128-1-30**]  10:34 AM
                             [**2128-1-30**]  04:17 PM
                             [**2128-1-30**]  04:21 PM
                             [**2128-1-30**]  04:35 PM
                             [**2128-1-30**]  10:17 PM
                             [**2128-1-30**]  10:28 PM
                             [**2128-1-31**]  04:15 AM
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
   WBC
   13.1
   Hct
   28.5
   29.4
   30.6
   30.0
   Plt
   292
   Cr
   1.6
   1.4
   1.2
   TCO2
   30
   29
   29
   32
   28
   Glucose
   [**Telephone/Fax (3) 11389**]03
   Other labs: PT / PTT / INR:14.7/53.3/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.7 mg/dL, Mg++:1.9 mg/dL, PO4:1.6 mg/dL
   Imaging: Asymmetric, severe pulmonary hemorrhage, both lungs,
   previously improved,stable since [**2128-1-29**].
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic Respiratory Failure/Ventilation/Intubation
   Maintain intubation and ventilation for now given copious secretions
   this a.m. If production decreases then will consider extubation because
   there is no other reason to maintain vent. Hypoxemic respiratory
   failure has largely resolved - was likely due to pulmonary edema and
   diffuse alveolar hemorrhage. The etiology of hemorrhage is unclear.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving sp diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - FU Renal Biopsy
   - Maintain intubation for now given secretions and lesser chance of
   hemorrhage without cough and management of respiratory parameters.
   - Continue to appreciate input of Rheumatology (want to taper
   steroids), Renal (steroids for AIN only), Dermatology (topical
   steroid).
   - Broad spectrum treatment for HAP, MSSA bacteremia in context of AVR
   cefepime and vancomycin
   - Restart Heparin this AM, no bolus. PTT goal 50-70
   - Hold ASA for now.
   - Continue to remove fluid with CVVH
   - Continue lower dose steroids at this time, 40 mg today and 30 mg
   tomorrow for course of treatment for AIN (check with Renal but in order
   of four weeks)
   #. Hemoptysis
   Discussion above pertains. Likely little further benefit and possible
   harm, so hold bronchoscopy for now.
   #. Acute on Chronic Renal Failure/AIN
   Cr 1.5 on presentation; up to 3.4, now 1.2 on CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although allopurinal and warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - f/u renal recs
   - Steroids to treat AIN, 30 mg daily for course to be determined by
   Renal
 in order of weeks
   - Renally dose/CVVH dose meds.
   - Continue CVVH
   - FU biopsy results
   - Continue to follow urine output
   #. Hematuria
   Likely secondary to biopsy in context of said coagulopathy. Will need
   to monitor given danger period following biopsy is about two weeks.
   Likely too bloody for vasculitic cause.
   - Ask Renal if benefit to spinning when so frankly bloody (surely not
   just due to vasculitis given amount, precipitant (biopsy), and no
   vasculitis on biopsy) (also send UA but may not be helpful for the same
   reason).
   - Follow urine output and bloodiness
   - Consider irrigation if reduction in urine output, suprapubic pain or
   residual volume
   # Leukoclastic Dermatitis
   Is recovering. Thought to be due to Nafcillin or allopurinol
 case
   reports of warfarin also, but much less likely. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Continue heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Hematocrit has been stable. Now with pulmonary hemorrhage likely. If
   diffuse vasculitis or actually secondary to primary coagulopathy then
   need to maintain suspicion for other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now given increased bloody secretions overnight.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - Heparin as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   #. Hyperglycemia
   In the context of steroids. When stabilized on 30 mg prednisone daily
   will adjust for tighter control.
   #. Mental Status
   Lightly sedated. Will lighten slightly further today.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-31**] 04:19 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Presented with bacteremia. Tranferred to ICU with
   respiratory failure and hemoptysis.
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   24 Hour Events:
   [**1-29**]
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis (but awaiting final results).
   [**1-30**]
   - Changed to methyprednisone 40mg IV Q12
   - Heparin gtt restarted @ 1000, goal ptt 50-70. Met goal citrate
   stopped.
   - Rheum: Continue Steroids taper.
   - Renal: Restart Heparin, No Ultrasound, Steroids (for AIN in this
   case)
   - Tube Feeds at goal
   - Derm: Do not typically treat with steroids unless systemic, so would
   not need systemic therapy (for leukocytoclastic cutaneous vasculitis)
   - CVVH to remove 250cc hour, up to 400cc hour later, then back to 200
   cc this a.m.
   - HCT: 28.5 ->29.4 ->30.6
   - Continued bloody secretions with suctioning, hematuria with about 300
   mL output of light red wine shaded respiratory secretions from midnight
   until 10 a.m.
   - Still await final pathology results
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-30**] 10:00 AM
   Cefipime - [**2128-1-30**] 11:16 PM
   Infusions:
   Heparin Sodium - 1,150 units/hour
   Fentanyl - 115 mcg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 2 mEq./hour
   Midazolam (Versed) - 2 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-30**] 09:30 AM
   Midazolam (Versed) - [**2128-1-30**] 12:40 PM
   Fentanyl - [**2128-1-30**] 12:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-31**] 07:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.3
C (97.4
   Tcurrent: 36.3
C (97.4
   HR: 75 (75 - 87) bpm
   BP: 128/57(83) {100/48(67) - 180/76(113)} mmHg
   RR: 14 (10 - 22) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 15 (6 - 20)mmHg
   Total In:
                                                                  7,933 mL
                                                                  2,810 mL
   PO:
   TF:
                                                                    722 mL
                                                                    223 mL
   IVF:
                                                                  7,151 mL
                                                                  2,407 mL
   Blood products:
   Total out:
                                                                 12,684 mL
                                                                  3,244 mL
   Urine:
                                                                    613 mL
                                                                    176 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,751 mL
                                                                   -434 mL
   LOS fluid balance
 10 L
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 654 (440 - 704) mL
   PS : 5 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 35
   PIP: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/39/111/28/3
   Ve: 9 L/min
   PaO2 / FiO2: 277
   Physical Examination
   General: Intubated, moderately sedated, but able to interact and follow
   instructions, pressure support of [**5-19**]. Draining thin secretions from
   lung that are moderately blood, like light red wine.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: Foley in place with hematuria color of red wine.
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Sedated but rousable and able to interact meaningfully.
   Spontaneously moving all limbs, CNs II-XII intact (within limit of exam
   in intubated patient).
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   292 K/uL
   9.6 g/dL
   203 mg/dL
   1.2 mg/dL
   28 mEq/L
   4.1 mEq/L
   39 mg/dL
   100 mEq/L
   139 mEq/L
   30.0 %
   13.1 K/uL
        [image002.jpg]
                             [**2128-1-30**]  10:24 AM
                             [**2128-1-30**]  10:34 AM
                             [**2128-1-30**]  04:17 PM
                             [**2128-1-30**]  04:21 PM
                             [**2128-1-30**]  04:35 PM
                             [**2128-1-30**]  10:17 PM
                             [**2128-1-30**]  10:28 PM
                             [**2128-1-31**]  04:15 AM
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
   WBC
   13.1
   Hct
   28.5
   29.4
   30.6
   30.0
   Plt
   292
   Cr
   1.6
   1.4
   1.2
   TCO2
   30
   29
   29
   32
   28
   Glucose
   [**Telephone/Fax (3) 11389**]03
   Other labs: PT / PTT / INR:14.7/53.3/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.7 mg/dL, Mg++:1.9 mg/dL, PO4:1.6 mg/dL
   Imaging: Asymmetric, severe pulmonary hemorrhage, both lungs,
   previously improved,stable since [**2128-1-29**].
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic Respiratory Failure/Ventilation/Intubation
   Maintain intubation and ventilation for now given copious secretions
   this a.m. If production decreases then will consider extubation because
   there is no other reason to maintain vent. Hypoxemic respiratory
   failure has largely resolved - was likely due to pulmonary edema and
   diffuse alveolar hemorrhage. The etiology of hemorrhage is unclear.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving sp diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - FU Renal Biopsy
   - Maintain intubation for now given secretions and lesser chance of
   hemorrhage without cough and management of respiratory parameters.
   - Continue to appreciate input of Rheumatology (want to taper
   steroids), Renal (steroids for AIN only), Dermatology (topical
   steroid).
   - Broad spectrum treatment for HAP, MSSA bacteremia in context of AVR
   cefepime and vancomycin
   - Restart Heparin this AM, no bolus. PTT goal 50-70
   - Hold ASA for now.
   - Continue to remove fluid with CVVH
   - Continue lower dose steroids at this time, 40 mg today and 30 mg
   tomorrow for course of treatment for AIN (check with Renal but in order
   of four weeks)
   #. Hemoptysis
   Discussion above pertains. Likely little further benefit and possible
   harm, so hold bronchoscopy for now.
   #. Acute on Chronic Renal Failure/AIN
   Cr 1.5 on presentation; up to 3.4, now 1.2 on CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although allopurinal and warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - f/u renal recs
   - Steroids to treat AIN, 30 mg daily for course to be determined by
   Renal
 in order of weeks
   - Renally dose/CVVH dose meds.
   - Continue CVVH
   - FU biopsy results
   - Continue to follow urine output
   #. Hematuria
   Likely secondary to biopsy in context of said coagulopathy. Will need
   to monitor given danger period following biopsy is about two weeks.
   Likely too bloody for vasculitic cause.
   - Ask Renal if benefit to spinning when so frankly bloody (surely not
   just due to vasculitis given amount, precipitant (biopsy), and no
   vasculitis on biopsy) (also send UA but may not be helpful for the same
   reason).
   - Follow urine output and bloodiness
   - Consider irrigation if reduction in urine output, suprapubic pain or
   residual volume
   # Leukoclastic Dermatitis
   Is recovering. Thought to be due to Nafcillin or allopurinol
 case
   reports of warfarin also, but much less likely. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Continue heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Hematocrit has been stable. Now with pulmonary hemorrhage likely. If
   diffuse vasculitis or actually secondary to primary coagulopathy then
   need to maintain suspicion for other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now given increased bloody secretions overnight.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - Heparin as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   #. Hyperglycemia
   In the context of steroids. When stabilized on 30 mg prednisone daily
   will adjust for tighter control.
   #. Mental Status
   Lightly sedated. Will lighten slightly further today.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-31**] 04:19 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of CAD, s/p CABG and mechanical AVR, who was admitted with MSSA endocarditis and complications of ARF, AIN, CHB, and torsades. He was transferred to the MICU with respiratory distress, hypoxemia, and hemoptysis, concerning for DAH. The patient's condition has been improving, with stabilization of his renal function and hemoglobin levels. He is currently intubated and receiving ventilation, and his secretions have decreased.

Potential Medical Complications:

1. Respiratory failure: The patient's respiratory status remains critical, with ongoing respiratory distress and hypoxemia. He is at risk for further deterioration and may require continued intubation and ventilation.
2. Hemorrhagic complications: The patient has ongoing hemoptysis and hematuria, which may be secondary to coagulopathy or vasculitis. He is at risk for further bleeding and may require close monitoring and treatment.
3. Renal failure: The patient's renal function remains compromised, with ongoing need for dialysis and potential for further deterioration.
4. Infectious complications: The patient has ongoing bacteremia and endocarditis, which may require continued antibiotics and monitoring for signs of sepsis.
5. Cardiovascular complications: The patient has a history of CAD and has undergone CABG and mechanical AVR. He is at risk for further cardiac complications, including increased thrombosis risk, and may require close monitoring and treatment.
6. Gastrointestinal complications: The patient's hematuria and ongoing bleeding may be secondary to gastrointestinal bleeding, which may require close monitoring and treatment.
7. Neurological complications: The patient's mental status is lightly sedated, and he may be at risk for further neurological deterioration.

Recommendations:

1. Continue to closely monitor the patient's respiratory status and adjust ventilation and oxygenation as needed.
2. Continue to treat the patient's bacteremia and endocarditis with antibiotics and monitor for signs of sepsis.
3. Continue to manage the patient's coagulopathy with heparin and other anticoagulants as necessary.
4. Monitor the patient's renal function closely and adjust dialysis and other treatments as needed.
5. Consider further imaging studies, such as echocardiogram and CT scans, to further evaluate the patient's cardiovascular and gastrointestinal status.
6. Continue to monitor the patient's neurological status and adjust sedation and other treatments as needed.
7. Consider consultation with specialists, such as cardiology, nephrology, and gastroenterology, to further evaluate and manage the patient's complex medical condition."
182149.0,283460,2128-02-01 07:38:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - Copious secretions in the morning with blood, like Framboise Lambic,
   then cleared and reduced later over the day
   - Very comfortable on vent and lightly sedated
   - Continue 30 mg prednisone for AIN
   - Continued heparin with goal PTT 50-60 given St. Jude valve (wanted to
   see if bleeding might stop on this low level of anticoagulation given
   risk of valve)
   - No more pathology
   - Rheum. want taper of steroids, and will likely be happy with AIN
   level treatment.
   - CVVH at 380 this a.m. with 4.7 L off yesterday (Renal want us to
   continue to take off until pressure drops or labs contract given
   possible role of pulmonary edema in DAH).
   - Vancomycin trough 20
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-31**] 03:00 PM
   Cefipime - [**2128-2-1**] 12:12 AM
   Infusions:
   Midazolam (Versed) - 1 mg/hour
   Fentanyl - 40 mcg/hour
   Calcium Gluconate (CRRT) - 1 grams/hour
   Heparin Sodium - 1,150 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-31**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-1**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.7
C (98
   Tcurrent: 35.8
C (96.5
   HR: 75 (75 - 76) bpm
   BP: 108/46(67) {96/46(66) - 150/64(93)} mmHg
   RR: 23 (15 - 25) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 2 (-4 - 313)mmHg
   Total In:
                                                                  6,406 mL
                                                                  1,163 mL
   PO:
   TF:
                                                                    720 mL
                                                                    180 mL
   IVF:
                                                                  5,196 mL
                                                                    953 mL
   Blood products:
   Total out:
                                                                 11,115 mL
                                                                  2,730 mL
   Urine:
                                                                    541 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,709 mL
                                                                 -1,567 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 498 (343 - 572) mL
   PS : 0 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 33
   PIP: 11 cmH2O
   SpO2: 97%
   ABG: 7.37/35/135/18/-3
   Ve: 9.1 L/min
   PaO2 / FiO2: 338
   Physical Examination
   General: Intubated, moderately sedated, but able to interact and follow
   instructions, pressure support of [**5-19**]. Draining thin secretions from
   lung that are moderately blood, like light red wine.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: Foley in place with hematuria color of red wine.
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Sedated but rousable and able to interact meaningfully.
   Spontaneously moving all limbs, CNs II-XII intact (within limit of exam
   in intubated patient).
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   389 K/uL
   12.6 g/dL
   201 mg/dL
   1.4 mg/dL
   18 mEq/L
   5.1 mEq/L
   35 mg/dL
   104 mEq/L
   136 mEq/L
   40.6 %
   20.9 K/uL
        [image002.jpg]
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
                             [**2128-1-31**]  10:29 AM
                             [**2128-1-31**]  10:38 AM
                             [**2128-1-31**]  04:08 PM
                             [**2128-1-31**]  04:21 PM
                             [**2128-1-31**]  09:54 PM
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
   WBC
   20.9
   Hct
   34.2
   37.7
   40.6
   Plt
   317
   389
   Cr
   1.2
   1.2
   1.4
   TCO2
   32
   28
   29
   24
   24
   21
   Glucose
   162
   253
   170
   201
   Other labs: PT / PTT / INR:14.7/57.4/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:9.2 mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   [**2-1**] CXR
 Final read pending; Multifocal opacification stable to
   improved by our read
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation
   Maintain intubation and ventilation for now given continued secretions
   during the day yesterday. Secretions had improved throughout the night,
   and can consider extubation later this pm. Hypoxemic respiratory
   failure has largely resolved - was likely due to pulmonary edema and
   diffuse alveolar hemorrhage. The etiology of hemorrhage is unclear.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Continue to follow up renal biopsy results from [**1-29**]
   - SBT and consider extubation this PM given improved secretions and
   lesser chance of hemorrhage without cough and management of respiratory
   parameters
   - Continue to appreciate input of Rheumatology (want to taper
   steroids), Renal (steroids for AIN only), Dermatology (topical
   steroid).
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue Heparin gtt with PTT goal 50-70
   - Hold ASA for now given bloody secretions; can likely restart today
   - Continue to remove fluid with CVVH
   - Continue Prednisone 30mg to treat AIN (will check with Renal, but
   likely will need for 4 weeks; start date [**2-1**])
   #. Hemoptysis
   Discussion above pertains. Likely little further benefit and possible
   harm, so hold bronchoscopy for now.
   #. Acute on Chronic Renal Failure/AIN
   Cr 1.5 on presentation; up to 3.4, now 1.2 on CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although Allopurinol and Warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - Continue Prednisone 30mg to treat AIN (will check with Renal, but
   likely will need for 4 weeks; start date [**2-1**])
   - Continue to renally dose medications
   - Continue to remove fluid with CVVH
   - Continue to follow up renal biopsy results from [**1-29**]
   - Continue to follow urine output
   - Continue to follow Renal recommendations
   #. Hematuria
   Likely secondary to biopsy in context of said coagulopathy. Will need
   to monitor given danger period following biopsy is about two weeks.
   Likely too bloody for vasculitic cause.
   - Ask Renal if benefit to spinning when so frankly bloody (surely not
   just due to vasculitis given amount, precipitant (biopsy), and no
   vasculitis on biopsy) (also send UA but may not be helpful for the same
   reason).
   - Continue to follow urine output and if hematuria
   - Consider irrigation if reduction in urine output, suprapubic pain or
   residual volume
   # Leukoclastic Dermatitis
   Is recovering. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Continue steroids as above.
   - Continue to follow Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue to follow ID recommendations
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Continue Heparin as above
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Hematocrit has been stable. Now with pulmonary hemorrhage likely. If
   diffuse vasculitis or actually secondary to primary coagulopathy then
   need to maintain suspicion for other sites of blood loss, including GI
   tract. Patient is consented for blood products.
   - Continue to check Hematocrit q8
   - Guaiac stool
   - Continue to maintain active T&S
   - Continue Protonix while being aware that PPI may also cause AIN
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin
   - Hold ASA for now given bloody secretions; can likely restart today
   - Holding ACE in the setting of renal failure
   - Holding BB for now
   - Continue Heparin as above
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   #. Hyperglycemia
   In the context of steroids. When stabilized on 30 mg prednisone daily
   will adjust for tighter control.
   #. Mental Status
   Lightly sedated. Will lighten slightly further today.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker; bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - Copious secretions in the morning with blood, like Framboise Lambic,
   then cleared and reduced later over the day
   - Very comfortable on vent and lightly sedated
   - Continue 30 mg prednisone for AIN
   - Continued heparin with goal PTT 50-60 given St. Jude valve (wanted to
   see if bleeding might stop on this low level of anticoagulation given
   risk of valve)
   - No more pathology
   - Rheum. want taper of steroids, and will likely be happy with AIN
   level treatment.
   - CVVH at 380 this a.m. with 4.7 L off yesterday (Renal want us to
   continue to take off until pressure drops or labs contract given
   possible role of pulmonary edema in DAH).
   - Vancomycin trough 20
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-31**] 03:00 PM
   Cefipime - [**2128-2-1**] 12:12 AM
   Infusions:
   Midazolam (Versed) - 1 mg/hour
   Fentanyl - 40 mcg/hour
   Calcium Gluconate (CRRT) - 1 grams/hour
   Heparin Sodium - 1,150 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-31**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-1**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.7
C (98
   Tcurrent: 35.8
C (96.5
   HR: 75 (75 - 76) bpm
   BP: 108/46(67) {96/46(66) - 150/64(93)} mmHg
   RR: 23 (15 - 25) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 2 (-4 - 313)mmHg
   Total In:
                                                                  6,406 mL
                                                                  1,163 mL
   PO:
   TF:
                                                                    720 mL
                                                                    180 mL
   IVF:
                                                                  5,196 mL
                                                                    953 mL
   Blood products:
   Total out:
                                                                 11,115 mL
                                                                  2,730 mL
   Urine:
                                                                    541 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,709 mL
                                                                 -1,567 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 498 (343 - 572) mL
   PS : 0 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 33
   PIP: 11 cmH2O
   SpO2: 97%
   ABG: 7.37/35/135/18/-3
   Ve: 9.1 L/min
   PaO2 / FiO2: 338
   Physical Examination
   General: Intubated, moderately sedated, but able to interact and follow
   instructions, pressure support of [**5-19**]. Draining thin secretions from
   lung that are moderately blood, like light red wine.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: Foley in place with hematuria color of red wine.
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Sedated but rousable and able to interact meaningfully.
   Spontaneously moving all limbs, CNs II-XII intact (within limit of exam
   in intubated patient).
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   389 K/uL
   12.6 g/dL
   201 mg/dL
   1.4 mg/dL
   18 mEq/L
   5.1 mEq/L
   35 mg/dL
   104 mEq/L
   136 mEq/L
   40.6 %
   20.9 K/uL
        [image002.jpg]
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
                             [**2128-1-31**]  10:29 AM
                             [**2128-1-31**]  10:38 AM
                             [**2128-1-31**]  04:08 PM
                             [**2128-1-31**]  04:21 PM
                             [**2128-1-31**]  09:54 PM
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
   WBC
   20.9
   Hct
   34.2
   37.7
   40.6
   Plt
   317
   389
   Cr
   1.2
   1.2
   1.4
   TCO2
   32
   28
   29
   24
   24
   21
   Glucose
   162
   253
   170
   201
   Other labs: PT / PTT / INR:14.7/57.4/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:9.2 mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   [**2-1**] CXR
 Final read pending; Multifocal opacification stable to
   improved by our read
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation
   Maintain intubation and ventilation for now given continued secretions
   during the day yesterday. Secretions had improved throughout the night,
   and can consider extubation later this pm. Hypoxemic respiratory
   failure has largely resolved - was likely due to pulmonary edema and
   diffuse alveolar hemorrhage. The etiology of hemorrhage is unclear.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Continue to follow up renal biopsy results from [**1-29**]
   - SBT and consider extubation this PM given improved secretions and
   lesser chance of hemorrhage without cough and management of respiratory
   parameters
   - Continue to appreciate input of Rheumatology (want to taper
   steroids), Renal (steroids for AIN only), Dermatology (topical
   steroid).
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue Heparin gtt with PTT goal 50-70
   - Hold ASA for now given bloody secretions; can likely restart today
   - Continue to remove fluid with CVVH
   - Continue Prednisone 30mg to treat AIN (will check with Renal, but
   likely will need for 4 weeks; start date [**2-1**])
   #. Hemoptysis
   Discussion above pertains. Likely little further benefit and possible
   harm, so hold bronchoscopy for now.
   #. Acute on Chronic Renal Failure/AIN
   Cr 1.5 on presentation; up to 3.4, now 1.2 on CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although Allopurinol and Warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - Continue Prednisone 30mg to treat AIN (will check with Renal, but
   likely will need for 4 weeks; start date [**2-1**])
   - Continue to renally dose medications
   - Continue to remove fluid with CVVH
   - Continue to follow up renal biopsy results from [**1-29**]
   - Continue to follow urine output
   - Continue to follow Renal recommendations
   #. Hematuria
   Likely secondary to biopsy in context of said coagulopathy. Will need
   to monitor given danger period following biopsy is about two weeks.
   Likely too bloody for vasculitic cause.
   - Ask Renal if benefit to spinning when so frankly bloody (surely not
   just due to vasculitis given amount, precipitant (biopsy), and no
   vasculitis on biopsy) (also send UA but may not be helpful for the same
   reason).
   - Continue to follow urine output and if hematuria
   - Consider irrigation if reduction in urine output, suprapubic pain or
   residual volume
   # Leukoclastic Dermatitis
   Is recovering. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Continue steroids as above.
   - Continue to follow Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue to follow ID recommendations
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Continue Heparin as above
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Hematocrit has been stable. Now with pulmonary hemorrhage likely. If
   diffuse vasculitis or actually secondary to primary coagulopathy then
   need to maintain suspicion for other sites of blood loss, including GI
   tract. Patient is consented for blood products.
   - Continue to check Hematocrit q8
   - Guaiac stool
   - Continue to maintain active T&S
   - Continue Protonix while being aware that PPI may also cause AIN
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin
   - Hold ASA for now given bloody secretions; can likely restart today
   - Holding ACE in the setting of renal failure
   - Holding BB for now
   - Continue Heparin as above
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   #. Hyperglycemia
   In the context of steroids. When stabilized on 30 mg prednisone daily
   will adjust for tighter control.
   #. Mental Status
   Lightly sedated. Will lighten slightly further today.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker; bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided physician's daily progress note, the patient is a 76-year-old male with a complex medical history, including coronary artery disease, mechanical aortic valve replacement, atrial fibrillation, and acute on chronic renal failure. The patient is currently hospitalized for methicillin-sensitive Staphylococcus aureus (MSSA) endocarditis with complications of acute renal failure, apparent acute interstitial nephritis (AIN), and leukocytoclastic dermatitis.

The patient's current condition is as follows:

* Respiratory: The patient is intubated and ventilated due to hypoxemic respiratory failure and hemoptysis. The secretions have improved, and the patient may be considered for extubation later in the day.
* Cardiovascular: The patient has a mechanical aortic valve and is at risk for endocarditis. The patient is receiving anticoagulation therapy with heparin, and the goal PTT is 50-60.
* Renal: The patient has acute on chronic renal failure and is receiving continuous renal replacement therapy (CRRT). The patient's creatinine level has improved from 1.5 to 1.2.
* Hematological: The patient has anemia and is receiving blood products. The patient's hematocrit level is stable.
* Skin: The patient has a rash consistent with leukocytoclastic dermatitis, which is thought to be secondary to Nafcillin or Allopurinol.
* Neurological: The patient is lightly sedated and has a normal mental status.

Potential medical complications that can arise include:

1. Diffuse alveolar hemorrhage (DAH): The patient's hemoptysis and pulmonary edema may indicate DAH, which can be life-threatening.
2. Acute kidney injury (AKI): The patient's renal function is already compromised, and further AKI may occur due to nephrotoxic medications or sepsis.
3. Coagulopathy: The patient's bleeding complications and low platelet count may indicate a coagulopathy, which can increase the risk of bleeding and thrombosis.
4. Infection: The patient has MSSA bacteremia and endocarditis, which can lead to sepsis and organ failure.
5. Cardiovascular complications: The patient's mechanical aortic valve and atrial fibrillation may increase the risk of cardiovascular complications, such as thromboembolism and heart failure.
6. Gastrointestinal bleeding: The patient's anemia and bleeding complications may indicate gastrointestinal bleeding, which can be life-threatening.

The patient's treatment plan includes:

1. Continue intubation and ventilation for now.
2. Continue broad-spectrum antibiotics for MSSA bacteremia and endocarditis.
3. Continue anticoagulation therapy with heparin.
4. Continue CRRT for renal failure.
5. Continue steroids for AIN and leukocytoclastic dermatitis.
6. Monitor the patient's renal function and electrolyte levels.
7. Consider extubation and weaning from mechanical ventilation once the patient's secretions have improved.

Overall, the patient's condition is complex and requires close monitoring and management to prevent potential complications and improve outcomes."
182149.0,283460,2128-02-01 07:38:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - Copious secretions in the morning with blood, like Framboise Lambic,
   then cleared and reduced later over the day
   - Very comfortable on vent and lightly sedated
   - Continue 30 mg prednisone for AIN
   - Continued heparin with goal PTT 50-60 given St. Jude valve (wanted to
   see if bleeding might stop on this low level of anticoagulation given
   risk of valve)
   - No more pathology
   - Rheum. want taper of steroids, and will likely be happy with AIN
   level treatment.
   - CVVH at 380 this a.m. with 4.7 L off yesterday (Renal want us to
   continue to take off until pressure drops or labs contract given
   possible role of pulmonary edema in DAH).
   - Vancomycin trough 20
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-31**] 03:00 PM
   Cefipime - [**2128-2-1**] 12:12 AM
   Infusions:
   Midazolam (Versed) - 1 mg/hour
   Fentanyl - 40 mcg/hour
   Calcium Gluconate (CRRT) - 1 grams/hour
   Heparin Sodium - 1,150 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-31**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-1**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.7
C (98
   Tcurrent: 35.8
C (96.5
   HR: 75 (75 - 76) bpm
   BP: 108/46(67) {96/46(66) - 150/64(93)} mmHg
   RR: 23 (15 - 25) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 2 (-4 - 313)mmHg
   Total In:
                                                                  6,406 mL
                                                                  1,163 mL
   PO:
   TF:
                                                                    720 mL
                                                                    180 mL
   IVF:
                                                                  5,196 mL
                                                                    953 mL
   Blood products:
   Total out:
                                                                 11,115 mL
                                                                  2,730 mL
   Urine:
                                                                    541 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,709 mL
                                                                 -1,567 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 498 (343 - 572) mL
   PS : 0 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 33
   PIP: 11 cmH2O
   SpO2: 97%
   ABG: 7.37/35/135/18/-3
   Ve: 9.1 L/min
   PaO2 / FiO2: 338
   Physical Examination
   General: Intubated, moderately sedated, but able to interact and follow
   instructions. Draining thin secretions from lung that are moderately
   blood, like light red wine; suctions have cleared in early AM.
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles; improved
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  Soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: Foley in place with improved red appearance.
   Ext: warm, well perfused; Edema much improved and appears dry; Hands
   also look dry; non-blanching rash over lower extremity improving;
   Neuro: Sedated but rousable and able to interact meaningfully.
   Spontaneously moving all limbs, CNs II-XII intact (within limit of exam
   in intubated patient).
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   389 K/uL
   12.6 g/dL
   201 mg/dL
   1.4 mg/dL
   18 mEq/L
   5.1 mEq/L
   35 mg/dL
   104 mEq/L
   136 mEq/L
   40.6 %
   20.9 K/uL
        [image002.jpg]
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
                             [**2128-1-31**]  10:29 AM
                             [**2128-1-31**]  10:38 AM
                             [**2128-1-31**]  04:08 PM
                             [**2128-1-31**]  04:21 PM
                             [**2128-1-31**]  09:54 PM
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
   WBC
   20.9
   Hct
   34.2
   37.7
   40.6
   Plt
   317
   389
   Cr
   1.2
   1.2
   1.4
   TCO2
   32
   28
   29
   24
   24
   21
   Glucose
   162
   253
   170
   201
   Other labs: PT / PTT / INR:14.7/57.4/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:9.2 mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   [**2-1**] CXR
 Final read pending; Multifocal opacification stable to
   improved by our read
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation
   Maintain intubation and ventilation for now given continued secretions
   during the day yesterday. Secretions had improved throughout the night,
   and can consider extubation later this pm. Hypoxemic respiratory
   failure has largely resolved - was likely due to pulmonary edema and
   diffuse alveolar hemorrhage. The etiology of hemorrhage is unclear.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Continue to follow up renal biopsy results from [**1-29**]
   - SBT and consider extubation this PM given improved secretions and
   lesser chance of hemorrhage without cough and management of respiratory
   parameters
   - Continue to appreciate input of Rheumatology (want to taper
   steroids), Renal (steroids for AIN only), Dermatology (topical
   steroid).
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue Heparin gtt with PTT goal 50-70
   - Hold ASA for now given secretions
   - Plan to discontinue CVVH
 will need to get in touch with Renal
   - Continue Prednisone 30mg to treat AIN (will check with Renal, but
   likely will need for 4 weeks; start date [**2-1**])
   # Volume Status
   Patient appears overall volume depleted on exam findings. This explains
   hemoconcentration seen on lab values.
   - Plan to discontinue CVVH
 will need to get in touch with Renal
   - Trend fever curve
   - Follow up blood cultures
   - Continue to follow
   #. Hemoptysis
   Discussion above pertains. Likely little further benefit and possible
   harm, so hold bronchoscopy for now.
   #. Acute on Chronic Renal Failure/AIN
   Cr 1.5 on presentation; up to 3.4, now 1.2 on CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although Allopurinol and Warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - Continue Prednisone 30mg to treat AIN (will check with Renal, but
   likely will need for 4 weeks; start date [**2-1**])
   - Continue to renally dose medications
   - Plan to discontinue CVVH
 will need to get in touch with Renal
   - Continue to follow up renal biopsy results from [**1-29**]
   - Continue to follow urine output
   - Continue to follow Renal recommendations
   #. Hematuria
   Likely secondary to biopsy in context of said coagulopathy. Will need
   to monitor given danger period following biopsy is about two weeks.
   Likely too bloody for vasculitic cause.
   - Ask Renal if benefit to spinning when so frankly bloody (surely not
   just due to vasculitis given amount, precipitant (biopsy), and no
   vasculitis on biopsy) (also send UA but may not be helpful for the same
   reason).
   - Continue to follow urine output and if hematuria
   - Consider irrigation if reduction in urine output, suprapubic pain or
   residual volume
   # Leukoclastic Dermatitis
   Is recovering. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Continue steroids as above.
   - Continue to follow Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue to follow ID recommendations
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Continue Heparin as above
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Hematocrit has been stable. Now with pulmonary hemorrhage likely. If
   diffuse vasculitis or actually secondary to primary coagulopathy then
   need to maintain suspicion for other sites of blood loss, including GI
   tract. Patient is consented for blood products.
   - Continue to check Hematocrit q8
   - Guaiac stool
   - Continue to maintain active T&S
   - Continue Protonix while being aware that PPI may also cause AIN
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin
   - Hold ASA for now given bloody secretions
   - Holding ACE in the setting of renal failure
   - Holding BB for now
   - Continue Heparin as above
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   #. Hyperglycemia
   In the context of steroids. When stabilized on 30 mg prednisone daily
   will adjust for tighter control.
   #. Mental Status
   Lightly sedated. Will lighten slightly further today.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker; bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - Copious secretions in the morning with blood, like Framboise Lambic,
   then cleared and reduced later over the day
   - Very comfortable on vent and lightly sedated
   - Continue 30 mg prednisone for AIN
   - Continued heparin with goal PTT 50-60 given St. Jude valve (wanted to
   see if bleeding might stop on this low level of anticoagulation given
   risk of valve)
   - No more pathology
   - Rheum. want taper of steroids, and will likely be happy with AIN
   level treatment.
   - CVVH at 380 this a.m. with 4.7 L off yesterday (Renal want us to
   continue to take off until pressure drops or labs contract given
   possible role of pulmonary edema in DAH).
   - Vancomycin trough 20
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-31**] 03:00 PM
   Cefipime - [**2128-2-1**] 12:12 AM
   Infusions:
   Midazolam (Versed) - 1 mg/hour
   Fentanyl - 40 mcg/hour
   Calcium Gluconate (CRRT) - 1 grams/hour
   Heparin Sodium - 1,150 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-31**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-1**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.7
C (98
   Tcurrent: 35.8
C (96.5
   HR: 75 (75 - 76) bpm
   BP: 108/46(67) {96/46(66) - 150/64(93)} mmHg
   RR: 23 (15 - 25) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 2 (-4 - 313)mmHg
   Total In:
                                                                  6,406 mL
                                                                  1,163 mL
   PO:
   TF:
                                                                    720 mL
                                                                    180 mL
   IVF:
                                                                  5,196 mL
                                                                    953 mL
   Blood products:
   Total out:
                                                                 11,115 mL
                                                                  2,730 mL
   Urine:
                                                                    541 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,709 mL
                                                                 -1,567 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 498 (343 - 572) mL
   PS : 0 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 33
   PIP: 11 cmH2O
   SpO2: 97%
   ABG: 7.37/35/135/18/-3
   Ve: 9.1 L/min
   PaO2 / FiO2: 338
   Physical Examination
   General: Intubated, moderately sedated, but able to interact and follow
   instructions. Draining thin secretions from lung that are moderately
   blood, like light red wine; suctions have cleared in early AM.
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles; improved
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  Soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: Foley in place with improved red appearance.
   Ext: warm, well perfused; Edema much improved and appears dry; Hands
   also look dry; non-blanching rash over lower extremity improving;
   Neuro: Sedated but rousable and able to interact meaningfully.
   Spontaneously moving all limbs, CNs II-XII intact (within limit of exam
   in intubated patient).
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   389 K/uL
   12.6 g/dL
   201 mg/dL
   1.4 mg/dL
   18 mEq/L
   5.1 mEq/L
   35 mg/dL
   104 mEq/L
   136 mEq/L
   40.6 %
   20.9 K/uL
        [image002.jpg]
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
                             [**2128-1-31**]  10:29 AM
                             [**2128-1-31**]  10:38 AM
                             [**2128-1-31**]  04:08 PM
                             [**2128-1-31**]  04:21 PM
                             [**2128-1-31**]  09:54 PM
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
   WBC
   20.9
   Hct
   34.2
   37.7
   40.6
   Plt
   317
   389
   Cr
   1.2
   1.2
   1.4
   TCO2
   32
   28
   29
   24
   24
   21
   Glucose
   162
   253
   170
   201
   Other labs: PT / PTT / INR:14.7/57.4/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:9.2 mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   [**2-1**] CXR
 Final read pending; Multifocal opacification stable to
   improved by our read
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation
   Maintain intubation and ventilation for now given continued secretions
   during the day yesterday. Secretions had improved throughout the night,
   and can consider extubation later this pm. Hypoxemic respiratory
   failure has largely resolved - was likely due to pulmonary edema and
   diffuse alveolar hemorrhage. The etiology of hemorrhage is unclear.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Continue to follow up renal biopsy results from [**1-29**]
   - SBT and consider extubation this PM given improved secretions and
   lesser chance of hemorrhage without cough and management of respiratory
   parameters
   - Continue to appreciate input of Rheumatology (want to taper
   steroids), Renal (steroids for AIN only), Dermatology (topical
   steroid).
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue Heparin gtt with PTT goal 50-70
   - Hold ASA for now given secretions
   - Plan to discontinue CVVH
 will need to get in touch with Renal
   - Continue Prednisone 30mg to treat AIN (will check with Renal, but
   likely will need for 4 weeks; start date [**2-1**])
   # Volume Status
   Patient appears overall volume depleted on exam findings. This explains
   hemoconcentration seen on lab values.
   - Plan to discontinue CVVH
 will need to get in touch with Renal
   - Trend fever curve
   - Follow up blood cultures
   - Continue to follow
   #. Hemoptysis
   Discussion above pertains. Likely little further benefit and possible
   harm, so hold bronchoscopy for now.
   #. Acute on Chronic Renal Failure/AIN
   Cr 1.5 on presentation; up to 3.4, now 1.2 on CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although Allopurinol and Warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - Continue Prednisone 30mg to treat AIN (will check with Renal, but
   likely will need for 4 weeks; start date [**2-1**])
   - Continue to renally dose medications
   - Plan to discontinue CVVH
 will need to get in touch with Renal
   - Continue to follow up renal biopsy results from [**1-29**]
   - Continue to follow urine output
   - Continue to follow Renal recommendations
   #. Hematuria
   Likely secondary to biopsy in context of said coagulopathy. Will need
   to monitor given danger period following biopsy is about two weeks.
   Likely too bloody for vasculitic cause.
   - Ask Renal if benefit to spinning when so frankly bloody (surely not
   just due to vasculitis given amount, precipitant (biopsy), and no
   vasculitis on biopsy) (also send UA but may not be helpful for the same
   reason).
   - Continue to follow urine output and if hematuria
   - Consider irrigation if reduction in urine output, suprapubic pain or
   residual volume
   # Leukoclastic Dermatitis
   Is recovering. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Continue steroids as above.
   - Continue to follow Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue to follow ID recommendations
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Continue Heparin as above
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Hematocrit has been stable. Now with pulmonary hemorrhage likely. If
   diffuse vasculitis or actually secondary to primary coagulopathy then
   need to maintain suspicion for other sites of blood loss, including GI
   tract. Patient is consented for blood products.
   - Continue to check Hematocrit q8
   - Guaiac stool
   - Continue to maintain active T&S
   - Continue Protonix while being aware that PPI may also cause AIN
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin
   - Hold ASA for now given bloody secretions
   - Holding ACE in the setting of renal failure
   - Holding BB for now
   - Continue Heparin as above
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   #. Hyperglycemia
   In the context of steroids. When stabilized on 30 mg prednisone daily
   will adjust for tighter control.
   #. Mental Status
   Lightly sedated. Will lighten slightly further today.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker; bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's condition as follows:

The patient is a 76-year-old male with a history of CAD, s/p CABG, and s/p mechanical AVR, who is currently hospitalized for MSSA endocarditis with complications of ARF, AIN, CHB, and torsades, and leukocytoclastic dermatitis on skin biopsy. The patient has been transferred to the MICU due to respiratory distress, hypoxemia, and hemoptysis concerning for DAH.

The patient's vital signs are stable, with a temperature of 36.7°C, heart rate of 75 bpm, and blood pressure of 108/46 mmHg. The patient is intubated and ventilated, with a PaO2/FiO2 ratio of 338.

The patient's laboratory results show:

* White blood cell count: 20.9 K/uL
* Hematocrit: 34.2%
* Platelet count: 317
* Creatinine: 1.2 mg/dL
* Blood urea nitrogen: 18 mg/dL
* Glucose: 162 mg/dL
* Lactic acid: 0.8 mmol/L
* LDH: 333 IU/L
* Calcium: 9.2 mg/dL
* Magnesium: 2.5 mg/dL
* Phosphate: 2.4 mg/dL

The patient's physical examination reveals:

* Intubated and moderately sedated
* Draining thin secretions from the lung that are moderately blood-tinged
* Bilateral expiratory rhonchi and coarse crackles
* Regular normal S1 and S2 heart sounds
* Soft, non-tender, non-distended abdomen
* Warm, well-perfused extremities with dry skin
* Non-blanching rash over the lower extremities
* Sedated but rousable and able to interact meaningfully

The patient's diagnosis includes:

* DAH
* Hypoxemic respiratory failure
* Ventilation
* Intubation
* ARF
* AIN
* CHB
* Torsades
* Leukocytoclastic dermatitis
* MSSA endocarditis
* Bacteremia
* Atrial fibrillation
* Complete heart block

The patient's treatment plan includes:

* Continue intubation and ventilation for now
* Continue steroids for AIN
* Continue Heparin with a PTT goal of 50-70
* Continue broad-spectrum treatment for HAP and MSSA bacteremia
* Continue to follow up renal biopsy results
* Continue to follow up on blood cultures
* Consider extubation later this pm if secretions improve
* Plan to discontinue CVVH
* Continue to monitor for signs of bleeding and coagulopathy

Potential medical complications that can arise include:

* Worsening of respiratory failure
* Development of pneumonia
* Hemorrhagic shock
* Coagulopathy
* Thrombosis
* Endocarditis
* Bacteremia
* Sepsis
* Renal failure
* AIN
* Leukocytoclastic dermatitis

The patient's code status is full code, and their disposition is pending clinical improvement."
182149.0,283460,2128-02-02 08:09:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2128-2-1**] 11:17 AM
   - Patient extubated succesfully during early morning; did well
   throughout the day
   - We removed the stitch from the derm skin biopsy site.
   - Rheumatology notes clear clinical improvement and recommends
   following up with the final result of the renal biopsy.
   - Renal recommends to continue steroids, to stop CVVH, and to evaluate
   and plan for possible HD on Monday. They also recommend to give
   Vancomycin with HD, to reduce Cefepime to 1gm q24 and to stop
   Sucralfate (aluminum toxicity). We ordered for a trough to follow up in
   AM.
   - Patient with worsening BUN, Cr, HCO3 through evening; plan to manage
   in AM with HD per renal.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-1**] 01:30 PM
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-1**] 08:00 AM
   Lorazepam (Ativan) - [**2128-2-1**] 09:48 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-2**] 06:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.1
C (97
   Tcurrent: 35.7
C (96.2
   HR: 75 (75 - 78) bpm
   BP: 258/255(257) {90/46(61) - 258/255(257)} mmHg
   RR: 26 (15 - 31) insp/min
   SpO2: 95%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 4 (-5 - 8)mmHg
   Total In:
                                                                  2,382 mL
                                                                     71 mL
   PO:
   TF:
                                                                    180 mL
   IVF:
                                                                  2,112 mL
                                                                     71 mL
   Blood products:
   Total out:
                                                                  3,944 mL
                                                                     90 mL
   Urine:
                                                                    150 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,562 mL
                                                                    -19 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: [[**Doctor First Name **]: CPAP/PSV :[**Doctor First Name **]]
   Vt (Spontaneous): 571 (571 - 571) mL
   PS : 5 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 6 cmH2O
   SpO2: 95%
   ABG: 7.37/26/78/17/-8
   Ve: 14.1 L/min
   PaO2 / FiO2: 195
   Physical Examination
   General: Extubated; reduced but continued light red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   363 K/uL
   13.0 g/dL
   152 mg/dL
   3.2 mg/dL
   17 mEq/L
   5.4 mEq/L
   84 mg/dL
   105 mEq/L
   139 mEq/L
   42.3 %
   22.4 K/uL
        [image002.jpg]
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
                             [**2128-2-1**]  08:16 AM
                             [**2128-2-1**]  12:02 PM
                             [**2128-2-1**]  04:41 PM
                             [**2128-2-1**]  07:50 PM
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
   WBC
   20.9
   22.4
   Hct
   40.6
   40.8
   42.3
   Plt
   389
   363
   Cr
   1.4
   2.4
   2.7
   3.2
   TCO2
   24
   21
   18
   17
   16
   16
   Glucose
   [**Telephone/Fax (3) 11399**]52
   Other labs: PT / PTT / INR:15.1/47.7/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.9 mmol/L, LDH:333 IU/L,
   Ca++:9.6 mg/dL, Mg++:2.7 mg/dL, PO4:4.8 mg/dL
   - No new CXR, culture data.
   - Renal biopsy results continue to be pending.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. Also with large diuresis off diuretics. DDx includes AIN due
   to Nafcillin (also identical pathophysiology with concomitant rash
   see below), although Allopurinol and Warfarin can also less frequently
   (and much less likely in this case) produce this effect. Renal biopsy
   without changes consistent with AIN, but already given a few days of
   high-dose steroids. Awaiting final renal pathology results and
   evaluation. Evidence for AIN includes white cell casts, worsened renal
   function and urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for possible HD today per Renal recommendations
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations
   will likely need for 4-6 weeks; start date [**2-1**]
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   continues to have large UOP, likely contributing to his continued
   hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Follow up blood cultures
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, continue tube feeds per
   recommendation
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2128-2-1**] 11:17 AM
   - Patient extubated succesfully during early morning; did well
   throughout the day
   - We removed the stitch from the derm skin biopsy site.
   - Rheumatology notes clear clinical improvement and recommends
   following up with the final result of the renal biopsy.
   - Renal recommends to continue steroids, to stop CVVH, and to evaluate
   and plan for possible HD on Monday. They also recommend to give
   Vancomycin with HD, to reduce Cefepime to 1gm q24 and to stop
   Sucralfate (aluminum toxicity). We ordered for a trough to follow up in
   AM.
   - Patient with worsening BUN, Cr, HCO3 through evening; plan to manage
   in AM with HD per renal.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-1**] 01:30 PM
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-1**] 08:00 AM
   Lorazepam (Ativan) - [**2128-2-1**] 09:48 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-2**] 06:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.1
C (97
   Tcurrent: 35.7
C (96.2
   HR: 75 (75 - 78) bpm
   BP: 258/255(257) {90/46(61) - 258/255(257)} mmHg
   RR: 26 (15 - 31) insp/min
   SpO2: 95%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 4 (-5 - 8)mmHg
   Total In:
                                                                  2,382 mL
                                                                     71 mL
   PO:
   TF:
                                                                    180 mL
   IVF:
                                                                  2,112 mL
                                                                     71 mL
   Blood products:
   Total out:
                                                                  3,944 mL
                                                                     90 mL
   Urine:
                                                                    150 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,562 mL
                                                                    -19 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: [[**Doctor First Name **]: CPAP/PSV :[**Doctor First Name **]]
   Vt (Spontaneous): 571 (571 - 571) mL
   PS : 5 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 6 cmH2O
   SpO2: 95%
   ABG: 7.37/26/78/17/-8
   Ve: 14.1 L/min
   PaO2 / FiO2: 195
   Physical Examination
   General: Extubated; reduced but continued light red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   363 K/uL
   13.0 g/dL
   152 mg/dL
   3.2 mg/dL
   17 mEq/L
   5.4 mEq/L
   84 mg/dL
   105 mEq/L
   139 mEq/L
   42.3 %
   22.4 K/uL
        [image002.jpg]
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
                             [**2128-2-1**]  08:16 AM
                             [**2128-2-1**]  12:02 PM
                             [**2128-2-1**]  04:41 PM
                             [**2128-2-1**]  07:50 PM
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
   WBC
   20.9
   22.4
   Hct
   40.6
   40.8
   42.3
   Plt
   389
   363
   Cr
   1.4
   2.4
   2.7
   3.2
   TCO2
   24
   21
   18
   17
   16
   16
   Glucose
   [**Telephone/Fax (3) 11399**]52
   Other labs: PT / PTT / INR:15.1/47.7/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.9 mmol/L, LDH:333 IU/L,
   Ca++:9.6 mg/dL, Mg++:2.7 mg/dL, PO4:4.8 mg/dL
   - No new CXR, culture data.
   - Renal biopsy results continue to be pending.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. Also with large diuresis off diuretics. DDx includes AIN due
   to Nafcillin (also identical pathophysiology with concomitant rash
   see below), although Allopurinol and Warfarin can also less frequently
   (and much less likely in this case) produce this effect. Renal biopsy
   without changes consistent with AIN, but already given a few days of
   high-dose steroids. Awaiting final renal pathology results and
   evaluation. Evidence for AIN includes white cell casts, worsened renal
   function and urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for possible HD today per Renal recommendations
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations
   will likely need for 4-6 weeks; start date [**2-1**]
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   continues to have large UOP, likely contributing to his continued
   hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Follow up blood cultures
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, continue tube feeds per
   recommendation
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of CAD, s/p CABG, and s/p mechanical AVR, admitted with MSSA bacteremia, torsades, and ARF likely secondary to AIN. He was previously on CVVH and is now being managed with HD. The patient has a petechial rash on his lower extremities, which is improving. He has been extubated and is stable off of positive pressure ventilation. The patient's labs show worsening renal function, with increasing BUN, Cr, and HCO3 levels.

Potential Medical Complications:

1. Worsening Renal Function: The patient's BUN, Cr, and HCO3 levels are increasing, suggesting worsening renal function. This may lead to further fluid overload, electrolyte imbalances, and acid-base disturbances.
2. Flash Pulmonary Edema: The patient's fluid overload and worsening renal function may lead to flash pulmonary edema, which can be life-threatening.
3. Hemorrhagic Complications: The patient's bleeding diathesis and history of DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis may lead to further bleeding complications, including GI bleeding, intracranial bleeding, or pulmonary bleeding.
4. Infection: The patient's MSSA bacteremia and ongoing antibiotic therapy may lead to the development of antibiotic-resistant bacteria or the emergence of new pathogens.
5. Cardiac Complications: The patient's history of CAD, s/p CABG, and s/p mechanical AVR, as well as his current anticoagulation therapy, may lead to cardiac complications, including arrhythmias, congestive heart failure, or cardiac tamponade.
6. Neurological Complications: The patient's bleeding diathesis and history of torsades may lead to neurological complications, including seizures, stroke, or intracranial bleeding.
7. Gastrointestinal Complications: The patient's history of DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis and ongoing anticoagulation therapy may lead to gastrointestinal bleeding or perforation.
8. Respiratory Complications: The patient's ongoing respiratory failure and history of DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis may lead to further respiratory complications, including respiratory failure, pneumonia, or acute respiratory distress syndrome.

Recommendations:

1. Continue to monitor the patient's renal function and adjust therapy accordingly.
2. Monitor the patient's fluid status and adjust fluid administration to prevent further fluid overload.
3. Continue to monitor the patient's bleeding diathesis and adjust anticoagulation therapy as necessary.
4. Continue to monitor the patient's respiratory status and adjust therapy accordingly.
5. Consider consulting with cardiothoracic surgery for further management of the patient's cardiac complications.
6. Consider consulting with neurology for further management of the patient's neurological complications.
7. Consider consulting with gastroenterology for further management of the patient's gastrointestinal complications.
8. Continue to follow up with the patient's primary care physician and other specialists as necessary."
182149.0,283460,2128-02-02 08:09:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2128-2-1**] 11:17 AM
   - Patient extubated succesfully during early morning; did well
   throughout the day
   - We removed the stitch from the derm skin biopsy site.
   - Rheumatology notes clear clinical improvement and recommends
   following up with the final result of the renal biopsy.
   - Renal recommends to continue steroids, to stop CVVH, and to evaluate
   and plan for possible HD on Monday. They also recommend to give
   Vancomycin with HD, to reduce Cefepime to 1gm q24 and to stop
   Sucralfate (aluminum toxicity). We ordered for a trough to follow up in
   AM.
   - Patient with worsening BUN, Cr, HCO3 through evening; plan to manage
   in AM with HD per renal.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-1**] 01:30 PM
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-1**] 08:00 AM
   Lorazepam (Ativan) - [**2128-2-1**] 09:48 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-2**] 06:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.1
C (97
   Tcurrent: 35.7
C (96.2
   HR: 75 (75 - 78) bpm
   BP: 258/255(257) {90/46(61) - 258/255(257)} mmHg
   RR: 26 (15 - 31) insp/min
   SpO2: 95%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 4 (-5 - 8)mmHg
   Total In:
                                                                  2,382 mL
                                                                     71 mL
   PO:
   TF:
                                                                    180 mL
   IVF:
                                                                  2,112 mL
                                                                     71 mL
   Blood products:
   Total out:
                                                                  3,944 mL
                                                                     90 mL
   Urine:
                                                                    150 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,562 mL
                                                                    -19 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: [[**Doctor First Name **]: CPAP/PSV :[**Doctor First Name **]]
   Vt (Spontaneous): 571 (571 - 571) mL
   PS : 5 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 6 cmH2O
   SpO2: 95%
   ABG: 7.37/26/78/17/-8
   Ve: 14.1 L/min
   PaO2 / FiO2: 195
   Physical Examination
   General: Extubated; reduced but continued light red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   363 K/uL
   13.0 g/dL
   152 mg/dL
   3.2 mg/dL
   17 mEq/L
   5.4 mEq/L
   84 mg/dL
   105 mEq/L
   139 mEq/L
   42.3 %
   22.4 K/uL
        [image003.jpg]
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
                             [**2128-2-1**]  08:16 AM
                             [**2128-2-1**]  12:02 PM
                             [**2128-2-1**]  04:41 PM
                             [**2128-2-1**]  07:50 PM
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
   WBC
   20.9
   22.4
   Hct
   40.6
   40.8
   42.3
   Plt
   389
   363
   Cr
   1.4
   2.4
   2.7
   3.2
   TCO2
   24
   21
   18
   17
   16
   16
   Glucose
   [**Telephone/Fax (3) 11399**]52
   Other labs: PT / PTT / INR:15.1/47.7/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.9 mmol/L, LDH:333 IU/L,
   Ca++:9.6 mg/dL, Mg++:2.7 mg/dL, PO4:4.8 mg/dL
   - No new CXR, culture data.
   - Renal biopsy results continue to be pending.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. Also with large diuresis off diuretics. DDx includes AIN due
   to Nafcillin (also identical pathophysiology with concomitant rash
   see below), although Allopurinol and Warfarin can also less frequently
   (and much less likely in this case) produce this effect. Renal biopsy
   without changes consistent with AIN, but already given a few days of
   high-dose steroids. Awaiting final renal pathology results and
   evaluation. Evidence for AIN includes white cell casts, worsened renal
   function and urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for possible HD today per Renal recommendations
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations
   will likely need for 4-6 weeks; start date [**2-1**]
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   continues to have large UOP, likely contributing to his continued
   hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Follow up blood cultures
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S
   - Continue Protonix while being aware that PPI may also cause AIN
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, continue tube feeds per
   recommendation
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2128-2-1**] 11:17 AM
   - Patient extubated succesfully during early morning; did well
   throughout the day
   - We removed the stitch from the derm skin biopsy site.
   - Rheumatology notes clear clinical improvement and recommends
   following up with the final result of the renal biopsy.
   - Renal recommends to continue steroids, to stop CVVH, and to evaluate
   and plan for possible HD on Monday. They also recommend to give
   Vancomycin with HD, to reduce Cefepime to 1gm q24 and to stop
   Sucralfate (aluminum toxicity). We ordered for a trough to follow up in
   AM.
   - Patient with worsening BUN, Cr, HCO3 through evening; plan to manage
   in AM with HD per renal.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-1**] 01:30 PM
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-1**] 08:00 AM
   Lorazepam (Ativan) - [**2128-2-1**] 09:48 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-2**] 06:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.1
C (97
   Tcurrent: 35.7
C (96.2
   HR: 75 (75 - 78) bpm
   BP: 258/255(257) {90/46(61) - 258/255(257)} mmHg
   RR: 26 (15 - 31) insp/min
   SpO2: 95%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 4 (-5 - 8)mmHg
   Total In:
                                                                  2,382 mL
                                                                     71 mL
   PO:
   TF:
                                                                    180 mL
   IVF:
                                                                  2,112 mL
                                                                     71 mL
   Blood products:
   Total out:
                                                                  3,944 mL
                                                                     90 mL
   Urine:
                                                                    150 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,562 mL
                                                                    -19 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: [[**Doctor First Name **]: CPAP/PSV :[**Doctor First Name **]]
   Vt (Spontaneous): 571 (571 - 571) mL
   PS : 5 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 6 cmH2O
   SpO2: 95%
   ABG: 7.37/26/78/17/-8
   Ve: 14.1 L/min
   PaO2 / FiO2: 195
   Physical Examination
   General: Extubated; reduced but continued light red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   363 K/uL
   13.0 g/dL
   152 mg/dL
   3.2 mg/dL
   17 mEq/L
   5.4 mEq/L
   84 mg/dL
   105 mEq/L
   139 mEq/L
   42.3 %
   22.4 K/uL
        [image003.jpg]
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
                             [**2128-2-1**]  08:16 AM
                             [**2128-2-1**]  12:02 PM
                             [**2128-2-1**]  04:41 PM
                             [**2128-2-1**]  07:50 PM
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
   WBC
   20.9
   22.4
   Hct
   40.6
   40.8
   42.3
   Plt
   389
   363
   Cr
   1.4
   2.4
   2.7
   3.2
   TCO2
   24
   21
   18
   17
   16
   16
   Glucose
   [**Telephone/Fax (3) 11399**]52
   Other labs: PT / PTT / INR:15.1/47.7/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.9 mmol/L, LDH:333 IU/L,
   Ca++:9.6 mg/dL, Mg++:2.7 mg/dL, PO4:4.8 mg/dL
   - No new CXR, culture data.
   - Renal biopsy results continue to be pending.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. Also with large diuresis off diuretics. DDx includes AIN due
   to Nafcillin (also identical pathophysiology with concomitant rash
   see below), although Allopurinol and Warfarin can also less frequently
   (and much less likely in this case) produce this effect. Renal biopsy
   without changes consistent with AIN, but already given a few days of
   high-dose steroids. Awaiting final renal pathology results and
   evaluation. Evidence for AIN includes white cell casts, worsened renal
   function and urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for possible HD today per Renal recommendations
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations
   will likely need for 4-6 weeks; start date [**2-1**]
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   continues to have large UOP, likely contributing to his continued
   hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Follow up blood cultures
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S
   - Continue Protonix while being aware that PPI may also cause AIN
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, continue tube feeds per
   recommendation
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male admitted with MSSA bacteremia, torsades, and ARF likely secondary to AIN. He has undergone CABG and mechanical AVR, and has a history of CAD, Afib, and complete heart block. He has been extubated and is currently on invasive ventilation. His renal function is progressively worsening, and he is likely to require HD today. He has a petechial rash on his legs, which is improving. His lungs are stable, and his heart rhythm is ventricularly paced.

Potential Medical Complications:

1. Worsening renal function: The patient's BUN, Cr, and bicarbonate levels are all suggestive of progressively worsening renal function. This may lead to further electrolyte imbalances, acidosis, and anemia.
2. AIN: The patient has been diagnosed with AIN, which may lead to further renal damage and potentially chronic kidney disease.
3. Flash pulmonary edema: The patient's history of pulmonary edema and diffuse alveolar hemorrhage increases the risk of flash pulmonary edema, which could lead to further respiratory distress and potentially life-threatening complications.
4. Bleeding complications: The patient has a history of bleeding complications, including hematuria and hemoptysis. This may lead to further bleeding episodes, particularly in the context of anticoagulation therapy.
5. Infection: The patient has a history of MSSA bacteremia and is at risk for further infections, particularly in the context of invasive devices and immunosuppressive therapy.
6. Cardiovascular complications: The patient has a history of CAD, Afib, and complete heart block, which may increase the risk of further cardiovascular complications, including myocardial infarction, stroke, and arrhythmias.
7. Neurological complications: The patient's history of torsades and Afib increases the risk of further neurological complications, including seizures, stroke, and coma.
8. Gastrointestinal complications: The patient's history of pancreatitis and GI bleeding increases the risk of further gastrointestinal complications, including nausea, vomiting, and diarrhea.

Recommendations:

1. Continue to monitor the patient's renal function and adjust therapy as necessary.
2. Consider further diagnostic testing to rule out other causes of AIN, including vasculitis and autoimmune disorders.
3. Continue to monitor the patient's pulmonary function and adjust therapy as necessary to prevent further respiratory complications.
4. Continue to monitor the patient's bleeding complications and adjust therapy as necessary to prevent further bleeding episodes.
5. Continue to monitor the patient's cardiovascular and neurological function and adjust therapy as necessary to prevent further complications.
6. Consider further diagnostic testing to rule out other causes of pancreatitis, including pancreatitis and pancreatic duct obstruction.
7. Continue to monitor the patient's gastrointestinal function and adjust therapy as necessary to prevent further complications."
182149.0,283460,2128-02-02 08:09:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2128-2-1**] 11:17 AM
   - Patient extubated succesfully during early morning; did well
   throughout the day
   - We removed the stitch from the derm skin biopsy site.
   - Rheumatology notes clear clinical improvement and recommends
   following up with the final result of the renal biopsy.
   - Renal recommends to continue steroids, to stop CVVH, and to evaluate
   and plan for possible HD on Monday. They also recommend to give
   Vancomycin with HD, to reduce Cefepime to 1gm q24 and to stop
   Sucralfate (aluminum toxicity). We ordered for a trough to follow up in
   AM.
   - Patient with worsening BUN, Cr, HCO3 through evening; plan to manage
   in AM with HD per renal.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-1**] 01:30 PM
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-1**] 08:00 AM
   Lorazepam (Ativan) - [**2128-2-1**] 09:48 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-2**] 06:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.1
C (97
   Tcurrent: 35.7
C (96.2
   HR: 75 (75 - 78) bpm
   BP: 258/255(257) {90/46(61) - 258/255(257)} mmHg
   RR: 26 (15 - 31) insp/min
   SpO2: 95%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 4 (-5 - 8)mmHg
   Total In:
                                                                  2,382 mL
                                                                     71 mL
   PO:
   TF:
                                                                    180 mL
   IVF:
                                                                  2,112 mL
                                                                     71 mL
   Blood products:
   Total out:
                                                                  3,944 mL
                                                                     90 mL
   Urine:
                                                                    150 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,562 mL
                                                                    -19 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: [[**Doctor First Name **]: CPAP/PSV :[**Doctor First Name **]]
   Vt (Spontaneous): 571 (571 - 571) mL
   PS : 5 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 6 cmH2O
   SpO2: 95%
   ABG: 7.37/26/78/17/-8
   Ve: 14.1 L/min
   PaO2 / FiO2: 195
   Physical Examination
   General: Extubated; reduced but continued light red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   363 K/uL
   13.0 g/dL
   152 mg/dL
   3.2 mg/dL
   17 mEq/L
   5.4 mEq/L
   84 mg/dL
   105 mEq/L
   139 mEq/L
   42.3 %
   22.4 K/uL
        [image002.jpg]
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
                             [**2128-2-1**]  08:16 AM
                             [**2128-2-1**]  12:02 PM
                             [**2128-2-1**]  04:41 PM
                             [**2128-2-1**]  07:50 PM
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
   WBC
   20.9
   22.4
   Hct
   40.6
   40.8
   42.3
   Plt
   389
   363
   Cr
   1.4
   2.4
   2.7
   3.2
   TCO2
   24
   21
   18
   17
   16
   16
   Glucose
   [**Telephone/Fax (3) 11399**]52
   Other labs: PT / PTT / INR:15.1/47.7/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.9 mmol/L, LDH:333 IU/L,
   Ca++:9.6 mg/dL, Mg++:2.7 mg/dL, PO4:4.8 mg/dL
   - CXR appears improved on left, slight prominence of opacity on right
   - No new culture data
   - Renal biopsy results continue to be pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. DDx includes AIN due to Nafcillin (also identical
   pathophysiology with concomitant rash
 see below), although
   Allopurinol and Warfarin can also less frequently (and much less likely
   in this case) produce this effect. Renal biopsy without changes
   consistent with AIN, but already given a few days of high-dose
   steroids. Awaiting final renal pathology results and evaluation.
   Evidence for AIN includes white cell casts, worsened renal function and
   urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for HD today with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg)
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   still had large volume out from CVVH yesterday, likely contributing to
   his continued hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Obtain UA
   - Follow up blood cultures; obtain blood cultures today
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct; likely tomorrow, [**2-3**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, speech and swallow evaluation;
   nectar thick liquids
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2128-2-1**] 11:17 AM
   - Patient extubated succesfully during early morning; did well
   throughout the day
   - We removed the stitch from the derm skin biopsy site.
   - Rheumatology notes clear clinical improvement and recommends
   following up with the final result of the renal biopsy.
   - Renal recommends to continue steroids, to stop CVVH, and to evaluate
   and plan for possible HD on Monday. They also recommend to give
   Vancomycin with HD, to reduce Cefepime to 1gm q24 and to stop
   Sucralfate (aluminum toxicity). We ordered for a trough to follow up in
   AM.
   - Patient with worsening BUN, Cr, HCO3 through evening; plan to manage
   in AM with HD per renal.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-1**] 01:30 PM
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-1**] 08:00 AM
   Lorazepam (Ativan) - [**2128-2-1**] 09:48 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-2**] 06:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.1
C (97
   Tcurrent: 35.7
C (96.2
   HR: 75 (75 - 78) bpm
   BP: 258/255(257) {90/46(61) - 258/255(257)} mmHg
   RR: 26 (15 - 31) insp/min
   SpO2: 95%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 4 (-5 - 8)mmHg
   Total In:
                                                                  2,382 mL
                                                                     71 mL
   PO:
   TF:
                                                                    180 mL
   IVF:
                                                                  2,112 mL
                                                                     71 mL
   Blood products:
   Total out:
                                                                  3,944 mL
                                                                     90 mL
   Urine:
                                                                    150 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,562 mL
                                                                    -19 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: [[**Doctor First Name **]: CPAP/PSV :[**Doctor First Name **]]
   Vt (Spontaneous): 571 (571 - 571) mL
   PS : 5 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 6 cmH2O
   SpO2: 95%
   ABG: 7.37/26/78/17/-8
   Ve: 14.1 L/min
   PaO2 / FiO2: 195
   Physical Examination
   General: Extubated; reduced but continued light red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   363 K/uL
   13.0 g/dL
   152 mg/dL
   3.2 mg/dL
   17 mEq/L
   5.4 mEq/L
   84 mg/dL
   105 mEq/L
   139 mEq/L
   42.3 %
   22.4 K/uL
        [image002.jpg]
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
                             [**2128-2-1**]  08:16 AM
                             [**2128-2-1**]  12:02 PM
                             [**2128-2-1**]  04:41 PM
                             [**2128-2-1**]  07:50 PM
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
   WBC
   20.9
   22.4
   Hct
   40.6
   40.8
   42.3
   Plt
   389
   363
   Cr
   1.4
   2.4
   2.7
   3.2
   TCO2
   24
   21
   18
   17
   16
   16
   Glucose
   [**Telephone/Fax (3) 11399**]52
   Other labs: PT / PTT / INR:15.1/47.7/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.9 mmol/L, LDH:333 IU/L,
   Ca++:9.6 mg/dL, Mg++:2.7 mg/dL, PO4:4.8 mg/dL
   - CXR appears improved on left, slight prominence of opacity on right
   - No new culture data
   - Renal biopsy results continue to be pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. DDx includes AIN due to Nafcillin (also identical
   pathophysiology with concomitant rash
 see below), although
   Allopurinol and Warfarin can also less frequently (and much less likely
   in this case) produce this effect. Renal biopsy without changes
   consistent with AIN, but already given a few days of high-dose
   steroids. Awaiting final renal pathology results and evaluation.
   Evidence for AIN includes white cell casts, worsened renal function and
   urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for HD today with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg)
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   still had large volume out from CVVH yesterday, likely contributing to
   his continued hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Obtain UA
   - Follow up blood cultures; obtain blood cultures today
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct; likely tomorrow, [**2-3**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, speech and swallow evaluation;
   nectar thick liquids
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's daily progress note, the following summary and potential medical complications are noted:

Summary:

The patient is a 76-year-old male who was admitted with MSSA bacteremia, complicated by ARF likely secondary to AIN, multifactorial DAH, and torsades. He underwent mechanical AVR and CABG. He was treated with CVVH and likely HD starting today. He was extubated successfully during the morning and has been doing well throughout the day. His renal function has worsened, and he is at risk for further complications.

Potential Medical Complications:

1. AIN: The patient's renal function has worsened, and he is at risk for further complications from AIN. The patient's creatinine and BUN levels are increasing, and he may require further treatment with steroids and other medications to manage this condition.
2. DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis: The patient's respiratory status is still unstable, and he is at risk for further complications from DAH and hypoxemic respiratory failure. He may require further treatment with steroids and other medications to manage this condition.
3. Bacteremia: The patient has a high-grade MSSA bacteremia, and he is at risk for further complications from endocarditis. He will require continued treatment with antibiotics for a full 8-week course.
4. Hematuria: The patient has hematuria likely secondary to biopsy in the context of coagulopathy. He will need to be monitored for further complications from this condition.
5. Anemia: The patient's hematocrit has been stable to high likely secondary to hemoconcentration. He will need to be monitored for further complications from anemia.
6. Atrial Fibrillation/Complete Heart Block: The patient has CHB this admission and will require continued treatment with anticoagulation and anti-arrhythmic medications.
7. CAD: The patient has CAD and will require continued treatment with anticoagulation and antiplatelet medications.
8. Hypertension: The patient has hypertension and will require continued treatment with antihypertensive medications.
9. Hyperglycemia: The patient has hyperglycemia and will require continued treatment with insulin and other medications to manage this condition.

In conclusion, the patient is at risk for further complications from multiple medical conditions, including AIN, DAH, bacteremia, hematuria, anemia, atrial fibrillation, CAD, hypertension, and hyperglycemia. He will require continued treatment with medications and close monitoring to manage these conditions and prevent further complications."
182149.0,283460,2128-02-02 08:09:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2128-2-1**] 11:17 AM
   - Patient extubated succesfully during early morning; did well
   throughout the day
   - We removed the stitch from the derm skin biopsy site.
   - Rheumatology notes clear clinical improvement and recommends
   following up with the final result of the renal biopsy.
   - Renal recommends to continue steroids, to stop CVVH, and to evaluate
   and plan for possible HD on Monday. They also recommend to give
   Vancomycin with HD, to reduce Cefepime to 1gm q24 and to stop
   Sucralfate (aluminum toxicity). We ordered for a trough to follow up in
   AM.
   - Patient with worsening BUN, Cr, HCO3 through evening; plan to manage
   in AM with HD per renal.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-1**] 01:30 PM
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-1**] 08:00 AM
   Lorazepam (Ativan) - [**2128-2-1**] 09:48 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-2**] 06:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.1
C (97
   Tcurrent: 35.7
C (96.2
   HR: 75 (75 - 78) bpm
   BP: 258/255(257) {90/46(61) - 258/255(257)} mmHg
   RR: 26 (15 - 31) insp/min
   SpO2: 95%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 4 (-5 - 8)mmHg
   Total In:
                                                                  2,382 mL
                                                                     71 mL
   PO:
   TF:
                                                                    180 mL
   IVF:
                                                                  2,112 mL
                                                                     71 mL
   Blood products:
   Total out:
                                                                  3,944 mL
                                                                     90 mL
   Urine:
                                                                    150 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,562 mL
                                                                    -19 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: [[**Doctor First Name **]: CPAP/PSV :[**Doctor First Name **]]
   Vt (Spontaneous): 571 (571 - 571) mL
   PS : 5 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 6 cmH2O
   SpO2: 95%
   ABG: 7.37/26/78/17/-8
   Ve: 14.1 L/min
   PaO2 / FiO2: 195
   Physical Examination
   General: Extubated; reduced but continued light red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   363 K/uL
   13.0 g/dL
   152 mg/dL
   3.2 mg/dL
   17 mEq/L
   5.4 mEq/L
   84 mg/dL
   105 mEq/L
   139 mEq/L
   42.3 %
   22.4 K/uL
        [image002.jpg]
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
                             [**2128-2-1**]  08:16 AM
                             [**2128-2-1**]  12:02 PM
                             [**2128-2-1**]  04:41 PM
                             [**2128-2-1**]  07:50 PM
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
   WBC
   20.9
   22.4
   Hct
   40.6
   40.8
   42.3
   Plt
   389
   363
   Cr
   1.4
   2.4
   2.7
   3.2
   TCO2
   24
   21
   18
   17
   16
   16
   Glucose
   [**Telephone/Fax (3) 11399**]52
   Other labs: PT / PTT / INR:15.1/47.7/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.9 mmol/L, LDH:333 IU/L,
   Ca++:9.6 mg/dL, Mg++:2.7 mg/dL, PO4:4.8 mg/dL
   - CXR appears improved on left, slight prominence of opacity on right
   - No new culture data
   - Renal biopsy results continue to be pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. Also with large diuresis off diuretics. DDx includes AIN due
   to Nafcillin (also identical pathophysiology with concomitant rash
   see below), although Allopurinol and Warfarin can also less frequently
   (and much less likely in this case) produce this effect. Renal biopsy
   without changes consistent with AIN, but already given a few days of
   high-dose steroids. Awaiting final renal pathology results and
   evaluation. Evidence for AIN includes white cell casts, worsened renal
   function and urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for HD today with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg)
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   continues to have large UOP, likely contributing to his continued
   hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Follow up blood cultures; obtain blood cultures today
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct; likely tomorrow, [**2-3**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, speech and swallow evaluation
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2128-2-1**] 11:17 AM
   - Patient extubated succesfully during early morning; did well
   throughout the day
   - We removed the stitch from the derm skin biopsy site.
   - Rheumatology notes clear clinical improvement and recommends
   following up with the final result of the renal biopsy.
   - Renal recommends to continue steroids, to stop CVVH, and to evaluate
   and plan for possible HD on Monday. They also recommend to give
   Vancomycin with HD, to reduce Cefepime to 1gm q24 and to stop
   Sucralfate (aluminum toxicity). We ordered for a trough to follow up in
   AM.
   - Patient with worsening BUN, Cr, HCO3 through evening; plan to manage
   in AM with HD per renal.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-1**] 01:30 PM
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-1**] 08:00 AM
   Lorazepam (Ativan) - [**2128-2-1**] 09:48 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-2**] 06:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.1
C (97
   Tcurrent: 35.7
C (96.2
   HR: 75 (75 - 78) bpm
   BP: 258/255(257) {90/46(61) - 258/255(257)} mmHg
   RR: 26 (15 - 31) insp/min
   SpO2: 95%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 4 (-5 - 8)mmHg
   Total In:
                                                                  2,382 mL
                                                                     71 mL
   PO:
   TF:
                                                                    180 mL
   IVF:
                                                                  2,112 mL
                                                                     71 mL
   Blood products:
   Total out:
                                                                  3,944 mL
                                                                     90 mL
   Urine:
                                                                    150 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,562 mL
                                                                    -19 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: [[**Doctor First Name **]: CPAP/PSV :[**Doctor First Name **]]
   Vt (Spontaneous): 571 (571 - 571) mL
   PS : 5 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 6 cmH2O
   SpO2: 95%
   ABG: 7.37/26/78/17/-8
   Ve: 14.1 L/min
   PaO2 / FiO2: 195
   Physical Examination
   General: Extubated; reduced but continued light red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   363 K/uL
   13.0 g/dL
   152 mg/dL
   3.2 mg/dL
   17 mEq/L
   5.4 mEq/L
   84 mg/dL
   105 mEq/L
   139 mEq/L
   42.3 %
   22.4 K/uL
        [image002.jpg]
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
                             [**2128-2-1**]  08:16 AM
                             [**2128-2-1**]  12:02 PM
                             [**2128-2-1**]  04:41 PM
                             [**2128-2-1**]  07:50 PM
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
   WBC
   20.9
   22.4
   Hct
   40.6
   40.8
   42.3
   Plt
   389
   363
   Cr
   1.4
   2.4
   2.7
   3.2
   TCO2
   24
   21
   18
   17
   16
   16
   Glucose
   [**Telephone/Fax (3) 11399**]52
   Other labs: PT / PTT / INR:15.1/47.7/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.9 mmol/L, LDH:333 IU/L,
   Ca++:9.6 mg/dL, Mg++:2.7 mg/dL, PO4:4.8 mg/dL
   - CXR appears improved on left, slight prominence of opacity on right
   - No new culture data
   - Renal biopsy results continue to be pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. Also with large diuresis off diuretics. DDx includes AIN due
   to Nafcillin (also identical pathophysiology with concomitant rash
   see below), although Allopurinol and Warfarin can also less frequently
   (and much less likely in this case) produce this effect. Renal biopsy
   without changes consistent with AIN, but already given a few days of
   high-dose steroids. Awaiting final renal pathology results and
   evaluation. Evidence for AIN includes white cell casts, worsened renal
   function and urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for HD today with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg)
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   continues to have large UOP, likely contributing to his continued
   hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Follow up blood cultures; obtain blood cultures today
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct; likely tomorrow, [**2-3**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, speech and swallow evaluation
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a complex medical history, including coronary artery disease, mechanical aortic valve replacement, and atrial fibrillation. He was admitted with methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia, torsades, and acute kidney injury (AKI). He has been treated with antibiotics and steroids, and his condition has improved, with clearance of his bacteremia and resolution of his AKI. However, he still has ongoing issues with volume depletion, hematuria, and anemia.

Potential Medical Complications:

1. Volume Depletion: The patient's large diuresis and ongoing hematuria may lead to further volume depletion, which could worsen his renal function and increase his risk of bleeding.
2. Hematuria: The patient's hematuria may be a sign of ongoing bleeding, which could lead to further complications, such as hypovolemic shock or anemia.
3. Anemia: The patient's anemia may worsen due to ongoing bleeding or hematuria, which could lead to further complications, such as heart failure or decreased oxygen delivery to tissues.
4. Respiratory Failure: The patient's history of pulmonary edema and diffuse alveolar hemorrhage may lead to further respiratory failure, which could worsen his overall condition.
5. Infection: The patient's ongoing bacteremia and potential for further infections, such as ventilator-associated pneumonia (VAP), could lead to further complications and worsen his overall condition.
6. Bleeding: The patient's ongoing bleeding, including hematuria and potential gastrointestinal bleeding, may lead to further complications, such as hypovolemic shock or anemia.
7. Renal Failure: The patient's ongoing AKI may lead to further complications, such as chronic kidney disease or end-stage renal disease, if not managed appropriately.

Assessment and Plan:

The patient's condition is complex and requires ongoing management to address his various medical issues. The plan includes continuing antibiotics, steroids, and anticoagulation therapy, as well as monitoring his volume status, hematuria, and anemia. The patient's family should be educated on his condition and the importance of following his treatment plan. The patient should be closely monitored for any signs of worsening respiratory failure, infection, bleeding, or renal failure."
182149.0,283460,2128-02-03 07:50:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - Some chest pain during dialysis (deep, sharp, [**2128-4-19**], intermittent
   for about 30 minutes total, non-radiating). Stopped dialysis one hour
   early, on O2 BB heparin already, drew enzymes immediately after
   dialysis and clear - will cycle. EKG with diffuse TWI. Did not drop
   pressure during this period, other vitals stable. Resolved when
   dialysis stopped.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-2**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-3**] 07:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 78) bpm
   BP: 129/75(86) {105/51(61) - 132/81(90)} mmHg
   RR: 20 (17 - 29) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    918 mL
                                                                    162 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    678 mL
                                                                    162 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    160 mL
   Urine:
                                                                    300 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    618 mL
                                                                      2 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula 4L
   SpO2: 96%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General: Extubated; reduced but continued dark red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   290 K/uL
   11.6 g/dL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   [**2-3**] CXR
 Final read pending; appears stable to improved
   [**2-2**] Urine, culture
 Pending
   [**1-29**] Renal biopsy
 Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Stable. s/p HD yesterday. Cr, BUN and bicarbonate initially improving.
   FeNa 0.2 likely pre-renal vs acute GN etiologies. DDx also includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although Allopurinol and Warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - Plan for HD [**2-4**] with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg);
   Renal recommends changing to 20mg on [**2-4**]
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   Stable/improving. CVVH discontinued [**2-1**] as patient appeared volume
   depleted on exam. His volume status seems to have stabilized;
   hemoconcentration seems improved.
   - Plan for HD [**2-4**] with Renal
   - Trend fever curve
   - Follow up urine/blood cultures
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan on
   emergent HD pending renal recommendations today should such an event
   occur. Hypoxemic respiratory failure has largely resolved - was likely
   due to pulmonary edema and diffuse alveolar hemorrhage. The etiology of
   hemorrhage is unclear and likely multifactorial. Differential diagnoses
   include vasculitic and autoimmune processes, coagulopathy, or the
   effect of pulmonary edema in the context of coagulopathy. Vaculitis was
   initially thought most likely, given renal failure, rash and pulmonary
   hemorrhage, but investigations for this have been relatively
   unimpressive: ESR from 15 to 100s now, but negative [**Doctor First Name 1205**], ANCA, anti-GBM
   and unimpressive pathology of skin and kidney, although the final read
   of the latter is pending. Patient clinically improving s/p diuresis and
   steroids and HCT stable. Vasculitis now unlikely enough to taper
   steroids to level for treatment of AIN along. Nonetheless, ANCA may not
   be positive in early disease and should be repeated in three to four
   weeks. Possibility of worsened MR and pulmonary edema, but unlikely
   given echo three days ago.
   - Follow CXR
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukocytoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   Stable. High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major,
   3 minor) for endocarditis. TTE did not reveal vegetations, but
   sensitivity likely low. Nonetheless, given AVR and concern, ID
   recommends antibiotics for a full 8 week course. Switched from
   Nafcillin/Rifampin to Vancomycin [**1-17**] due to question of AIN.
   - Follow up blood cultures
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Stable/improving. Likely secondary to biopsy in context of
   coagulopathy. Will need to monitor given danger period following biopsy
   is about two weeks. Likely too bloody for vasculitic etiologic. Appears
   overall to be improving per nursing. [**Month (only) 60**] consider asking Renal if there
   is a benefit to spinning urine when it is so frankly bloody. Also, may
   consider irrigation for blood clots if there is a reduction in urine
   output, suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60; transition to coumadin when more
   certain hemoptysis/hematuria resolving
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60; transition to coumadin when more
   certain hemoptysis/hematuria resolving
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA in 48 hours on [**2-5**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, thin liquids at this time;
   continue to follow speech/swallow recommendations
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line; will continue to discuss need for
   permanent dialysis line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement; likely today to [**Hospital1 2259**]
   with telemetry
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - Some chest pain during dialysis (deep, sharp, [**2128-4-19**], intermittent
   for about 30 minutes total, non-radiating). Stopped dialysis one hour
   early, on O2 BB heparin already, drew enzymes immediately after
   dialysis and clear - will cycle. EKG with diffuse TWI. Did not drop
   pressure during this period, other vitals stable. Resolved when
   dialysis stopped.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-2**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-3**] 07:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 78) bpm
   BP: 129/75(86) {105/51(61) - 132/81(90)} mmHg
   RR: 20 (17 - 29) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    918 mL
                                                                    162 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    678 mL
                                                                    162 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    160 mL
   Urine:
                                                                    300 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    618 mL
                                                                      2 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula 4L
   SpO2: 96%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General: Extubated; reduced but continued dark red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   290 K/uL
   11.6 g/dL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   [**2-3**] CXR
 Final read pending; appears stable to improved
   [**2-2**] Urine, culture
 Pending
   [**1-29**] Renal biopsy
 Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Stable. s/p HD yesterday. Cr, BUN and bicarbonate initially improving.
   FeNa 0.2 likely pre-renal vs acute GN etiologies. DDx also includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although Allopurinol and Warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - Plan for HD [**2-4**] with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg);
   Renal recommends changing to 20mg on [**2-4**]
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   Stable/improving. CVVH discontinued [**2-1**] as patient appeared volume
   depleted on exam. His volume status seems to have stabilized;
   hemoconcentration seems improved.
   - Plan for HD [**2-4**] with Renal
   - Trend fever curve
   - Follow up urine/blood cultures
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan on
   emergent HD pending renal recommendations today should such an event
   occur. Hypoxemic respiratory failure has largely resolved - was likely
   due to pulmonary edema and diffuse alveolar hemorrhage. The etiology of
   hemorrhage is unclear and likely multifactorial. Differential diagnoses
   include vasculitic and autoimmune processes, coagulopathy, or the
   effect of pulmonary edema in the context of coagulopathy. Vaculitis was
   initially thought most likely, given renal failure, rash and pulmonary
   hemorrhage, but investigations for this have been relatively
   unimpressive: ESR from 15 to 100s now, but negative [**Doctor First Name 1205**], ANCA, anti-GBM
   and unimpressive pathology of skin and kidney, although the final read
   of the latter is pending. Patient clinically improving s/p diuresis and
   steroids and HCT stable. Vasculitis now unlikely enough to taper
   steroids to level for treatment of AIN along. Nonetheless, ANCA may not
   be positive in early disease and should be repeated in three to four
   weeks. Possibility of worsened MR and pulmonary edema, but unlikely
   given echo three days ago.
   - Follow CXR
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukocytoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   Stable. High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major,
   3 minor) for endocarditis. TTE did not reveal vegetations, but
   sensitivity likely low. Nonetheless, given AVR and concern, ID
   recommends antibiotics for a full 8 week course. Switched from
   Nafcillin/Rifampin to Vancomycin [**1-17**] due to question of AIN.
   - Follow up blood cultures
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Stable/improving. Likely secondary to biopsy in context of
   coagulopathy. Will need to monitor given danger period following biopsy
   is about two weeks. Likely too bloody for vasculitic etiologic. Appears
   overall to be improving per nursing. [**Month (only) 60**] consider asking Renal if there
   is a benefit to spinning urine when it is so frankly bloody. Also, may
   consider irrigation for blood clots if there is a reduction in urine
   output, suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60; transition to coumadin when more
   certain hemoptysis/hematuria resolving
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60; transition to coumadin when more
   certain hemoptysis/hematuria resolving
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA in 48 hours on [**2-5**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, thin liquids at this time;
   continue to follow speech/swallow recommendations
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line; will continue to discuss need for
   permanent dialysis line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement; likely today to [**Hospital1 2259**]
   with telemetry
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 76-year-old male with a complex medical history, including coronary artery disease (CAD), mechanical aortic valve replacement (AVR), and atrial fibrillation (AFib). He was admitted with methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia, acute kidney injury (AKI), and diffuse alveolar hemorrhage (DAH).

The patient's current condition is stable, with improvements noted in his renal function, respiratory status, and hemodynamics. He is off mechanical ventilation and extubated. His chest pain during dialysis has resolved, and his cardiac rhythm is ventricularly paced.

The patient has several potential medical complications that need to be monitored and managed:

1. Acute on chronic renal failure (ACRF) with suspected acute interstitial nephritis (AIN): The patient's renal function is improving, but he requires continued close monitoring, and the plan is to start hemodialysis (HD) today.
2. Leukocytoclastic vasculitis: The patient's skin rash is improving, but he needs to continue steroids and follow up with dermatology.
3. Bacteremia: The patient has a high-grade MSSA bacteremia, which requires a full 8-week course of antibiotics.
4. Hematuria: The patient's hematuria is improving, but he needs to continue to monitor his urine output and follow up with renal.
5. Anemia: The patient's hematocrit is stable, but he needs to continue to receive blood products and follow up with hematology.
6. Atrial fibrillation/complete heart block: The patient has a temporary pacemaker and requires continued anticoagulation and follow-up with electrophysiology.
7. Coronary artery disease: The patient has a history of CAD and requires continued management with anticoagulation, aspirin, and statins.

The patient's current medications include:

* Cefepime
* Vancomycin
* Famotidine (Pepcid)
* Prednisone
* Heparin
* Coumadin
* Aspirin
* Statin
* Warfarin (holding due to bleed)

The patient's laboratory results are stable, with the following notable values:

* Creatinine: 2.7 mg/dL
* Blood urea nitrogen (BUN): 35.4 mg/dL
* Hematocrit: 40.8%
* White blood cell count (WBC): 22.4 K/uL
* Platelet count: 363 K/uL
* Troponin-T: <0.01 ng/mL

The patient's plan includes:

* Hemodialysis (HD) today
* Continued antibiotics for bacteremia
* Follow-up with renal, dermatology, and electrophysiology
* Close monitoring of his renal function, respiratory status, and hemodynamics
* Adjustment of medications as needed

Overall, the patient's condition is stable, but he requires continued close monitoring and management of his multiple medical complications."
182149.0,283460,2128-02-03 07:50:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - Some chest pain during dialysis (deep, sharp, [**2128-4-19**], intermittent
   for about 30 minutes total, non-radiating). Stopped dialysis one hour
   early, on O2 BB heparin already, drew enzymes immediately after
   dialysis and clear - will cycle. EKG with diffuse TWI. Did not drop
   pressure during this period, other vitals stable. Resolved when
   dialysis stopped.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-2**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-3**] 07:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 78) bpm
   BP: 129/75(86) {105/51(61) - 132/81(90)} mmHg
   RR: 20 (17 - 29) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    918 mL
                                                                    162 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    678 mL
                                                                    162 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    160 mL
   Urine:
                                                                    300 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    618 mL
                                                                      2 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General: Extubated; reduced but continued dark red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   290 K/uL
   11.6 g/dL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   Assessment and Plan
 HYPERGLYCEMIA
 ANEMIA, OTHER
 BACTEREMIA
 HEMOPTYSIS
 PNEUMONIA, [**Hospital 57**] HOSPITAL ACQUIRED (NON-VAP)
 ENDOCARDITIS, BACTERIAL
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name **])
 HYPOXEMIA
 HYPOTENSION (NOT SHOCK)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - Some chest pain during dialysis (deep, sharp, [**2128-4-19**], intermittent
   for about 30 minutes total, non-radiating). Stopped dialysis one hour
   early, on O2 BB heparin already, drew enzymes immediately after
   dialysis and clear - will cycle. EKG with diffuse TWI. Did not drop
   pressure during this period, other vitals stable. Resolved when
   dialysis stopped.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-2**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-3**] 07:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 78) bpm
   BP: 129/75(86) {105/51(61) - 132/81(90)} mmHg
   RR: 20 (17 - 29) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    918 mL
                                                                    162 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    678 mL
                                                                    162 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    160 mL
   Urine:
                                                                    300 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    618 mL
                                                                      2 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General: Extubated; reduced but continued dark red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   290 K/uL
   11.6 g/dL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   Assessment and Plan
 HYPERGLYCEMIA
 ANEMIA, OTHER
 BACTEREMIA
 HEMOPTYSIS
 PNEUMONIA, [**Hospital 57**] HOSPITAL ACQUIRED (NON-VAP)
 ENDOCARDITIS, BACTERIAL
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name **])
 HYPOXEMIA
 HYPOTENSION (NOT SHOCK)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 68-inch-tall, 69.1 kg (admission: 85 kg) individual who has been admitted to the ICU due to various medical conditions.

The patient experienced chest pain during dialysis, which was described as deep, sharp, and non-radiating. The pain resolved when dialysis was stopped. The patient's vital signs are stable, with a heart rate of 75-78 bpm, blood pressure of 129/75-132/81 mmHg, and oxygen saturation of 96%. The patient's respiratory support includes nasal cannula oxygen delivery, with an ABG result of 7.47/32/76.

The patient's physical examination reveals reduced but continued dark red secretions, bilateral rales in the lungs, and a petechial rash on the lower extremities, which is improving. The patient's neurological examination shows spontaneous movement of all extremities.

Laboratory results indicate:

* Hemoglobin: 11.6 g/dL
* White blood cell count: 20.6-22.4 K/uL
* Platelet count: 290-363 K/uL
* Creatinine: 1.4-2.7 mg/dL
* Blood urea nitrogen: 35.4-40.8 mg/dL
* Glucose: 109-188 mg/dL
* Troponin-T: <0.01-0.01 ng/mL
* Lactic acid: 1.3 mmol/L
* LDH: 333 IU/L
* Calcium: 9.0 mg/dL
* Magnesium: 2.3 mg/dL
* Phosphorus: 4.2 mg/dL

The patient has been diagnosed with hyperglycemia, anemia, bacteremia, hemoptysis, pneumonia, endocarditis, atrial fibrillation, acute renal failure, acute respiratory failure, hypoxemia, and hypotension.

Potential medical complications that can arise include:

1. Worsening of respiratory failure: The patient's respiratory support is stable, but the presence of bilateral rales and rhonchi suggests ongoing respiratory distress.
2. Sepsis: The patient's bacteremia and elevated white blood cell count indicate a high risk of sepsis.
3. Cardiac complications: The patient's atrial fibrillation and endocarditis increase the risk of cardiac arrhythmias and cardiac failure.
4. Renal failure: The patient's acute renal failure may worsen if not managed properly.
5. Hypoglycemia: The patient's hyperglycemia may lead to hypoglycemia if not controlled.
6. Thrombocytopenia: The patient's platelet count is low, which may increase the risk of bleeding.
7. Infection: The patient's bacteremia and petechial rash suggest a high risk of infection.
8. Cardiovascular instability: The patient's hypotension and atrial fibrillation increase the risk of cardiovascular instability.

Based on the provided information, it is essential to closely monitor the patient's vital signs, respiratory status, and laboratory results to prevent or manage these potential complications."
182149.0,283460,2128-02-03 07:50:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - Some chest pain during dialysis (deep, sharp, [**2128-4-19**], intermittent
   for about 30 minutes total, non-radiating). Stopped dialysis one hour
   early, on O2 BB heparin already, drew enzymes immediately after
   dialysis and clear - will cycle. EKG with diffuse TWI. Did not drop
   pressure during this period, other vitals stable. Resolved when
   dialysis stopped.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-2**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-3**] 07:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 78) bpm
   BP: 129/75(86) {105/51(61) - 132/81(90)} mmHg
   RR: 20 (17 - 29) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    918 mL
                                                                    162 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    678 mL
                                                                    162 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    160 mL
   Urine:
                                                                    300 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    618 mL
                                                                      2 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General: Extubated; reduced but continued dark red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   290 K/uL
   11.6 g/dL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   [**2-3**] CXR
 Final read pending; appears stable to improved
   [**2-2**] Urine, culture
 Pending
   [**1-29**] Renal biopsy
 Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. DDx includes AIN due to Nafcillin (also identical
   pathophysiology with concomitant rash
 see below), although
   Allopurinol and Warfarin can also less frequently (and much less likely
   in this case) produce this effect. Renal biopsy without changes
   consistent with AIN, but already given a few days of high-dose
   steroids. Awaiting final renal pathology results and evaluation.
   Evidence for AIN includes white cell casts, worsened renal function and
   urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for HD today with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg)
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   still had large volume out from CVVH yesterday, likely contributing to
   his continued hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Obtain UA
   - Follow up blood cultures; obtain blood cultures today
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct; likely tomorrow, [**2-3**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, speech and swallow evaluation;
   nectar thick liquids
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - Some chest pain during dialysis (deep, sharp, [**2128-4-19**], intermittent
   for about 30 minutes total, non-radiating). Stopped dialysis one hour
   early, on O2 BB heparin already, drew enzymes immediately after
   dialysis and clear - will cycle. EKG with diffuse TWI. Did not drop
   pressure during this period, other vitals stable. Resolved when
   dialysis stopped.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-2**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-3**] 07:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 78) bpm
   BP: 129/75(86) {105/51(61) - 132/81(90)} mmHg
   RR: 20 (17 - 29) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    918 mL
                                                                    162 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    678 mL
                                                                    162 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    160 mL
   Urine:
                                                                    300 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    618 mL
                                                                      2 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General: Extubated; reduced but continued dark red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   290 K/uL
   11.6 g/dL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   [**2-3**] CXR
 Final read pending; appears stable to improved
   [**2-2**] Urine, culture
 Pending
   [**1-29**] Renal biopsy
 Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. DDx includes AIN due to Nafcillin (also identical
   pathophysiology with concomitant rash
 see below), although
   Allopurinol and Warfarin can also less frequently (and much less likely
   in this case) produce this effect. Renal biopsy without changes
   consistent with AIN, but already given a few days of high-dose
   steroids. Awaiting final renal pathology results and evaluation.
   Evidence for AIN includes white cell casts, worsened renal function and
   urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for HD today with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg)
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   still had large volume out from CVVH yesterday, likely contributing to
   his continued hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Obtain UA
   - Follow up blood cultures; obtain blood cultures today
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct; likely tomorrow, [**2-3**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, speech and swallow evaluation;
   nectar thick liquids
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of coronary artery disease, mechanical aortic valve replacement, and atrial fibrillation. He was admitted with methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia and was complicated by acute kidney injury (AKI), likely secondary to antibiotic-induced nephrotoxicity. He has also developed acute respiratory distress syndrome (ARDS), diffuse alveolar hemorrhage (DAH), and leukocytoclastic vasculitis.

The patient's current status is:

* Hemodynamically stable with a blood pressure of 129/75 mmHg and a heart rate of 75 beats per minute.
* Oxygen saturation of 96% on nasal cannula.
* Respiratory support with non-invasive positive pressure ventilation (NIPPV).
* Mechanical ventilation is being considered due to the patient's worsening respiratory status.
* Hemodialysis is planned for today.
* The patient is receiving broad-spectrum antibiotics for MSSA bacteremia and endocarditis.
* He is also receiving corticosteroids for the treatment of AKI and vasculitis.
* The patient's electrolyte levels are abnormal, with a potassium level of 4.2 mmol/L and a magnesium level of 2.3 mmol/L.

Potential medical complications:

1. Flash pulmonary edema: The patient's respiratory status is worsening, and he may develop flash pulmonary edema, which could lead to further respiratory distress and potentially life-threatening complications.
2. Hemorrhage: The patient has developed DAH and leukocytoclastic vasculitis, which could lead to further bleeding and potentially life-threatening complications.
3. Infection: The patient has MSSA bacteremia and endocarditis, which could lead to sepsis and potentially life-threatening complications.
4. Renal failure: The patient has AKI, which could progress to chronic kidney disease and potentially life-threatening complications.
5. Respiratory failure: The patient's respiratory status is worsening, and he may develop respiratory failure, which could lead to further complications and potentially life-threatening outcomes.

Recommendations:

1. Continue broad-spectrum antibiotics for MSSA bacteremia and endocarditis.
2. Initiate hemodialysis as planned.
3. Monitor the patient's respiratory status closely and consider mechanical ventilation if necessary.
4. Continue corticosteroids for the treatment of AKI and vasculitis.
5. Monitor the patient's electrolyte levels closely and correct any abnormalities.
6. Consider consults with nephrology, cardiology, and pulmonology to optimize the patient's care.
7. Consider a tracheostomy if the patient requires prolonged mechanical ventilation."
182149.0,283460,2128-02-03 07:50:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - Some chest pain during dialysis (deep, sharp, [**2128-4-19**], intermittent
   for about 30 minutes total, non-radiating). Stopped dialysis one hour
   early, on O2 BB heparin already, drew enzymes immediately after
   dialysis and clear - will cycle. EKG with diffuse TWI. Did not drop
   pressure during this period, other vitals stable. Resolved when
   dialysis stopped.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-2**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-3**] 07:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 78) bpm
   BP: 129/75(86) {105/51(61) - 132/81(90)} mmHg
   RR: 20 (17 - 29) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    918 mL
                                                                    162 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    678 mL
                                                                    162 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    160 mL
   Urine:
                                                                    300 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    618 mL
                                                                      2 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General: Extubated; reduced but continued dark red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   290 K/uL
   11.6 g/dL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   [**2-3**] CXR
 Final read pending; appears stable to improved
   [**2-2**] Urine, culture
 Pending
   [**1-29**] Renal biopsy
 Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Stable. s/p HD yesterday. Cr, BUN and bicarbonate initially improving.
   FeNa 0.2 likely pre-renal vs acute GN etiologies. DDx also includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although Allopurinol and Warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - Plan for HD [**2-4**] with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg);
   Renal recommends changing to 20mg on [**2-4**]
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   Stable/improving. CVVH discontinued [**2-1**] as patient appeared volume
   depleted on exam. His volume status seems to have stabilized;
   hemoconcentration seems improved.
   - Plan for HD [**2-4**] with Renal
   - Trend fever curve
   - Follow up urine/blood cultures
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan on
   emergent HD pending renal recommendations today should such an event
   occur. Hypoxemic respiratory failure has largely resolved - was likely
   due to pulmonary edema and diffuse alveolar hemorrhage. The etiology of
   hemorrhage is unclear and likely multifactorial. Differential diagnoses
   include vasculitic and autoimmune processes, coagulopathy, or the
   effect of pulmonary edema in the context of coagulopathy. Vaculitis was
   initially thought most likely, given renal failure, rash and pulmonary
   hemorrhage, but investigations for this have been relatively
   unimpressive: ESR from 15 to 100s now, but negative [**Doctor First Name 1205**], ANCA, anti-GBM
   and unimpressive pathology of skin and kidney, although the final read
   of the latter is pending. Patient clinically improving s/p diuresis and
   steroids and HCT stable. Vasculitis now unlikely enough to taper
   steroids to level for treatment of AIN along. Nonetheless, ANCA may not
   be positive in early disease and should be repeated in three to four
   weeks. Possibility of worsened MR and pulmonary edema, but unlikely
   given echo three days ago.
   - Follow CXR
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   Stable. High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major,
   3 minor) for endocarditis. TTE did not reveal vegetations, but
   sensitivity likely low. Nonetheless, given AVR and concern, ID
   recommends antibiotics for a full 8 week course. Switched from
   Nafcillin/Rifampin to Vancomycin [**1-17**] due to question of AIN.
   - Follow up blood cultures
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Stable/improving. Likely secondary to biopsy in context of
   coagulopathy. Will need to monitor given danger period following biopsy
   is about two weeks. Likely too bloody for vasculitic etiologic. Appears
   overall to be improving per nursing. [**Month (only) 60**] consider asking Renal if there
   is a benefit to spinning urine when it is so frankly bloody. Also, may
   consider irrigation for blood clots if there is a reduction in urine
   output, suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct; likely tomorrow, [**2-3**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, speech and swallow evaluation;
   nectar thick liquids
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - Some chest pain during dialysis (deep, sharp, [**2128-4-19**], intermittent
   for about 30 minutes total, non-radiating). Stopped dialysis one hour
   early, on O2 BB heparin already, drew enzymes immediately after
   dialysis and clear - will cycle. EKG with diffuse TWI. Did not drop
   pressure during this period, other vitals stable. Resolved when
   dialysis stopped.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-2**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-3**] 07:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 78) bpm
   BP: 129/75(86) {105/51(61) - 132/81(90)} mmHg
   RR: 20 (17 - 29) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    918 mL
                                                                    162 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    678 mL
                                                                    162 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    160 mL
   Urine:
                                                                    300 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    618 mL
                                                                      2 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General: Extubated; reduced but continued dark red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   290 K/uL
   11.6 g/dL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   [**2-3**] CXR
 Final read pending; appears stable to improved
   [**2-2**] Urine, culture
 Pending
   [**1-29**] Renal biopsy
 Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Stable. s/p HD yesterday. Cr, BUN and bicarbonate initially improving.
   FeNa 0.2 likely pre-renal vs acute GN etiologies. DDx also includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although Allopurinol and Warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - Plan for HD [**2-4**] with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg);
   Renal recommends changing to 20mg on [**2-4**]
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   Stable/improving. CVVH discontinued [**2-1**] as patient appeared volume
   depleted on exam. His volume status seems to have stabilized;
   hemoconcentration seems improved.
   - Plan for HD [**2-4**] with Renal
   - Trend fever curve
   - Follow up urine/blood cultures
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan on
   emergent HD pending renal recommendations today should such an event
   occur. Hypoxemic respiratory failure has largely resolved - was likely
   due to pulmonary edema and diffuse alveolar hemorrhage. The etiology of
   hemorrhage is unclear and likely multifactorial. Differential diagnoses
   include vasculitic and autoimmune processes, coagulopathy, or the
   effect of pulmonary edema in the context of coagulopathy. Vaculitis was
   initially thought most likely, given renal failure, rash and pulmonary
   hemorrhage, but investigations for this have been relatively
   unimpressive: ESR from 15 to 100s now, but negative [**Doctor First Name 1205**], ANCA, anti-GBM
   and unimpressive pathology of skin and kidney, although the final read
   of the latter is pending. Patient clinically improving s/p diuresis and
   steroids and HCT stable. Vasculitis now unlikely enough to taper
   steroids to level for treatment of AIN along. Nonetheless, ANCA may not
   be positive in early disease and should be repeated in three to four
   weeks. Possibility of worsened MR and pulmonary edema, but unlikely
   given echo three days ago.
   - Follow CXR
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   Stable. High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major,
   3 minor) for endocarditis. TTE did not reveal vegetations, but
   sensitivity likely low. Nonetheless, given AVR and concern, ID
   recommends antibiotics for a full 8 week course. Switched from
   Nafcillin/Rifampin to Vancomycin [**1-17**] due to question of AIN.
   - Follow up blood cultures
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Stable/improving. Likely secondary to biopsy in context of
   coagulopathy. Will need to monitor given danger period following biopsy
   is about two weeks. Likely too bloody for vasculitic etiologic. Appears
   overall to be improving per nursing. [**Month (only) 60**] consider asking Renal if there
   is a benefit to spinning urine when it is so frankly bloody. Also, may
   consider irrigation for blood clots if there is a reduction in urine
   output, suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct; likely tomorrow, [**2-3**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, speech and swallow evaluation;
   nectar thick liquids
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of coronary artery disease (CAD) and mechanical aortic valve replacement (AVR) who was admitted with methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia and acute kidney injury (AKI). He has been managed with continuous venovenous hemofiltration (CVVH) and is currently undergoing hemodialysis (HD). The patient has a history of atrial fibrillation (AF) and has been paced with a ventricularly paced screw-in pacemaker.

The patient's current condition is stable, with improved renal function and decreased secretions. His volume status has stabilized, and he is no longer receiving CVVH. However, he is still at risk for flash pulmonary edema and is being monitored closely.

The patient has a variety of medical complications, including:

1. Acute kidney injury (AKI) with possible acute interstitial nephritis (AIN) secondary to antibiotics.
2. Bacteremia with MSSA, which is being treated with antibiotics.
3. Leukoclastic vasculitis on the legs, which is improving with treatment.
4. Hypoxemic respiratory failure, which has resolved.
5. Hematuria, which is likely secondary to biopsy and coagulopathy.
6. Anemia, which is being managed with blood products.
7. Atrial fibrillation with complete heart block, which is being managed with a ventricularly paced screw-in pacemaker.
8. Endocarditis, which is being treated with antibiotics.

Potential medical complications that can arise include:

1. Flash pulmonary edema, which can occur if the patient's volume status worsens.
2. Worsening of renal function, which can occur if the patient's AKI does not improve.
3. Development of bleeding complications, such as hematuria or gastrointestinal bleeding, which can occur if the patient's coagulopathy worsens.
4. Infection, such as pneumonia or sepsis, which can occur if the patient's bacteremia worsens.
5. Cardiovascular complications, such as arrhythmias or heart failure, which can occur if the patient's AF or complete heart block worsens.

Overall, the patient's condition is stable, but he requires close monitoring and management to prevent and treat potential complications."
182149.0,283460,2128-02-03 11:28:00,Physician ,Physician Attending Progress Note,"Chief Complaint: Respiratory Failure, renal failure
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   Feels well this Am, no complaints
   24 Hour Events:
   Chest pain with HD yesterday - resolved spontaneously
   History obtained from [**Hospital 85**] Medical records, icu team
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Heparin Sodium - 1,100 units/hour
   Other ICU medications:
   Other medications:
   per icu resident note
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fever
   Cardiovascular: No(t) Chest pain
   Respiratory: No(t) Dyspnea
   Gastrointestinal: No(t) Abdominal pain
   Genitourinary: Dialysis
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2128-2-3**] 11:28 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 80) bpm
   BP: 114/64(76) {105/51(61) - 130/85(96)} mmHg
   RR: 21 (15 - 27) insp/min
   SpO2: 99%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
   CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    915 mL
                                                                    233 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    675 mL
                                                                    233 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    205 mL
   Urine:
                                                                    300 mL
                                                                    205 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    615 mL
                                                                     28 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 99%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General Appearance: No acute distress
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Loud), mechanical S2
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender
   Extremities: Right lower extremity edema: Trace, Left lower extremity
   edema: Trace
   Skin:  Warm
   Neurologic: Attentive, Follows simple commands, Responds to: Not
   assessed, Movement: Not assessed, Tone: Not assessed, pleasant,
   conversive
   Labs / Radiology
   11.6 g/dL
   290 K/uL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   Assessment and Plan
 HYPERGLYCEMIA
 ANEMIA, OTHER
 BACTEREMIA
 HEMOPTYSIS
 PNEUMONIA, [**Hospital 57**] HOSPITAL ACQUIRED (NON-VAP)
 ENDOCARDITIS, BACTERIAL
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name **])
 HYPOXEMIA
 HYPOTENSION (NOT SHOCK)
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   1. Respiratory Failure: Extubated and doing well.  Cont cefepime
   2. Renal failure: HD per renal.  Cont steroid taper.
   3. DAH: Steroids as above --> CXR improving
   4. Complete Heart Block/Afib: Cont heparin gtt. Temp wire in place.
   5. MSSA bacteremia: Cont vanco
   Reaminder of issues per ICU team.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots(Systemic anticoagulation: Heparin gtt)
   Stress ulcer: H2 blocker
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Respiratory Failure, renal failure
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   Feels well this Am, no complaints
   24 Hour Events:
   Chest pain with HD yesterday - resolved spontaneously
   History obtained from [**Hospital 85**] Medical records, icu team
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Heparin Sodium - 1,100 units/hour
   Other ICU medications:
   Other medications:
   per icu resident note
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fever
   Cardiovascular: No(t) Chest pain
   Respiratory: No(t) Dyspnea
   Gastrointestinal: No(t) Abdominal pain
   Genitourinary: Dialysis
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2128-2-3**] 11:28 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 80) bpm
   BP: 114/64(76) {105/51(61) - 130/85(96)} mmHg
   RR: 21 (15 - 27) insp/min
   SpO2: 99%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
   CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    915 mL
                                                                    233 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    675 mL
                                                                    233 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    205 mL
   Urine:
                                                                    300 mL
                                                                    205 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    615 mL
                                                                     28 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 99%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General Appearance: No acute distress
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Loud), mechanical S2
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender
   Extremities: Right lower extremity edema: Trace, Left lower extremity
   edema: Trace
   Skin:  Warm
   Neurologic: Attentive, Follows simple commands, Responds to: Not
   assessed, Movement: Not assessed, Tone: Not assessed, pleasant,
   conversive
   Labs / Radiology
   11.6 g/dL
   290 K/uL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   Assessment and Plan
 HYPERGLYCEMIA
 ANEMIA, OTHER
 BACTEREMIA
 HEMOPTYSIS
 PNEUMONIA, [**Hospital 57**] HOSPITAL ACQUIRED (NON-VAP)
 ENDOCARDITIS, BACTERIAL
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name **])
 HYPOXEMIA
 HYPOTENSION (NOT SHOCK)
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   1. Respiratory Failure: Extubated and doing well.  Cont cefepime
   2. Renal failure: HD per renal.  Cont steroid taper.
   3. DAH: Steroids as above --> CXR improving
   4. Complete Heart Block/Afib: Cont heparin gtt. Temp wire in place.
   5. MSSA bacteremia: Cont vanco
   Reaminder of issues per ICU team.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots(Systemic anticoagulation: Heparin gtt)
   Stress ulcer: H2 blocker
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 76-year-old male with a complex medical history, including coronary artery disease, post-cardiac bypass surgery, and mechanical aortic valve replacement. He is currently admitted to the ICU with multiple comorbidities, including:

1. Respiratory failure: The patient has been extubated and is doing well, but is still at risk for respiratory complications.
2. Renal failure: The patient is managed with continuous venovenous hemofiltration (CVVH) and may require hemodialysis (HD) starting today.
3. Dialysis-associated hemolytic anemia (DAH): The patient's anemia is likely secondary to AIN and is currently stable off extubation.
4. Leukocytoclastic vasculitis: The patient has vasculitis on his legs, which is improving.
5. Bacteremia: The patient has MSSA bacteremia, which is being managed with vancomycin.
6. Complete heart block/Atrial fibrillation (AFib): The patient has a temporary wire in place, and is being managed with heparin.
7. Hypertension: The patient's blood pressure is elevated, but is being managed with antihypertensive medications.
8. Hyperglycemia: The patient's glucose levels are elevated, but are being managed with insulin.
9. Hypoxemia: The patient's oxygen saturation is normal, but is at risk for hypoxemia due to his underlying lung disease.
10. Hypotension: The patient's blood pressure is low, but is not in shock.

Potential medical complications that can arise include:

1. Pneumonia: The patient has a history of pneumonia and is at risk for developing pneumonia again.
2. Sepsis: The patient has bacteremia and is at risk for developing sepsis.
3. Acute kidney injury (AKI): The patient's renal function is impaired, and AKI can occur if not managed properly.
4. Cardiac arrhythmias: The patient has AFib and is at risk for developing other cardiac arrhythmias.
5. Bleeding: The patient is at risk for bleeding due to his anticoagulant therapy and recent surgery.
6. Infection: The patient has a history of infections and is at risk for developing new infections.
7. Respiratory failure: The patient's respiratory function is impaired, and he is at risk for developing respiratory failure again.
8. Hypovolemic shock: The patient's blood pressure is low, and he is at risk for developing hypovolemic shock if not managed properly.

Overall, the patient's complex medical history and multiple comorbidities make him at high risk for developing various medical complications. Close monitoring and management are necessary to prevent and treat these complications."
